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Abstract 
TP228 is a large low copy number plasmid harbouring the parFGH partition 
cassette. The centromere-like site parH is located upstream of the parFG genes. ParF 
is a Walker-type ATPase of the ParA superfamily.  ParG is a centromere binding 
protein and a transcriptional repressor of the parFG genes. ParF associates with 
ParG bound to parH forming the segrosome complex. It has been recently observed 
that ParF oscillates over the nucleoid in the presence of the entire parFGH system 
and oscillation is responsible for plasmid segregation. ParG is a dimeric protein: 
each monomer consists of a folded ribbon-helix-helix  domain and an unstructured 
N-terminal tail. ParG enhances ParF ATPase activity and promotes ParF self-
assembly through its flexible N-terminus.  
 
In the present study, the role of the ParG N-terminus in plasmid partition was 
dissected. Residues crucial for plasmid partition were identified and found to form 
three clusters within the tail. One cluster is located at the extreme tip of the N-
terminus that is the most flexible region. The second cluster is present in a linker-
type region around amino acids 11-12-13 and the third is positioned in the arginine 
finger loop. When ParG mutant proteins were purified and characterised, they were 
all found to be efficient in DNA binding, transcriptional repression and in enhancing 
ParF polymerization. However, all the ParG mutants were impaired in stimulating 
ParF ATPase activity. Alteration of the residues in the tip and linker region resulted 
into a weaker interaction with ParF. The mutants were further investigated by using 
confocal and super resolution microscopy to visualize protein and plasmid 
positioning in the cell. Time-lapse experiments showed plasmids were static over 
time and that ParF oscillation over the nucleoid was abolished in the presence of 
mutant proteins. All the three clusters of the N-terminal tail are responsible for 
stimulating ParF ATPase activity and failure to do so may lead to lack of ParF 
oscillation. It is possible that the residues in the ParG N-terminus are strategically 
placed to carry out interaction and activation functions towards the common goal of 
coordinated interplay with ParF for efficient plasmid segregation. The data indicate 
that, a functional ParG N-terminal tail is a prerequisite for ParF oscillation and 
plasmid segregation. Based on these findings, a novel plasmid partition model is 
proposed which may apply to ParA-mediated partition in other plasmid systems. 
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1.1 Plasmids 
Plasmids are extra-chromosomal genetic elements (Lederberg, 1952) present mostly 
in bacteria and some lower eukaryotes. Most plasmids are double-stranded circular 
entities, which are physically separated from the host chromosome. Plasmids are not 
essential for the growth of the host under normal conditions, so they can be 
accommodated or removed from the cell without any lethal effect (Clowes, 1972). 
Plasmids can be divided into conjugative and non-conjugative types. Conjugative 
plasmids encode tra genes that can induce conjugation and the transfer of plasmids 
to bacteria. There are various types of plasmids depending upon the functions. R 
plasmid encodes antibiotics, F plasmid facilitates transfer of chromosomal DNA, col 
plasmid produces bacteriocin and the virulence plasmid causes diseases in its host. 
Plasmids sizes range from 1 to 1000 kilobase pairs (kbp). Plasmids also vary in their 
copy numbers. Low copy number plasmids like P1 and F are maintained at one to 
two per cell whereas in medium to high copy number plasmids like ColE1 over 50-
100 copies per cell are found. Plasmids exhibit organized and independent 
replication machinery and are stably transferred to the daughter cells. The plasmid 
has to replicate its DNA once per cell cycle to transfer its copy to the daughter cells 
on cell division. Irrespective of its independent replication system, plasmids also use 
host components during replication. 
 
1.2 Multidrug resistance plasmids 
Among the many interests in the study of plasmids, one is the fact that plasmids are 
small and relatively simple in their genetic composition and can be easily modified 
and used in recombinant DNA technology. Another important feature of plasmids is 
their ability to confer crucial properties like virulence and antibiotic resistance to 
bacteria. Concern about antibiotics resistance was imminent since the discovery of 
penicillin in 1928, but a marked increase in this phenomenon has been seen in the 
last three decades. Antibiotics act on bacteria by using different modes like 
impairing or inhibiting cell wall synthesis, protein synthesis and targeting the DNA 
(Neu, 1992). Resistance to antibiotics can be developed through different 
mechanisms, for example, by utilizing changes in bacterial chromosomes and/or 
more rarely, by changing expression of some of the chromosomal genes. Another 
method is by acquisition of mobile genetic elements such as transposons, which can 
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integrate in the chromosome and can harbour resistance genes. But the most widely 
occurring mode is the presence of drug resistant plasmid (Johnson and Nolan, 2009). 
Plasmids can transfer the resistance laterally or horizontally i.e. intra and inter 
transfer both in species and genera is widely seen (Carattoli, 2009) and is found in 
Gram-positive as well as Gram-negative bacteria. Plasmid mediated resistance is 
observed in a number of antibiotic classes ranging from β-lactams (e.g. penicillin, 
ampicillin and cephalosporin), amino glycosides (e.g. gentamycin), various 
tetracycline drugs, macrolides and chloramphenicol (Williams and Hergenrother, 
2008). The presence of antibiotic selective pressure for longer duration in bacterial 
environment results in emergence of drug resistance. Increase in the prevalence of 
drug resistance may be attributed to various factors such as generous use of 
antibiotics, inconsistent prescription practices among physicians worldwide, patient 
demands for antibiotics in viral illness and extensive utilization of antibiotics in 
animal feeds. The study of the drug resistance plasmid has thus becomes a very 
important approach to control infection. These studies will help to devise a strategy 
for restraining the occurrence of drug resistance and reduce the limitation of 
antibiotic chemotherapy. 
 
1.3 Plasmid replication  
Similar to chromosome, plasmids also contain an origin of replication, ori which is a 
cis-acting region where replication starts and proteins involved in replication bind 
(Bramhill and Kornberg, 1988). Most of the plasmids employ Rep proteins which 
are specific to the plasmid origin and which are encoded on plasmid DNA (Actis et 
al., 1999). The Rep protein has two motifs, a leucine zipper like (LZ) motif for 
protein-protein interaction which regulates monomer-dimer equilibrium and a DNA 
binding helix-turn-helix motif (HTH) (Garcia de Viedma et al., 1996, Garcia de 
Viedma et al., 1995b). Rep protein along with the ori region also binds to the 
inverted repeats of the rep promoter region where it acts as an auto-regulator (Garcia 
de Viedma et al., 1995a). There are three general mechanisms involved in plasmid 
replication which are theta, rolling circle and strand displacement (del Solar et al., 
1998).  
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The system under investigation in this project is of plasmid TP228. The partition 
cassette parFGH of plasmid TP228 is cloned into a vector pFH450. This vector 
contains two origins of replication i.e. P1 for low and pMB1 for medium copy 
number. P1 and R2 exhibit theta type replication (Kiewiet et al., 1993). P1 type ori 
sites contain directly repeated sequences, termed iterons. Iterons mediated 
replication is established in many unit or a low copy number plasmid replicons. 
Iterons contain binding sites for the plasmid-encoded Rep proteins and have 
properties essential for plasmid replication and its control. Plasmid P1 replication is 
dependent on the initiator protein RepA and the chromosome encoded DnaA protein. 
RepA-DNA binding is stimulated by heat shock chaperones. The heat shock 
chaperons convert RepA dimers into monomers and activate monomeric RepA, 
which recognizes the iterons in the ori site and results in wrapping of the DNA 
around RepA. DnaA melts the DNA and stimulates the RepA-DNA binding. DnaB 
favourably loads on to one of the DNA strands and replication proceeds into the 
unidirectional mode. Efficient replication of P1 requires adenine methylation of the 
five GATC sites of the origin (del Solar et al., 1998). The pMB1 origin of replication 
is similar to ColE1 type, which is extensively studied. Replication of ColE1-type 
plasmids is commenced at a distinctive ori site and unlike other plasmid families, 
instead of plasmid-encoded protein for replication initiation; ColE1 requires the host 
encoded DNA Polymerase I (PolI), RNA polymerase and ribonuclease RNase H. 
During the replication process upstream of ori region synthesis of an RNA molecule, 
called RNA II is occurred first. This RNA II extends from its initiation and its 3' end 
forms a duplex with the template plasmid DNA. RNase H, which digests the RNA II 
at the replication origin, recognizes RNA II-DNA duplex and generates free 3'-
hydroxyl group which acts as primer for DNA synthesis. Once PolI begins the DNA 
strand synthesis, RNase H digests the remaining part of RNA II, which is still 
complexed to the template DNA. ColE1 DNA replication proceeds unidirectionally 
in the θ-shaped manner with the initiation of the lagging strand synthesis at specific 
ColE1 sites (Actis et al., 1999). 
 
1.4 Plasmid maintenance  
After replication, the plasmid copy has to be transferred to the daughter cell stably. 
There are a number of mechanisms utilised by plasmids to carry out effective 
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transfer of plasmid copies. Medium to high copy number plasmids are usually 
transferred to daughter cells by passive diffusion to avoid mis-segregation of 
plasmids. At the replication level, the copy numbers are maintained for stability. The 
addiction system, which involves the toxin-antitoxin (TA) encoding genes, helps to 
kill daughter cells that lack plasmids. Virulence and antibiotic resistance genes 
encoded by plasmids, force bacteria to retain plasmids for survival. Most 
importantly, plasmids also harbour dedicated partition mechanisms to ensure their 
stable inheritance. Importantly, all these mechanisms provide potential targets to 
fight bacterial infection.  
 
1.4.1 Replication control 
It is important for plasmid stability that the copy number is maintained at its standard 
level. Plasmid copy numbers are controlled at the replication level by two 
mechanisms, antisense RNA and DNA iterons (Actis et al., 1999). Antisense RNA 
controls the replication either by keeping Rep protein synthesis in check or by 
reducing the RNA primer activity. In plasmid R1, CopA which is antisense RNA 
interacts with CopT, an mRNA for Rep protein and thus produces inhibition of the 
Rep protein synthesis (Blomberg et al., 1990). Whereas in the plasmid ColE1 (in 
which antisense RNA was discovered for the first time) the antisense RNA I 
interacts with the RNA primer, RNA II, and the duplex formed inhibit initiation of 
replication (Lacatena and Cesareni, 1981). Iterons are repeated sequences present 
within the plasmid replicons and are found in a variety of plasmids. Rep proteins 
interact with iterons and exhibit negative control on replication. In plasmid P1, the 
copy control locus incA contains iteron. When bound to incA, RepA is proposed to 
create a steric hindrance at origin of replication, oriR which leads to a negative effect 
on replication (Abeles et al., 1995). 
 
1.4.2 Multimer resolution system 
Homologous recombination in circular DNA gives rise to dimers during the 
crossover process and the multimerization of DNA can cause plasmid instability also 
called as “dimer catastrophe” (Summers et al., 1993). The site-specific 
recombination system has been shown to act on the dimers to convert them to 
monomers and thus helps in maintaining plasmid copy number (Sherratt et al., 
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1984). These multimer resolution systems are found in both high and low copy 
number plasmids (Summers and Sherratt, 1984). In multi-copy plasmids like ColE1, 
the host encoded recombinase proteins XerCD act on plasmid cer (resolution) site to 
convert dimers into monomers. The low copy number P1 plasmid is efficiently 
maintained owing to its loxP-cre site-specific recombination system. P1 Cre 
recombinase mediates the site-specific recombination between two loxP sites on 
dimer (Austin et al., 1981). 
 
1.4.3 Toxin-antitoxin system 
Plasmid maintenance is also ensured by the toxin-antitoxin system, which is also 
referred to as post-segregational cell killing or addiction system. The principle 
behind this mechanism is that bacterial cells are killed due to the deleterious effects 
of plasmid removal. The TA system is based on two components; one is a toxin 
gene, which encodes a stable protein, and the other encodes an antitoxin. If plasmid-
free cells are generated because of any error, the TA complex is still transferred to 
the bacterial cell. The toxin can cause detrimental effect on bacteria as the 
neutralising antitoxin is short lived and the source of antitoxin is removed in the 
plasmid-free environment (Hayes, 2003). TA cassettes are classified into five types 
(Hayes and Kedzierska, 2014). In type I TA system, small but stable protein acts as a 
toxin whereas antisense RNA is the antitoxin. In type II TA system, both toxin and 
antitoxin are small proteins but toxin protein is stable and antitoxin is labile. In type 
III, RNA acts as an antitoxin and directly interacts with the toxin protein. In type IV, 
both toxin and antitoxin are proteins but antitoxin prevents toxin from binding to its 
target. In the last type of TA system, mRNA acts as a toxin on which antitoxin 
protein acts in the form of ribonuclease and impair the mRNA synthesis. Type I and 
II TA systems are widely present in the prokaryotes. Plasmid R1 exhibits both types 
of TA systems. The hok-sok system encoded by parB locus is a type I system in 
plasmid R1 where the expression of toxin Hok (host killing) is repressed by the 
antitoxin antisense RNA sok (suppressor of killing) (Gerdes et al., 1986). The parD 
(kid, kis) locus of plasmid R1 is type II TA system. The toxin Kid is an 
endoribonuclease which is neutralised by the unstable Kis protein (Diago-Navarro et 
al., 2010). Plasmid F also shows type II TA system, ccd in which the toxin CcdB 
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inactivates DNA gyrase, which leads to DNA lesions and cell death (Critchlow et al., 
1997).  
 
1.4.4. Active plasmid partition system 
For low copy number plasmids, it is extremely important that the replicated plasmid 
copies be transferred to the daughter cells with the highest precision. Extensive work 
carried out recently in the field of plasmid research contradicts the long standing 
notion that passive transfer is sufficient for plasmid maintenance from one 
generation to the next. It is now established that plasmid segregation is an active 
process and utilises a dedicated partition system (Nordstrom and Austin, 1989). A 
typical par system contains cis-acting centromere sequences and two partition genes 
parA and parB. The plasmid partition system is the basis of this study and will be 
discussed in detail with respect to all its aspects in the following sections.  
 
ParAB-parS system has also been implicated in bacterial chromosome segregation 
(Reyes-Lamothe et al., 2012). ParAB-parS partition system in C. crescentus is 
essential for viability. Chromosomal par systems function similarly to plasmid par 
system. 
 
1.5 Plasmid partition systems 
Partition systems are indispensable for segregation of low copy number plasmids. 
Partition systems are composed of three components, a cis-acting centromere-like 
partition site, a Walker or an actin or tubulin type NTPase and a centromere binding 
protein (CBP) (Hayes and Barillà, 2006b). The centromere-like site performs its 
function similarly to the eukaryotic centromere, where a partition complex forms. 
The partition genes generally designated as parA and parB, are usually present in the 
same operon and one of the partition proteins act as auto-regulator of this operon 
(Mori et al., 1989). It is very important to control the transcription of partition genes 
for plasmid stability. The plasmid partition system also serves as incompatibility 
determinants as plasmids with similar partition sites cannot co-exist (Austin and 
Nordstrom, 1990). In 1983 Austin and Hiraga groups reported the partition 
mechanism of P1 (ParABS) and F plasmid (SopABC) respectively (Austin and 
Abeles, 1983);(Ogura and Hiraga, 1983). Subsequently in 1986 the Gerdes group 
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reported the characterization of partition locus of R1 plasmid (ParMRC) (Gerdes and 
Molin, 1986). These initial studies into active partition systems were instrumental in 
the field of low copy number plasmid segregation. Depending on the differences 
between ATPase, plasmid partition systems can be classified into four different types 
(Schumacher, 2008). 
 
1.5.1 Type I 
Type I partition system exhibits a Walker-type ATPase and is further divided into 
two subtypes, Ia and Ib. There are a number of differences between Ia and Ib 
systems with respect to the position of centromere, length of ParA and ParB proteins 
and mode of transcriptional repression (Schumacher, 2008). Type Ia has centromere 
downstream of the par operon and type Ib shows the centromere upstream of the par 
operon. Type Ia ParA proteins (around 251-420 residues) and ParB proteins (182-
336) are longer compared to Ib ParA proteins (208-227 residues) and ParB proteins 
(46-113 residues) (Schumacher, 2008). ParA proteins of type Ia also act as a 
transcriptional repressor. This is attributed to their HTH motif at the N-terminal end 
(Schumacher, 2007). In type Ib systems, instead of ParA proteins, ParB proteins act 
as transcriptional repressors. Type I ParB proteins do not show any sequence 
homology with each other. CBPs of Ia are complex and usually contain three 
domains i.e. NTPase binding (N-terminal), DNA-binding (central, HTH motif) and 
dimerization domain (C-terminal) (Schumacher, 2007). Type Ib CBPs, although not 
homologues by their amino acid sequences, show a common Ribbon-Helix-Helix 
(RHH) structural motif (Schumacher, 2007). 
 
1.5.1.1 Partition system of P1 plasmid 
P1 is a unit copy number E. coli plasmid. Partition cassette parABS is responsible for 
the stable segregation of plasmid P1. The centromere parS of P1 is around 80 bp and 
present downstream of the parAB genes (Figure 1.1). The parS site contains A boxes 
which are formed by four hexamers and B boxes, formed by two heptamers present 
at two different locations on the DNA and the DNA binding protein ParB recognises 
both these motifs (Martin et al., 1987). The parS site is made available for ParB by 
the action of Integration Host Factor (IHF) on parS. For efficient P1 plasmid 
partitioning, the spacing between A and B boxes and IHF is crucial (Hayes et al., 
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1994). IHF introduces a bend in parS site on binding to its recognition site and by 
doing this it facilitates the binding of ParB to the A and B box across the bend of 
each arm (Hayes and Austin, 1994). IHF and ParB binding at parS is cooperative as 
they increase each other’s affinity to the parS site by modifying protein-DNA 
interactions. In the resultant partition complex, parS wraps around the ParB-IHF 
core (Funnell, 1991). ParB binds to parS site as a dimer. ParB contains three 
important regions- HTH domain, a flexible linker and a dimerization domain 
(Schumacher and Funnell, 2005). ParB dimerization domain is made up of 
antiparallel sheet and coiled-coil structure. ParB binds to hexamer and heptamer 
motifs in various combinations, hence the A and B boxes incorporate more ParB 
dimers or pairing of adjacent plasmids (Vecchiarelli et al., 2007). ParB dimers load 
on parS site and ParB-ParB and ParB-DNA interactions lead to the formation of a 
large nucleoprotein complex (Bouet et al., 2000). ParA, a Walker-type ATPase does 
not bind directly to parS DNA but is recruited by ParB to form a segrosome. ParA 
structure contains N-terminal region, HTH motif and the large C-terminal domain for 
the interaction with ParB (Dunham et al., 2009). The ParA N-terminus contains a 
DNA binding HTH domain which promotes association with the operator and thus 
acts as transcriptional repressor (Dunham et al., 2009). ParB also enhances this 
repression activity. ParA performs various functions depending upon its NTP bound 
form. ParA-ADP is required for parAB operon repression (Davis et al., 1992) 
whereas ParA-ATP is responsible for dimerization (Davey and Funnell, 1994), and 
interaction with ParB (Bouet and Funnell, 1999). ATP hydrolysis by ParA is 
essential for segregation and is also responsible for controlling ATP-ADP switch. 
ParA binds to non-specific DNA and the ATP-bound form is required for this 
activity (Vecchiarelli et al., 2010). The intracellular studies of the P1 partition 
proteins showed that ParB forms foci when it is bound to the parS site on plasmid 
and ParA is required for the movement of plasmid to the cell quarter position (Li and 
Austin, 2002b). Plasmids harbouring ParB mutations were seen as a stagnant foci at 
the midcell position and produced division defects in the cell. It is possible that the 
plasmid segregation is linked to the cell division (Li and Austin, 2002a). Contrary to 
the ParB foci, ParA was found to be diffuse indicating that it is not directly bound to 
the plasmid (Erdmann et al., 1999). 
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1.5.1.2 Partition system of F plasmid 
The E. coli F plasmid is a low copy number plasmid and contains stability of 
partition (sop) cassette sopABC of type Ia. The centromere sopC site is located 
downstream of sopAB genes and contains 12 repeats of 43 bp sequences (Figure 1.1) 
(Austin and Abeles, 1983). Each of the 12 repeats contains 7 bp inverted repeats. 
SopB recognises the repeats in sopC and binds to it as a dimer to form a partition 
complex. The sopC in F plasmid and parS in P1 plasmid are different in sequence 
and their organisation indicating that the partition complexes formed by them are 
different. When bound to sopC, SopB wraps around DNA in a right-handed coil and 
thus induces overall relaxation of supercoils in F plasmid. The ParB homologues in 
type Ia partition loci have low sequence similarity but many of them use HTH 
domain for the DNA binding indicating that even though ParBs recognise different 
centromere motifs they may employ similar structural domains for DNA binding. A 
single repeat in the sopC is sufficient for the F plasmid partition (Biek and Shi, 
1994). SopB binding to the single repeat in sopC serves as a nucleating core to 
which many SopB dimers bind to form a large partition complex (Mori et al., 1989). 
The SopA is a Walker-type ATPase and binds to SopB to form segrosome at sopC. 
SopA also acts as an auto-repressor of sopAB operon and binds to the four repeats 
within the sopAB promoter region (Mori et al., 1989). The ATP binding motif of 
SopA is important for partition and mutations in this domain change the integrity of 
Walker motif and results in partition defects (Libante et al., 2001). SopA-ATP 
complex undergoes polymerization and shows long filaments. SopA polymerization 
is inhibited by DNA (Bouet et al., 2007). It has been demonstrated by intracellular 
studies that the SopA filaments extend proportional to the rate of plasmid partition. 
In the presence of SopB-sopC complex, SopA polymers radiate out, a feature which 
resembles the mitotic spindle in eukaryotes (Lim et al., 2005). SopA was shown to 
oscillate from pole to pole at nucleoid tip and thus place the plasmid at required 
position for the segregation. An alternative model for F plasmid partition was also 
proposed which relies on the SopA gradient and is described in section 1.9.1.1 later 
in this chapter.  
 
1.5.1.3 Type Ib partition systems 
The Agrobacterium tumefaciens plasmid pTAR contains parABS partition cassette of 
type Ib. The partition genes parAB are situated downstream of the pTAR parS site 
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(Figure 1.1). The ParA protein is a Walker-type ATPase (222 residues) and ParB (94 
residues) is a centromere binding protein. ParB acts as a transcriptional repressor and 
ParA augments this function (Kalnin et al., 2000). Plasmid pSM19035 of 
Streptococcus pyogenes harbours δ/ω/parS partition cassette of type Ib. The parS site 
in pSM19035 is made up of six separate DNA sequences. The downstream par locus 
encodes two trans-acting genes δ and ω. Protein δ is Walker-type ATPase. Protein ω 
is CBP and a transcriptional repressor (Pratto et al., 2008). The focus of this study is 
the partition locus of plasmid TP228 which is type Ib partition cassette and discussed 
in detail later in this chapter. 
 
1.5.2 Type II 
In the type II segregation cassette, the ATPase protein, ParM, belongs to the 
actin/Hsp70 superfamily. The partition site parC is located upstream of the par 
operon. The type II partition system is similar in organization to type Ib. The 
plasmid R1 is a well-studied example of the type II system. The centromere binding 
protein, ParR acts as a transcriptional repressor. The ParM proteins are 276-336 
amino acids long whereas ParR proteins are small and range between 46-120 
residues.  
 
1.5.2.1 Partition system of R1 plasmid 
The partition cassette parMRC of plasmid R1 encodes for ParM, an actin type 
ATPase and ParR, a centromere binding protein (Jensen and Gerdes, 1997). The 
centromere site parC is located upstream of parMR genes and comprises 5 tandem 
repeats of 2 sets of 10 bp sequences (Figure 1.1). The centromere site also contains 
the promoter sequence for parMR operon. ParR acts as a transcriptional repressor of 
parMR operon (Moller-Jensen et al., 2007). ParR binds to parC and forms the 
partition complex. ParR dimerization might be responsible for the plasmid pairing 
which is proposed to be the first step in plasmid segregation (Moller-Jensen et al., 
2007). Plasmid pairing increases in the presence of ParM-ATP complex. ParM is a 
member of the actin superfamily of proteins and eukaryotic actin and the bacterial 
MreB are members of this family. ParM forms double helical protofilaments similar 
to F-actin (van den Ent et al., 2002). But in contrast to F-actin, ParM filaments have 
a left handed twist and exhibit bidirectional growth. When bound to ATP ParM 
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undergoes polymerization. ParM can also bind to GTP and its GTPase activity is 
more efficient than the ATPase activity (Popp et al., 2008). The short and unstable 
ParM filaments, present throughout the cell get stabilised by the ParR-parC 
complex. The ParM polymers extend by addition of ParM-ATP complex to the 
stabilised ParM filaments. This process is called insertional polymerization and 
mediates  the  movement  of  plasmid  towards  the  pole  (Moller-Jensen et al., 
2003). ParM depolymerizes, plasmid is  diffused  back  into  the cell and  other ParM    
polymers capture them. This process continues till the plasmid segregation.  
 
1.5.3 Type III 
The type III partition system was recently identified and a few plasmids of Bacillus 
species exhibit the partition cassette of type III. The main characteristic of this type 
is the nucleotide binding protein TubZ, which is part of the tubulin/FtsZ GTPase 
superfamily (Ni et al., 2010). An example of the type III system is plasmid pBtoxis 
in Bacillus thuringiensis (Tang et al., 2007). The partition site tubC contains four 12 
bp pseudo-repeats. The TubR encoding gene is found downstream in the par locus 
and TubZ is found downstream (Figure 1.1). TubR is a DNA binding protein with no 
sequence homology with any other CBP. TubR structure contains HTH motif and 
acts as a transcriptional repressor of tubRZ genes. The TubZ protein, a GTPase, 
shows GTP dependent polymerization and the polymers formed appear tubulin-like 
(Larsen et al., 2007). 
 
1.5.4 Type IV 
The Type IV partition system is most unusual as it contains only one par gene for 
plasmid stabilization. It was proposed that this single protein plays the role of both 
centromere binding protein and motor protein. The plasmid pSK1 of Staphylococcus 
aureus is the example of type IV (Simpson et al., 2003). The Par protein (245 
residues) of pSK1 performs the segregation function and in the par operon no other 
gene was identified. The Par protein possibly contains an HTH motif and coiled-
coiled domain as predicted by structural studies. The N-terminal HTH motif may 
help in binding the centromere, whereas the central coiled-coiled domain may play a 
role in polymerization (Schumacher, 2008).  
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Figure 1.1. Organization of partition loci in various plasmid systems.  
Partition genes shown in green are either Walker-type ATPase or actin or tubulin homologues. Centromere binding protein encoding genes are shown in red. 
The centromere sites containing repeated sequence are shown as grey arrows. P1 centromere site is complex, it contains hexamer (purple) and heptamer 
(yellow) repeats and an Integration host factor (IHF) binding site (blue). Adapted from (Hayes and Barillà, 2006b). 
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1.6 Partition system of plasmid TP228 
This project involves the study of the molecular mechanisms and dynamics of the 
segregation of the multidrug resistance plasmid TP228 in E. coli. Plasmid TP228 
was originally isolated from Salmonella newport and confers resistance to a wide 
range of antibiotics such as aminoglycosides, tetracycline, sulphonamide and some 
metal ions. Plasmid TP228 falls under the IncX1 incompatibility group. It harbours a 
well-studied partition system, ParFGH of type Ib, in which ParF is a Walker-type 
ATPase and ParG is a centromere binding protein (Hayes, 2000). These two trans-
acting proteins are assembled on the cis-acting parH centromere site. ParG was 
shown to bind to the DNA region upstream of the parF gene which was speculated 
to contain the partition site (Barillà and Hayes, 2003). Later on, it was revealed that 
this site contains repeat elements and part of this region also acts as an operator 
(Carmelo et al., 2005). ParG binds to both the centromere and the operator site. 
Thus, ParG acts as the transcriptional repressor of the putative parFGH operon. 
ParF, on ATP binding, undergoes polymerization (Barillà et al., 2005). ParG binds to 
parH and then recruits ParF in this complex to form a segrosome. The typical 
organization of the TP228 partition system is shown in Figure 1.2A. 
 
1.6.1 Centromere site parH 
In eukaryotes, the centromere is a region to which mitotic spindle-like microtubules 
associate. It is part of the chromosome and is known as the primary constriction site. 
Cell division fails to progress properly in the absence of the centromere and leads to 
chromosome instability. In bacteria, like the origin of replication, the centromere site 
is also speculated to be present as a single copy per chromosome. Although the B. 
subtilis has multiple parS sites. In plasmids, centromere site provides the foundation 
to which ParB proteins bind and form the partition complex known as segrosome. 
Plasmids exhibit diverse centromeres, which are variable in sequence, positioning, 
numbers, lengths and direction (Hayes and Barillà, 2006a). Centromere sites are 
specific for each partition system and are optimised to ensure that the ParB proteins 
from the same partition system bind to them (Hayes and Austin, 1993). The 
centromere site is present downstream of the two partition genes in case of the large 
parA operons, and upstream of the genes for the small parA operons. 
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The DNA sequence upstream of the parF translation start codon contains direct and 
indirect repeat motifs. During initial efforts to study the region upstream of the 
parFG genes, the 80 bp DNA sequence immediately upstream of parF gene was 
analysed. An inverted repeat (IR) was identified in this region, which consisted of 
imperfect 16 bp half-sites separated by a 4 bp spacer. These 16 bp half-sites were 
shown to be the operator site for the parFG genes (Carmelo et al., 2005). Subsequent 
analysis of this region showed that the operator site (OF) consists of 8 tetramer 
repeats 5’-ACTC-3’ (three direct and five inverted) separated by AT-rich 4 bp 
spacers (Zampini et al., 2009). ParG does bind a single tetramer box of 5’-ACTC-3’ 
but two adjacent tetramer boxes are required to form a nucleoprotein complex. Thus 
the entire operator site is coated by eight ParG dimers (Zampini et al., 2009). Recent 
analysis examining regions further upstream of OF site revealed that the DNA 
sequence about 160 bp upstream of parF translation start codon contains in total 20 
direct and indirect repeat motifs of 5’-ACTC-3’ separated by 4 bp AT-rich spacers 
(Figure 1.2B). A boundary between the partition site and operator site in this region 
was drawn. Out of the 20 repeats, eight repeats adjacent to the parF gene constitute 
the operator site and a cluster of 12 repeats further up from this site acts as the 
partition site of plasmid TP228, denoted as parH (Wu et al., 2011a). The partition 
site parH and the operator site, OF, are both able to act as a centromere, although the 
efficiency of operator site is more modest than that of the parH site (Wu et al., 
2011a). 
 
All the twelve repeats in the parH site (Figure 1.2C) are essential as the sequential 
deletion of tetramers reduces centromere function. Changes in the tetramers by 
inserting base variations did not show any adverse effect on the centromere activity, 
suggesting that the parH site is elastic in vivo (Wu et al., 2011a). Along with the 
invert repeats in the parH site, the spacers also play an important role for proper 
binding of ParG to the entire centromere. It was also reported that parH site lacks the 
intrinsic curvature found in other centromere sites (Wu et al., 2011a). The lack of 
bend in parH DNA avoids the centromere being locked in a fixed position. Thus 
during segrosome formation the centromere might become stretched and bind to 
ParG and ParF.  
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Figure 1.2. The parFGH segregation module. 
A. The TP228 plasmid partition cassette comprises two genes which encode a Walker-type ATPase ParF (green), a CBP, ParG (brown) and the centromere 
parH (blue), which is located upstream of the segregation locus. ParG binds to operator site and acts as a transcriptional repressor. ParG also assembles on 
centromere. The ParF is recruited into the segrosome by interactions with ParG. B. Organization of the partition site parH and operator site upstream of parF 
gene. The partition site is made up of 12 degenerate repeats, while the operator site contains 8 repeats. C. DNA sequence of partition site parH. 12 degenerate 
repeats of 5’-ACTC-3’ with AT rich spacers constitute the parH site of plasmid TP228. The repeats are boxed and denoted by arrows. The green arrows 
indicate direct repeats and the blue arrow represents the inverted repeat. 
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1.6.2 Walker-type ATPase ParF 
ParF, a 22 kDa protein, is a Walker-type ATPase and is a member of the ParA 
superfamily of plasmid and chromosome segregation proteins. Proteins that bind and 
hydrolyse nucleotides are crucial for various cellular processes. These proteins 
belong to several chain folds, for example the dinucleotide-binding fold and the 
related tubulin/FtsZ fold, the mononucleotide binding fold (P-loop NTPases), the 
protein kinase fold, the histidine kinases/HSP90/TopoII fold and HSP70/RNAase H 
fold (Leipe et al., 2002). Among these, P-loop NTPase are the most widespread. At 
the sequence level, the P-loop NTPase fold is characterized by the N-terminal 
Walker motif, which consists of a flexible loop. The loop typically adopts the 
sequence pattern GXXGXGK (a classic Walker A motif) whose function is to 
properly position the triphosphate moiety of a bound nucleotide (Walker et al., 
1982). The ParA superfamily of ATPases falls under the superclass of P-loop 
NTPases. The Walker A motif of this family is XKGGXXK, which is known as 
deviant motif as it differs from the classical motif (Koonin, 1993). ParA ATPases 
show a conserved lysine in the KGG motif, which interacts with the terminal oxygen 
atom of the β-phosphate group of ATP across the interface. The conserved lysine 
suggests that these proteins might be dimers (Lutkenhaus and Sundaramoorthy, 
2003). Deviant Walker A motif containing proteins are involved in various 
functions. MinD, a Walker-type ATPase, is involved in the correct placement of the 
cell division site in E. coli and is ubiquitous in bacteria. The ParA/Soj family 
ATPases are involved in chromosome and plasmid segregation.  
 
 34 
 
Figure 1.3. Structure of ParF.  
A. ParF monomer. Partition protein ParF of plasmid TP228 in the presence of ADP is a monomer. The secondary structures are labelled. The α-helices are 
aqua, β-sheets are purple and the loops are pink. B. ParF dimer. ParF in the presence of non-hydrolysable ATP, AMPPCP is a dimer (Schumacher et al., 
2012). ATP is shown as silver sticks. The structures were generated by using PyMol (DeLano, 2002). 
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Evolutionarily, ParF is more related to the MinD subgroup of cell division proteins 
than to the archetypical ParA proteins. ParF is shorter than ParA and does not have a 
DNA binding domain. ParF homologues are found in plasmids pTAR, pVT745 and 
pB171 (Machón, C., et al 2007). The deviant Walker A motif in ParF is 
PKGGSGKT and it is located at the N-terminal end (residues 9-16). In Walker-type 
ATPases, the less conserved Walker B motif is also present. In ParF, residues 73-83 
constitute the Walker B motif. Recently the crystal structure of ParF was solved in 
the presence of ADP and phosphomethylphosphonic acid adenylate ester (AMPPCP) 
(Schumacher et al., 2012). ParF is monomeric when in complexed with ADP and 
binding to ATP leads to dimerization. The ParF monomer is composed of seven β-
sheets and eight α-helices (Figure 1.3A). The lysine at position 10 from the ParF 
Walker A motif interacts with ATP across the interface and forms the dimers (Figure 
1.3B). ParF was shown to be able to self-associate and ATP binding promotes 
polymerization of ParF (Barillà and Hayes, 2003). Partner protein ParG further 
enhances this polymerization into extensive multi-stranded filaments (Barillà et al., 
2005). ADP is reported as a repressor of ParF polymerization. The cycle of ParF 
polymerization and depolymerization may drive the partitioning process in plasmid 
TP228. It has been reported that ParF-K15Q and ParF-G11V mutations in the 
Walker A motif failed to polymerize and are partition deficient, thus pointing at the 
connection of polymerization and partition (Barillà et al., 2005).  
 
1.6.2.1 ParF polymerization and its ultrastructure  
The crystal structure of ParF revealed a striking feature of ParF. The ParF-ATP 
complex formed linear ParF polymers within the crystals, with various cross-
contacts between ParF dimers (Schumacher et al., 2012). A patch of multiple proline 
residues (102-112) is responsible for one of the cross-contacts. This proline-rich 
motif from one unit is inserted next to the nucleotide binding pocket of another unit. 
The ‘dimer of dimers’ of ParF is shown to be the building block of the linear 
polymer (Figure 1.4A). The ParF polymer has two interfaces: interface 1 is created 
by contacts made by residue 61-71 with two separate groups i.e. residues 87-98 and 
residues 117-129 and interface 2 involves contact made by residues 49-60 and 168-
192.  
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The stages of ParF polymerization were previously investigated by negative-stain 
electron microscopy (EM). In the absence of ATP, purified ParF appeared as 
globular particles whose size ranges from 10 to 20 nm (Figure 1.4Bi) (Barillà et al., 
2005). When ParF was incubated with ATP, it quickly assembled into needle-like 
projections (~100 nm long) that soon appeared to increase in length (Figure 1.4Bii). 
One end of many of the polymers had an uneven, ravelled appearance, whereas the 
opposite end was more compact. Higher magnification images revealed a multi-
stranded ultrastructure of parallel proto-filaments (Figure 1.4Biii). High-
magnification EM images show that ParF fibres assembled in the presence of ParG 
are thicker and longer than those observed in its absence. 
 
Nucleotide-dependent polymerization by NTPases plays an important role in 
fundamental processes like cell division, which is essential for the survival and 
propagation of all living species. FtsZ is a tubulin-like protein that self-assembles 
into linear proto-filaments (termed as ‘thick filaments’) in a GTP dependent manner 
by the interaction of the plus end of one subunit with the minus end of another 
subunit, resulting in a head-to-tail geometry (Tonthat et al., 2011). The ParM protein 
encoded by the E. coli plasmid R1 represents a subfamily of bacterial actins. ParM 
assembles into two-stranded helical filaments in a nucleotide-dependent manner; 
these filaments are actin-like in structure, but exhibit the dynamic instability of 
eukaryotic microtubules. Polymerization of ParM between plasmids has been shown 
to drive plasmid separation; and ParM is required for the movement of replicated 
plasmids from mid-cell toward the cell poles (Moller-Jensen et al., 2003). ParA of 
the par2 locus of plasmid pB171 has been shown to form cytoskeletal-like structures 
that dynamically relocated over the nucleoid (Ringgaard et al., 2009). As some ParA 
proteins have shown polymerization properties and filament-like structure, they are 
indicated as the bacterial cytoskeleton apparatus.  
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Figure 1.4. ParF-AMPPCP complex leads to ParF polymerization and observed as 
filaments by EM.  
A. The linear ParF polymer is composed of dimer-of-dimer units. The ParF dimers and two 
polymer interfaces are denoted. The diagram is taken from (Schumacher et al., 2012). B. 
The EM images of ParF filaments. i. In the absence of ATP, ParF appeared as globular 
protein, indicated by white arrow heads. ii. In the presence of ATP (2 mM), ParF (2.16 µM) 
shows polymer formation. iii. ParF filaments are observed at higher magnification. Image is 
reproduced from (Barillà et al., 2005). 
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1.6.3 Centromere binding protein, ParG 
ParG is a 8.6 kDa centromere binding protein and present in monomer-dimer 
equilibrium in solution. ParG is unrelated to any of the ParB proteins. The ParG 
dimer consists of two highly interwined C-domains, which form a folded structure, 
and two mobile N-terminal tails (Figure 1.5) (Golovanov et al., 2003). Residues 34-
41 form a β strand, while 42-55 and 60-74 form two α helices thus giving rise to a 
ribbon-helix-helix (RHH) structure. In the dimer, each of the β strands forms an 
antiparallel β sheet structure and the four α helices are tightly packed together above 
the β sheet (Figure 1.5). The folded C-domains have a hydrophobic core formed by 
side chains of amino acid residues V37, V39, F41, K45, R48, F49, V64, L67, V68, 
W71 and L72 which are involved in ParG dimerization (Golovanov et al., 2003).  
The folded C-terminal domain is involved in three functions: 
1. Dimerization of ParG. 
2. DNA binding at the centromere and operator site. 
3. Interaction with the partner protein ParF and recruiting it to the segrosome 
complex.  
 
The N-terminal region present at the two ends of the dimer is a flexible tail 
consisting of amino acid residues 1-32. Two structural characteristics of the tail are: 
the presence of an arginine finger motif with an arginine at the 19
th
 position (Barillà 
et al., 2007) and the transient β structure formed by residues 23-29 (Carmelo et al., 
2005). The transient β structure interacts with the β sheet of the C-terminal domain, 
exhibiting an extended β sheet.  
 
1.6.3.1 Role of ParG as a centromere binding protein and transcription factor  
Most of the prokaryotic transcription factors have a HTH motif and previously it was 
assumed that the α-recognition helix from this motif is inserted into the DNA major 
grove. However, the structures of MetJ and Arc transcriptional repressor proteins 
have shown that their N-terminal β strand is positioned in the DNA major groove. 
These structures led to the identification of the new ribbon-helix-helix (RHH) 
superfamily of transcription factors (Knight et al., 1989). The positively charged 
amino acids like arginine and lysine from the β strand at the N-terminus in most of 
the RHH proteins make direct sequence specific contact to the nucleotide bases 
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(Schreiter and Drennan, 2007). Thus, the RHH superfamily is defined by the feature 
of DNA binding by β-strands, whereas the HTH superfamily members employ an α-
helix to contact DNA at the major groove (Aravind et al., 2005). The N-terminal 
residues of transcriptional repressors Arc and Mnt determine the operator binding 
specificity (Knight and Sauer, 1989). This functionally diverse protein superfamily 
regulates the transcription of genes that are involved in various cellular processes 
including cell division and control of plasmid copy number (Schreiter and Drennan, 
2007). Auto-repressors of the type Ia partition family contain N-terminal HTH fold, 
whereas type Ib, e.g. ParG, and type II, e.g. ParR, centromere binding proteins 
contain a RHH fold (Schumacher, 2008). Most of the RHH proteins form dimers of 
dimers upon DNA binding (Zampini et al., 2009).  
 
Like other RHH family members, ParG binds DNA by inserting a β ribbon i.e. the 
two β-sheets into the major groove (Figure 1.5). The residues R36, N38 and N40 
located on one side of the β strand from each monomer are implicated in making key 
interactions with DNA (Golovanov et al., 2003). ParG binds to the centromere parH 
and the operator site OF with equal efficiency. ParG binds differently to the sub-sites 
of partition site parH (Wu et al., 2011a). The tetramer motifs are responsible for the 
direct contact with ParG whereas the spacer boxes might confer stability to the ParG-
DNA complex. The AT-rich spacers might also be responsible for providing 
flexibility because of which ParG may be able to become associated as a dimer of 
dimers to coat the entire parH site. ParG binds to the eight repeats of the OF site and 
acts as a transcriptional repressor of the parFG genes. A detailed study of ParG 
binding to OF demonstrated that ParG binds with different affinities to the sub-sites 
of the operator DNA sequence. The operator site tetramers may have evolved with a 
sequence variation in inverted and direct repeats and different AT contents in the 
spacer boxes to form a well-organised nucleoprotein complex, which is necessary for 
transcription control of parFG (Zampini et al., 2009). 
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Figure 1.5. Structure of ParG dimer.  
ParG dimer- Two ribbons formed by the β-sheets (yellow) in antiparallel position and 4 α-
helices compactly arranged (red). N-terminal tails (green) are seen at the left and right side 
of the structure. The structure was generated by using PyMol (DeLano, 2002). 
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1.6.3.2 Importance of the ParG N-terminal flexible tail  
The ParG N-terminal domain is unstructured but still multifunctional. The N-
terminal truncated proteins Δ9 ParG, Δ19 ParG and Δ30 ParG have been 
instrumental to determine the importance of the N-terminus in various functions of 
ParG (Carmelo et al., 2005).  
The N-terminal flexible tail of ParG is involved in the functions described below: 
1. Partition site binding affinity of ParG is altered by the N-terminal end (Wu, 
M., et al 2011). The ParG deletion mutant proteins showed an increase in 
non-specific DNA binding. The transient secondary structure formed in the 
N-terminal region by residues 23-29 may provide additional contacts within 
the partition site conferring the specificity related to the DNA binding 
(Carmelo et al., 2005).  
2. ParG acts as a transcriptional repressor of the parFG operon and this function 
is modulated by the N-terminal end (Carmelo et al., 2005, Zampini et al., 
2009). The Δ19 and Δ30 ParG displayed weaker repression of the parFG 
genes, suggesting the requirement of a full-length tail for the regulation of 
parFG cassette.  
3. ATP triggers ParF polymerization and addition of ParG further enhances the 
polymerization. ParG might carry out this function by either bundling the 
ParF filaments or stabilizing the proto-filaments. The effect of ParG on ParF 
polymerization is independent of ATP. ParF mutants, defective in ATP-
induced polymerization, were shown to be responsive to ParG that was able 
to induce polymerization (Dobruk-Serkowska et al., 2012). In the absence of 
ATP, ParG flexible tails may help to wrap around the ParF monomers either 
on the same or parallel filaments to activate the polymerization process. The 
truncated ParG mutant proteins were shown to be unable to enhance ParF 
polymerization beyond the ATP induced polymerization. This indicated that 
the tail may help to arrange the ParF polymers into filaments (Barillà et al., 
2007). This behaviour is similar to that of formin-like factors which act on 
eukaryotic actin or microtubule-like protein which regulate tubulin kinetics.  
4. ParG augments the ATPase activity of ParF by around 30 fold (Barillà et al., 
2005). The arginine finger motif present in the ParG flexible N-terminal end 
has been demonstrated to be responsible to bring out the ATPase activation 
in ParF (Barillà et al., 2007). Interestingly Δ9 ParG also showed decrease in 
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the ATPase activation even though the first nine residues do not harbour the 
arginine finger motif. This provided key evidence for the crucial role for the 
entire N-terminal tail in stimulating ParF ATPase activity. 
 
1.7 Other ParF related Walker-type ATPases 
1.7.1 SopA protein of plasmid F 
The E. coli F plasmid has its own active segregation mechanism operated by the type 
Ia partition cassette sopABC (Mori et al., 1986). SopA is a Walker-type ATPase and 
homologous to ParA ATPase of the P1 plasmid. SopB contains an HTH motif and is 
a centromere binding protein. SopA interacts with SopB and sopC. Excess of SopA 
showed destabilization of the plasmid, hence the role of SopA as a repressor of the 
sopAB operon is important for the segregation of plasmid F (Lemonnier et al., 2000). 
The N-terminal domain of SopA showed a putative HTH motif which confers 
specificity during promoter-operator binding (Ravin et al., 2003). The SopA-SopB 
interaction is also responsible for the proper regulation of the partition locus. The N-
terminal domain of SopB was demonstrated to be essential for the strong interaction 
with SopA (Kim and Shim, 1999). During an intracellular localisation study, SopA 
was also found to be localised on the nucleoid (Hirano et al., 1998). Mutation 
K120R, in the ATP-binding motif in SopA resulted in a lack of segregation (Libante 
et al., 2001). SopA showed ATP-dependent polymerization and DNA appeared to be 
the inhibitor of the polymerization process. SopB displayed an opposite effect to that 
of DNA and helped to further enhance SopA polymerization resulting in plasmid 
displacement and segregation (Bouet et al., 2007). Apart from binding specific DNA 
sequences at the centromere, SopB also demonstrated non-specific contacts, which 
bridge the DNA motifs in the centromere site. This way SopB spreads over the DNA 
and makes it unavailable to antagonise SopA polymerization (Schumacher et al., 
2010). The interaction of SopA with the non-specific DNA is attributed to the lysine 
residue at position 340. Mutation of this residue resulted in plasmid destabilization 
(Castaing et al., 2008). ATP-dependant non-specific DNA binding is also 
responsible for the ATP hydrolysis by SopA protein. The partner protein SopB also 
showed the stimulation of SopA ATPase activity by employing R36 of the arginine 
finger motif (Ah-Seng et al., 2009). Two different mechanisms are postulated for F 
plasmid segregation. The cycle of SopA polymerization and depolymerization may 
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shuttle the plasmid (Lim et al., 2005). On the contrary, it is also proposed that the 
SopA molecules form a concentration gradient and display a diffusion-ratchet 
mechanism for plasmid segregation (Vecchiarelli et al., 2013). 
 
1.7.2 ParA protein of plasmid pB171 
The E. coli plasmid pB171 has two partition loci, par1and par2. The par2 locus 
exhibits a type Ib partition system and the partition cassette encodes Walker-type 
ATPase ParA and centromere binding protein ParB (Ebersbach and Gerdes, 2001). 
ParB binds to the cis-acting centromere site parC2. ParA of pB171 is more related to 
MinD protein than to the ParA from P1 plasmid. ParA showed interaction with ParB 
protein. ParA protein also binds to both ATP and ADP. ATP binding results in ParA 
polymerization (Ebersbach et al., 2006). The intracellular study of fluorescently 
labelled ParA and ParB proteins showed that, the ParA-GFP protein localised to the 
nucleoid and in the presence of parC and ParB exhibited oscillation from one end of 
the nucleoid to the other (Ebersbach and Gerdes, 2004). The ParA polymers 
appeared as spiral-shaped structures and are supposed to provide the force for 
plasmid segregation. Mutation in the Walker A box abolished the ParA oscillation 
and also altered the plasmid localisation in vivo. 
 
1.7.3 Chromosomal partition protein Soj of B. subtilis 
In Bacilus subtilis, the Soj and SpoOJ proteins are homologues of plasmid partition 
proteins, ParA and ParB respectively and responsible for chromosome segregation 
and sporulation (Ireton et al., 1994). Similar to ParA proteins, Soj also binds to DNA 
and acts as a transcriptional repressor of sporulation gene expression (Quisel et al., 
1999). The partner protein Spo0J binds to a number of parS sites clustered near the 
chromosome origin of replication oriC (Marston and Errington, 1999). Soj, a 
Walker-type ATPase, on ATP binding undergoes dimerization. Soj dimer binds to 
DNA non-specifically and form nucleoprotein filaments (Leonard et al., 2005). 
Spo0J stimulates the ATPase activity of Soj and the N-terminus of Spo0J is 
implicated in this role (Autret et al., 2001). The intracellular localisation study of the 
Soj protein showed that it forms nucleoid associated dynamic structures. The 
assembly and disassembly of Soj protein over the nucleoid is attributed to the ATP 
hydrolysis stimulated by Spo0J (Marston and Errington, 1999, Quisel et al., 1999). 
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Soj mutants do not show segregation defect, but Spo0J null mutants exhibit 
anucleate cells (Ireton et al., 1994).  
 
The crystal structure of Soj from the Gram-negative hyperthermophile Thermus 
thermophilus was solved in three different forms, opo, ADP-bound and hydrolysis 
deficient mutant D44A form (Leonard et al., 2005). The opo and ADP-bound forms 
of Soj are monomeric, whereas ATP-bound Soj is a dimer. Soj contains eight β-
strands, seven parallel and one antiparallel. These β-sheets form a twisted arch, 
twelve α-helices are located outside of the arch (Figure 1.6A) (Leonard et al., 2005). 
The lysine (K15) in Walker box binds ATP and forms a dimer. The α and γ 
phosphates of the ATP are stabilised by the lysine residues from each monomer. The 
ATP dependent dimer is a molecular switch where ATP binding facilitates DNA 
binding and the Spo0J mediated ATP hydrolysis lead to Soj relocation (Leonard et 
al., 2005).  
 
1.7.4 Cell division protein MinD of E. coli 
The MinCDE protein system is responsible for determining the position of the FtsZ-
ring in E. coli and facilitates selection of division site at mid-cell. MinD protein 
interacts with other two Min proteins i.e. MinC and MinE. MinD, a Walker-type 
ATPase dimerises in the presence of ATP and binds to MinC and the membrane 
(Lutkenhaus and Sundaramoorthy, 2003). The C-terminal amphiphathic helix of 
MinD is responsible for membrane binding (Zhou and Lutkenhaus, 2003). MinD 
binds to the membrane at the cell poles and recruits MinC that is an inhibitor of the 
Z-ring formation. MinE, on the other hand removes MinD from membrane by 
stimulating its ATPase activity and thus displaces MinC from MinD (Hu et al., 
2003). In MinD, the sites for binding to MinC and MinE are overlapping and present 
at dimer interface (Ma et al., 2004, Park et al., 2011). MinD has been shown to be 
oscillating from pole to pole in vivo (Raskin and de Boer, 1999). The ATPase 
stimulation by MinE and the membrane association are necessary for MinD 
oscillation (Hu and Lutkenhaus, 2001). During oscillation, MinE rings follow MinD-
MinC complex present at the polar zone. MinE rings travel to the pole and displace 
the MinD-MinC complex from the membrane, at one pole and the complex 
reassembles at the opposite pole. Thus, oscillations, which occur several times in a 
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cell cycle, help to keep MinC away from mid-cell (Ma et al., 2004). Residues R21, 
L22 and A18 in MinE play important role in ATPase stimulation. MinE, a small 
protein of 88 amino acids, has been shown to undergo dramatic structural changes on 
binding to MinD. It has been suggested that MinE releases a membrane targeting 
sequence (MST) domain and an anti-MinCD domain on binding to MinD (Park et 
al., 2011). The MST domain contains conserved hydrophobic residues which are not 
exposed to solvent when MinE is traveling through the cytoplasm thus avoiding the 
membrane association of MinE in the absence of MinD. This keeps MinE available 
to interact with MinD and carry out MinD oscillation (Ghasriani et al., 2010). The 
exact mechanism behind the MinD oscillation is still argued. Formation of MinD 
filaments in the presence of ATP, membrane and MinE is suggested as one reason 
for oscillation (Suefuji et al., 2002) A reaction-diffusion mechanism is also 
suggested for MinD assemblies (Loose et al., 2008), whereas a mechanical stress by 
tethering MinD and MinE molecules to the membrane is also proposed for the 
oscillation (Ivanov and Mizuuchi, 2010).  
 
Structures of MinD from various organisms have been reported. The structure of E. 
coli MinD is described here (Figure 1.6B). A hydrolysis deficient MinD D40A 
mutant protein without its first 10 residues was crystallised (Wu et al., 2011b). 
Similar to its other homologues like Soj and ParF, MinD also dimerises in the 
presence of ATP. A lysine at position 11 (K11) in the deviant Walker A box binds to 
ATP, which leads to MinD dimerization. The orientation of MinD on the membranes 
has also been described. The C-termini from both monomers are placed on the same 
face of dimer which comes in close contact with membrane. In the monomer form, 
amino acids D152, S148 and E146 interact with the conserved lysine (K11), while in 
the dimer, S148 and E146 also make cross contacts with the adjacent chain at the 
dimer interface. A glycine at position 12 also make contact with the γ-phosphate 
across the dimer interface.  
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Figure 1.6. Structure of Soj (D44A) and MinD (D40A) dimers.  
A. Chromosome partition protein Soj of Thermus thermophilus in the presence of ATP forms a dimer. B. In the presence of ATP, E. coil division site 
selection protein MinD forms a dimer. The secondary structures are labelled. The α-helices are aqua, β-sheets are purple and the loops are pink. ATP is shown 
as silver sticks. The structures were generated by using PyMol (DeLano, 2002). 
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1.8 Other ParG related ParB proteins 
1.8.1 Protein ω of plasmid pSM19035  
Plasmid pSM19035 from Streptococcus pyogenes is a broad-host-range low copy 
number plasmid of Inc18 family and is maintained in other Gram-positive bacteria 
(Lioy et al., 2010). The segregation locus (Seg2) of plasmid pSM19035 contains a 
cis-acting parS site and two partition genes encoding proteins δ and ω (Dmowski et 
al., 2006). Protein δ is a Walker-type ATPase of ParA family from type Ib partition 
system and forms a dimer (δ2) in the presence of ATP (Pratto et al., 2008). Protein ω 
is homo-dimer in solution (ω2), contains 71 amino acids and acts as a centromere-
binding protein. Omega also works as a global regulator as it controls the expression 
of various genes like copS, which is involved in copy number control, segregation 
genes δ and ω and toxin-antitoxin proteins encoding genes ε and ζ (Dmowski et al., 
2006). Protein ω2 acts as a transcriptional repressor that binds to the promoter region 
upstream of a copS, δ and ω genes. The centromere site parS is made up of the 
promoter regions of copS, δ and ω genes and it contains direct and inverted 10, 7 and 
9 heptamer repeats respectively. Omega is a member of MetJ/Arc transcriptional 
repressor family and its crystal structure has revealed that it contains a RHH fold 
(Murayama et al., 2001). The homodimer ω2 is made up of 2 β-sheets (residues 28-
32) and 4 α-helices (34-46 and 51-66) as shown in Figure 1.7A. The antiparallel β-
sheets contact the DNA at a major groove. The arginine at position 31 and threonine 
at position 29 in β-sheet are involved in interaction with DNA (Murayama et al., 
2001). Thr29 has been shown to be necessary for specific DNA binding (Pratto et 
al., 2008). The N-terminal end contains 20 amino acids, which were not detected in 
the crystal structure indicating that the N-terminus is a disordered domain 
(Murayama et al., 2001). The crystal structure of Omega in the presence of DNA has 
also been solved but without the 19 residues at the N-terminus (Weihofen et al., 
2006). The DNA used was a two heptad sequence from the parS site. Surprisingly in 
the absence of the N-terminus region Omega showed binding to the DNA. The in 
vitro analysis revealed that the ω2 binding to single heptad is poor but increases with 
addition of more heptad units. Along with the β-sheets, which contact DNA at major 
groove, the N-termini of helices α2 also lock the phosphate backbone of the DNA 
sequences. Even though the N-termini is not required for DNA binding, it has been 
shown that Δ19 ω2 fails to activate ATP hydrolysis activity of the partner protein δ 
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(Pratto et al., 2008). Polymerization of δ2 on DNA is also demonstrated to be 
dependent on ω2-parS complex (Pratto et al., 2008). 
 
1.8.2 Protein ParR of plasmid pB171  
A virulence plasmid pB171 from E. coli contains two par loci, par1 and par2 
(Ebersbach and Gerdes, 2001). These loci are placed adjacent but in opposite 
direction. par1 locus contains parMRC partition cassette of type II whereas par2 
locus exhibits parABC cassette of type Ib. The partition site parC1 is shared between 
both loci and contains 10 direct hexameric repeats. parC1 also contains promoter 
sequences for both the par1 and par2 loci. Downstream of parB another centromere-
like site was observed called parC2, which contains 18 direct hexameric repeats. 
Both, ParR and ParB proteins bind to the parC1 site and act as repressors of par1 
and par2 operon respectively. Interestingly ParB was shown to be an efficient 
repressor of the par1 operon, exhibiting the cross-talk regulation between two par 
loci (Ringgaard et al., 2007). The crystal structure of ParR has been solved and it 
was revealed that it is a member of MetJ/Arc transcriptional repressor family having 
a DNA binding RHH motif (Moller-Jensen et al., 2007). In ParR homodimer, a RHH 
motif is found at the N-terminus and each monomer contains 1 β-strand and 5/4 α-
helices (one monomer contains extra α-helix near the C-terminus). In the ParR 
dimer, two β-strands are arranged in antiparallel fashion and two α-helices are lined 
over it, followed by the remaining helices (Figure 1.7B). The 12 dimers of ParR 
arranged in a helical manner in which N-termini face outward of the helix and C-
termini face inward. α-helices 1 and 2 are responsible for stability of DNA 
interaction whereas α-helices 3, 4 and 5 make inter-dimer interactions. The helical 
structure of ParR may act as a scaffold on which partition site DNA, parC1 wraps 
(Moller-Jensen et al., 2007). Interestingly the C-terminus of ParR is found to be 
disordered and the DNA binding activity is carried out by the N-terminus. Similar to 
R1 partition, which is prototype of type II partition system, ParR-parC1 complex 
formation might be involved in activating ParM to form dynamic filaments that on 
ATP hydrolysis push the plasmid copies apart for segregation (Moller-Jensen et al., 
2003, Salje et al., 2010). 
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1.8.3 Protein ParR of plasmid pSK41 
The multidrug resistant plasmid pSK41 from Staphylococcus aureus exhibits a type 
II partition cassette, parMRC (Moller-Jensen et al., 2002). Upstream of parM gene 
sequence, a centromere site parC is located, which contains four 20 bp direct repeats 
(Schumacher et al., 2007). A centromere binding protein ParR binds to the 20 bp 
repeats with high affinity and in co-operative manner. The DNA binding residues are 
present at the N-terminus hence the crystal structure was obtained for the N-terminal 
region (ParRN) with a 20-mer DNA fragment. The DNA-binding motif was 
identified as RHH where β strand is made up of resides 5-12, two α-helices are made 
up of residues 26-25 and 33-47 (Figure 1.7C). Like other RHH proteins the β strands 
from each monomer is arranged in an antiparallel manner and the α-helices are 
compactly placed on one side of the β-sheets to form a dimer. The ParR-DNA 
complex forms a super-helical structure. Six dimer of dimers of ParRN form a helix 
and the DNA wraps on the convex surface of the helix. The 20 bp DNA has an 
intrinsic bend and an enlarged major groove, which helps in binding to the ParR. The 
ParR antiparallel β-sheets inserted into the major groove and the residues K7, K11 
and L3 from the β strand are indicated in making DNA contacts. The residues R29, 
R37, T31 and Y17 are involved in dimer interface interactions. The C-terminal 
domain of ParR protein is necessary to recruit ParM protein in segrosome. ParM 
fails to bind to ParRN hence the ParM-ParR interaction is determined by the C-
terminus.  
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Figure 1.7. Structures of Omega (ω2) dimer and ParR dimer from pB171 and pSK41.  
A. ω2 protein from Streptococcus pyogenes plasmid pSM19035. The ribbon formed by the β-sheets (yellow) in antiparallel position and 4 α-helices compactly 
arranged (red). N-terminal tails (green) are seen at the left and right side of the structure. B. Type II CBP, ParR from E. coli plasmid pB171. The ribbon 
formed by the β-sheets (yellow) in antiparallel position and 9 α-helices compactly arranged (red). C. Type II CBP, ParR from Staphylococcus aureus plasmid 
pSK41. The ribbon formed by the β-sheets (yellow) in antiparallel position and 4 α-helices compactly arranged (red). The structures were generated by using 
PyMol (DeLano, 2002). 
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1.9 Mechanisms of plasmid segregation 
The genetic organization of partition loci is quite similar in all types of plasmid 
partition systems. The nucleotide binding protein, NTPase provides the force 
required for DNA segregation, while a repeated DNA sequence either upstream or 
downstream, acts as a cis-acting centromere site. A centromere binding protein plays 
a role of mediator between the NTPase and the centromere and regulates the 
expression of partition protein. Interestingly, all these common components together 
carry out plasmid partition through unrelated mechanisms in the different types of 
partition systems. The molecular mechanisms involved in plasmid partition are 
described here.  
 
1.9.1 The ParA mediated plasmid partition mechanisms 
ParA driven plasmid segregation has been comprehensively studied (Barillà et al., 
2007, Hwang et al., 2013, Ringgaard et al., 2009, Vecchiarelli et al., 2013). ParA 
protein plays a central role in plasmid partition but as it shows a variation in its 
structure and change in its functions depending upon its ATP and ADP bound states, 
researchers have not reached an agreement as to a single mechanism for all types of 
plasmid partition mediated by the ParA proteins.  
 
1.9.1.1 Diffusion-ratchet mechanism for type Ia plasmid partition system 
Partition of plasmid P1 is carried out by Walker-type ATPase ParA, CBP ParB and 
centromere site parS (Erdmann et al., 1999). The HTH motif in ParA is responsible 
for specific DNA binding and leads to transcriptional regulation of parAB operon 
(Bouet and Funnell, 1999). Unlike most of the other ParA proteins, P1 ParA shows 
dimerization in apo, and ADP-bound form also (Dunham et al., 2009). The ADP 
bound form is responsible for specific DNA binding whereas ATP binding facilitates 
non-specific DNA binding (Vecchiarelli et al., 2010). During plasmid segregation, 
the initial steps of ParB binding to centromere site and recruiting ParA in the 
nucleoprotein complex to form the segrosome are similar to those occurring in other 
systems. However, how the ParB-parS cargo is moved to the final destination is 
debated. The Funnell and Mizucchi groups have proposed a diffusion-ratchet 
mechanism based on results obtained employing a cell free system (Figure 1.8). For 
this they used a DNA-carpeted flowcell, which mimics the nucleoid (Hwang et al., 
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2013, Vecchiarelli et al., 2010). Fluorescently labelled ParA, ParB and parS 
harbouring plasmid were added to the flowcell. Depending upon the findings from 
the cell free system experiment the P1 plasmid partition model is proposed. ParA 
when complexed with ATP (activated form), binds to the nucleoid. ParB is bound to 
plasmid at partition site parS. The plasmid becomes bridged to the DNA by ParA-
ParB interaction. When ParB stimulates ParA ATPase activity, ParA is released from 
the nucleoid and diffuses away (ParA-ADP form) before encountering another 
position on nucleoid to bind. As ParA is removed, the ParB-parS complex also 
detaches from the nucleoid and a ParA depletion zone forms. ParB-parS follow the 
ParA and diffuse towards the high ParA concentration zone. The replicated plasmid 
complexes move in opposite direction as the ParA-depletion zone inhibits them from 
coming together again. 
 
A diffusion-ratchet mechanism is also described for F plasmid partition. In a similar 
cell free system, fluorescently labelled SopA and ATP are added in a flow-cell 
(Vecchiarelli et al., 2013). In the presence of ATP, SopA attaches to the DNA 
carpet. Upon introduction of the SopB-SopC complex in the flow cell, SopA-SopB 
interaction transiently bridges the plasmid to DNA carpet. SopB stimulates the 
ATPase activity, which leads to release of SopA from the carpet, creating a SopA 
free zone. The release of SopA from the carpet is quicker than the P1 ParA one 
hence weak SopA depletion zones are formed. The plasmid remains anchored to the 
carpet for longer and then dissociates. Based on these observations, it has been 
proposed that the plasmid may surf on the DNA carpet and follow the wave of SopA 
ATPase gradients for segregation (Vecchiarelli et al., 2014). 
 
Recently, a DNA-relay mechanism was put forward for chromosome segregation in 
Caulobacter crescentus mediated by ParA. It has been proposed that the elastic 
nature of nucleoid enables ParA-ATP dimer to bind to the chromosome as a 
momentary tether. ParB binds to the chromosome via centromere and this 
nucleoprotein complex attaches to the ParA-ATP tether. The elastic nature of the 
nucleoid, the ParA-ATP tether and ParA gradient formation contribute to the relay of 
ParB-chromosome complex within the cell for segregation (Lim et al., 2014). 
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Figure 1.8. Diagrammatic representation of diffusion-ratchet mechanism.  
ParB via parS forms a plasmid partition complex. ParA-ATP in activated form binds the 
nucleoid. ParA interacts with ParB and attaches ParB-plasmid complex to nucleoid. ParB 
stimulates ParA ATPase activity, which leads to ParA-ADP formation. ParA-ADP 
dissociates from the nucleoid resulting in ParA depletion zone on nucleoid. Slowly ParA 
diffuses in the cell, binds to ATP and attaches to the nucleoid at the opposite side. Higher 
ParA concentration results in diffusion of plasmid towards it. Replicated plasmid complexes 
move in opposite direction as ParA depletion zone pushes them towards higher ParA 
concentration site. Adapted from (Vecchiarelli et al., 2010). 
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1.9.1.2 Pulling mechanism for type Ib plasmid partition system 
 Plasmid partition by a pulling mechanism was proposed by Gerdes group for par2 
locus of plasmid pB171 (Ringgaard et al., 2009). pB171 ParA dimerization in the 
presence of ATP and polymerization in presence of DNA is consistent with other 
ParA proteins from various plasmid systems. ParA binds DNA non-specifically and 
utilises the nucleoid as a scaffold (Ebersbach et al., 2006). ParA also employs 
plasmids on nucleoid. When fluorescently labelled ParA and ParB were analysed in 
vivo, ParA was found to exhibit a filamentous structure (Ringgaard et al., 2009). 
ParB binds to parC2 on plasmid. ParA filament assemblies that are spread on the 
nucleoid contact ParB-parC2 complex. On ParA-ParB interaction, ParB stimulates 
the ATPase activity of ParA, resulting into depolymerization of ParA. This leads to 
retraction of ParA filaments from the plasmid. ParA appears to shrink and move to 
the other end of the cell. At this point the plasmid is either released from ParA 
filaments or dragged behind the shrinking polymers (Figure 1.9A). Eventually ParA 
depolymerises completely and the filamentous structure disappears. ParA starts 
assembling into filament at the opposite pole and again contacts the plasmid, 
undergoes depolymerization and the cycle of assembly/disassembly starts all over 
again. During this cycle, ParA carries out time-averaged equi-distribution of the 
plasmid in the cell. The ATP hydrolysis by ParA provides the force required for 
oscillation in order to pull the plasmid in the cell. 
 
1.9.2 Pushing mechanism by actin-type proteins for type II partition 
system 
Multiple-antibiotic-resistant plasmid R1 from E. coli, exhibits type II partition 
system and so far is the most well-characterized active plasmid partition system 
(Salje et al., 2010). The parMRC partition cassette contains parM which encodes an 
ATPase, parR which encodes for ParR, a CBP, and a centromere parC (Jensen and 
Gerdes, 1997). The ParM protein provides force for plasmid segregation hence 
called motor protein and is a member of actin-type of ATPases. ParM structure 
shows an ATP-binding pocket with the residues of actin fold located around this 
pocket (van den Ent et al., 2001). At atomic level, the ParM filaments look like F-
actin as they assemble into polar, twisted and double stranded filament but they are 
bi-directional unlike actin (Moller-Jensen et al., 2002). The ParM filaments traverse 
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through the entire cell. ParM filaments are dynamic as on ATP binding they 
polymerize and on ATP hydrolysis they depolymerize. ParR binds to centromere to 
form partition complex. ParR from the type II plasmid pSK41 and pB171 shows a 
RHH motif and the centromere DNA wraps around the ParR assembly in helical 
fashion. ParR from plasmid R1 is also speculated to have the RHH motif and forms 
super helical partition complex (Schumacher, 2012). ParM filaments search for the 
plasmid in the cell. The C-terminus of the ParR interacts with ParM. ParM filaments 
are stabilized by ParR bound to parC and the filaments are formed by the addition of 
ParM-ATP at both ends, giving rise to insertional polymerization (Gerdes et al., 
2010). The elongating polymers push the plasmids in opposite direction for 
segregation (Figure 1.9B) (Garner et al., 2007). On ATP hydrolysis ParR-parC 
dissociates from one end of the polymer. 
 
1.9.3 Tram-like mechanism by tubulin-type proteins for type III 
partition system 
Plasmid pBtoxis from B. thuringiensis exhibits the tubZRC type III partition locus 
(Tang et al., 2007). TubR, a CBP is a dimer and acts as a transcriptional repressor. 
TubR contains a winged-HTH motif. The residues in the wing region might interact 
with the DNA at minor groove whereas the N-terminal helices bind to the major 
groove (Ni et al., 2010). Protein TubZ is a GTPase and contains a tubulin fold 
similar to FtsZ (Ni et al., 2010). TubZ has been shown to polymerize when it binds 
to GTP (Larsen et al., 2007) and an EM study has shown the formation of double 
stranded TubZ filaments (Aylett et al., 2010). The C-terminal end of TubZ is flexible 
and shown to be responsible for interacting with partner protein TubR (Ni et al., 
2010). Plasmid segregation was shown to follow a tram-like mechanism (Figure 
1.9C) (Schumacher, 2012). In this model, TubR bound to tubC site on plasmid 
interacts with TubZ polymers through the flexible C-terminal domain of TubZ. TubZ 
filaments show minus and plus ends. GTP binding at the plus end leads to elongation 
and GTP hydrolysis results in retraction of polymers at the minus end displaying the 
tread-milling feature (Larsen et al., 2007). This tread-milling helps to move the 
TubZ filaments with the plasmid-TubR cargo to the pole. The TubZ filaments are 
speculated to bend at the cell pole, which leads to the dropping off of the plasmid- 
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TubR cargo. The TubZ filaments may then travel to other side of the cell in search of 
a new cargo.  
 57 
 
Figure 1.9. Diagrammatic representation of plasmid partition mechanisms.  
A. Type Ib pulling mechanism for plasmid pB171. In this system, the nucleoid is used as a scaffold. ParA-ATP binds to nucleoid and undergoes 
polymerization. When ParA polymers meet ParB-plasmid complex, ParA interacts with ParB. ParB stimulates ParA ATPase activity which leads to ParA 
depolymerization and formation of ParA-ADP. The retracting ParA polymers pull plasmids in opposite direction. B. Type II pushing mechanism for plasmid 
R1. ParM forms filaments, which are stabilized by ParR-parC complex. Centromere DNA wraps around a ring of ParR dimers. ParM interacts with ParR at 
the inner side of the ring. ParM polymers grow continuously and elongated polymers push plasmids to opposite side in the cell. C. Type III tramming 
mechanism in plasmid pBtoxis. According to this model TubZ forms filaments and through its flexible C-terminal domain, it binds to TubR-tubC complex. 
Treadmilling by TubZ filaments move TubR-plamid complex to the cell pole. These filaments bend at the cell pole and facilitate the dropping-off of TubR-
plasmid cargo from the TubR “tram”. TubZ filaments then find another cargo and transport it to the opposite side of the cell. Reproduced from (Schumacher, 
2012).  
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1.10 Aim and objectives  
Multiple drug resistance is a global health threat. As plasmids play a major role in 
conferring drug resistance to bacteria, the study of plasmid partition at the molecular 
level is very important. The aim of this project is to study the molecular mechanism 
and dynamics of partition of multidrug resistance low-copy plasmids using plasmid 
TP228 as a model. Plasmid TP228 contains the parFGH partition cassette which 
harbours partition site parH and encodes two partition proteins ParF (a ParA type 
ATPase) and ParG (a CBP). The ParG N-terminal end though flexible, is implicated 
in various functions. The focus of this project is on the N-terminus of ParG. Given 
the number of independent functions of the N-terminal region of ParG and its 
importance in partition, the study of this region will provide an insightful picture of 
role of ParG in the process of plasmid segregation. This project will also investigate 
the intracellular activity of ParF and ParG and illuminate the dynamics of the 
partition system in vivo. The objectives of this study are as follows: 
1. Generating mutations in individual amino acids of the ParG N-terminal end 
by using alanine scanning mutagenesis. 
2. Determining plasmid partition efficiency of all the ParG N-terminal mutants. 
This analysis will reveal the residues in this region that are crucial for 
plasmid segregation. 
3. Studying the effect of N-terminal mutations on the DNA binding activity of 
ParG. 
4. Investigating the effect of N-terminal mutations on the transcriptional 
repressor function of ParG. 
5. Characterizing the effect of N-terminal mutations on the polymerization of 
ParF in the presence and absence of ATP.  
6. Examining the effect of N-terminal mutations on the stimulation of the 
ATPase activity of ParF. 
7. Visualizing the localization patterns and dynamics of ParF, wild type and 
mutant ParG proteins in the cell by fluorescence microscopy. To this end, 
both conventional and super-resolution fluorescence microscopy will be 
exploited. 
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2.1 Media, antibiotics, strains and plasmids 
2.1.1 Media 
2.1.1.1 Luria-Bertani solid and liquid media 
Bacteria were grown in Luria-Bertani (LB) broth (Fisher scientific) or on LB agar 
(Formedium) media at 37ºC. LB broth or agar media were prepared by dissolving a 
specified quantity of commercially bought anhydrous mixture in a specified volume 
of distilled water and sterilising by autoclaving (121ºC for 20 minutes). The 
composition of media is given in Table 2.1. 
 
Table 2.1 List of components of LB medium. 
Components Concentration g/L 
Tryptone 10 
Yeast extract  5 
Sodium Chloride 10 
Agar (for solid medium) 12 
 
2.1.1.2 M9 medium. 
A 10x M9 stock salt solution was prepared according to the Table 2.2. All the 
components were dissolved in distilled water to a final volume of 1 litre and 
autoclaved at 121ºC for 20 minutes. M9 complete medium was prepared by mixing 
1X M9 stock salt solution with remaining ingredients as given in Table 2.3. With the 
exception of the M9 stock salt solution, all the components of M9 medium were 
sterilised using a 0.2 µm filter and added according to the requirement in the final 
media.  
 
Table 2.2 List of components of the 10x M9 stock salt solution. 
Components Quantity (g) 
Na2HPO4.7H2O 64  
KH2PO4 15  
NaCl 2.5  
NH4Cl 5  
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Table 2.3 List of components of complete M9 medium. 
Components of M9 medium 
1X M9 salt solution (table 2.2) 
2 mM MgSO4 
0.1 mM CaCl2 
0.2% Glucose 
 
2.1.2 Antibiotics 
Antibiotics were used as and when indicated in specified concentration as given in 
Table 2.4. 
 
Table 2.4 List of the antibiotics used in this study 
Antibiotics Stock concentration Working concentration 
Chloramphenicol 30 mg/ml in ethanol 30 µg/ml (cloning) 
10 µg/ml (partition assay) 
Ampicillin  100 mg/ml in dH2O 100 µg/ml 
Kanamycin 50 mg/ml in dH2O 50 µg/ml 
 
2.1.3 Strains  
The Escherichia coli strains used in this study are described in Table 2.5. 
 
Table 2.5 List of bacterial strains 
Strains Genotype  Application 
DH5α F–Φ80lacZΔM15 Δ(lacZYA-argF) 
U169 recA1 endA1 hsdR17 (rK–, mK+) 
phoA supE44 λ– thi-1 gyrA96 relA1 
Cloning 
BR825  polA which has inactivated DNA 
polymerase gene for supporting only 
low copy number replication (Ludtke et 
al., 1989). 
Plasmid partition 
assay 
BL21 (DE3) fhuA2 [lon] ompT gal (λ DE3) [dcm] 
∆hsdS 
Gene overexpression 
and protein production 
SP850 relA1 spoT (cya-1400)::Km thi-1 e14
- -
 Bacterial two-hybrid 
assay 
BW25113 [Δ(araD-araB)567Δ(rhaD-rhaB)568 
ΔlacZ4787 (::rrnB-3) hsdR514 rph-1], 
Microscopy 
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2.1.4 Plasmids 
The plasmids used in this study are given in the Table 2.6. Some of the plasmids 
were available in the laboratory as lab stock; others were constructed during the 
course of this work.  
 
Table 2.6 List of plasmids used in this study. 
Plasmid name Details Antibiotic 
marker 
pFH450 A pBR322 derivative having P1 and 
ColE1 origins of replication without any 
partition elements (Hayes, 2000). 
Chloramphenicol 
pFH547 A pBR322 derivative having P1 and 
ColE1 origins of replication with the wild 
type partition cassette parFGH (Hayes, 
2000). 
Chloramphenicol 
pET22b(+) A translation vector with the 
bacteriophage T7 promoter and (His)6-tag 
at the N-terminal end (Novogen). 
Ampicillin 
pDM3.0 The reporter gene xylE cloned 
downstream of the parFG promoter 
sequence (Zampini et al., 2009). 
Kanamycin 
pET.ParG The plasmid partition gene parG cloned 
into vector pET22b(+) (Barillà et al., 
2005). 
Ampicillin 
pET.ParF The plasmid partition gene parF cloned 
into vector pET22b(+) (Barillà et al., 
2005). 
Ampicillin 
pT25  A pACYC184 derivative having a T25 
fragment corresponding to the amino 
acids 1–224 of the catalytic domain of 
adenylate cyclase, CyaA (Karimova et 
al., 1998). 
Ampicillin 
pT25ParF The plasmid partition gene parF cloned 
into pT25 (Barillà and Hayes, 2003). 
Ampicillin 
pT18 A derivative of pBluescript II KS having 
a T18 fragment corresponding to the 
amino acids 225–399 of the catalytic 
Chloramphenicol 
Table 2.6 contd. 
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domain of adenylate cyclase, CyaA 
(Karimova et al., 1998). 
pT18.ParG The plasmid partition gene parG cloned 
into pT18 (Barillà and Hayes, 2003). 
Chloramphenicol 
pBM20 A derivative of pFH547 in which the 
fluorophore gene mCherry is cloned in 
the frame with the partition gene parG 
(McLeod, B. unpublished data). 
Chloramphenicol 
pBAD.parF The egfp gene which was cloned in the 
frame with parF, under the control of the 
arabinose-inducible promoter pBAD 
(McLeod, B. unpublished data). 
Ampicillin 
pMBS2A 
 
parGS2A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBL3A 
 
parGL3A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBE4A 
 
parGE4A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBK5A 
 
parGK5A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBH7A 
 
parGH7A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBT8A 
 
parGT8A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBK12A 
 
parGK12A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBS9A 
 
parGS9A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBE17A parGE17A allele cloned into pFH547 Chloramphenicol 
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 vector by using ClaI and HpaI sites (this 
work). 
pMBK11A 
 
parGK11A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBM13A 
 
parGM13A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBT14A parGT14A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBN18A parGN18A allel cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBG16A parGG16A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBL21A parGL21A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBE22A parGE22A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBV24A parGV24A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBV25A parGV25A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBT26A parGT26A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBP28A parGP28A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBV29A parGV29A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
Chloramphenicol 
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work). 
pMBS30A parGS30A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBS31A parGS31A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pMBG32A parGG32A allele cloned into pFH547 
vector by using ClaI and HpaI sites (this 
work). 
Chloramphenicol 
pET-MBL3A 
 
parGL3A allele cloned into pET-22b (+) 
vector by using NdeI and XhoI sites (this 
work). 
Ampicillin 
pET-MBK5A parGK5A allele cloned into pET-22b (+) 
vector by using NdeI and XhoI sites (this 
work). 
Ampicillin 
pET-MBK12A parGK12A allele cloned into pET-22b (+) 
vector by using NdeI and XhoI sites (this 
work). 
Ampicillin 
pET-MBK11A parGK11A allele cloned into pET-22b (+) 
vector by using NdeI and XhoI sites (this 
work). 
Ampicillin 
pET-MBM13A parGM13A allele cloned into pET-22b 
(+) vector by using NdeI and XhoI sites 
(this work). 
Ampicillin 
pET-MBN18A parGN18A allele cloned into pET-22b (+) 
vector by using NdeI and XhoI sites (this 
work). 
Ampicillin 
pDB-ParG-R19A parGR19A allele cloned into pET-22b (+) 
vector by using NdeI and XhoI sites 
(Barillà et al., 2007). 
Ampicillin 
pETMBL21A parGL21A allele cloned into pET-22b (+) 
vector by using NdeI and XhoI sites (this 
work). 
Ampicillin 
pBART18ParGL3A  parGL3A allele cloned into pT18 vector 
by using XhoI and HindIII sites (Rodway, 
B. unpublished data). 
Chloramphenicol 
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pBART18ParGK5A  parGK5A allele cloned into pT18 vector 
by using XhoI and HindIII sites (Rodway, 
B. unpublished data). 
Chloramphenicol 
pT18ParGK11A parGK11A allele cloned into pT18 vector 
by using XhoI and HindIII sites (this 
work). 
Chloramphenicol 
pT18ParGK12A parGK12A allele cloned into pT18 vector 
by using XhoI and HindIII sites (this 
work). 
Chloramphenicol 
pT18ParGM13A parGM13A allele cloned into pT18 vector 
by using XhoI and HindIII sites (this 
work). 
Chloramphenicol 
pT18ParGN18A parGN18A allele cloned into pT18 vector 
by using XhoI and HindIII sites (this 
work). 
Chloramphenicol 
pT25ParGK12A parGK12A allele cloned into pT25 vector 
by using kpnI and PstI sites (this work). 
Ampicillin 
pT18ParGR19A parGR19A allele cloned into pT18 vector 
by using XhoI and HindIII sites (this 
work). 
Chloramphenicol 
pT18ParGL21A parGL21A allele cloned into pT18 vector 
by using XhoI and HindIII sites (this 
work). 
Chloramphenicol 
pBM20-L3A parGL3A allele cloned into pBM20 
vector by using BstXI and HpaI sites (this 
work). 
Chloramphenicol 
pBM20-K5A parGK5A allele cloned into pBM20 
vector by using BstXI and HpaI sites (this 
work). 
Chloramphenicol 
pBM20-K11A parGK11A allele cloned into pBM20 
vector by using BstXI and HpaI sites (this 
work). 
Chloramphenicol 
pBM20-K12A parGK12A allele cloned into pBM20 
vector by using BstXI and HpaI sites (this 
work). 
Chloramphenicol 
pBM20-M13A parGM13A allele cloned into pBM20 
vector by using BstXI and HpaI sites (this 
Chloramphenicol 
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work). 
pBM20-N18A parGN18A allele cloned into pBM20 
vector by using BstXI and HpaI sites (this 
work). 
Chloramphenicol 
pBM20ParGR19A parGR19A allele cloned into pBM20 
vector by using BstXI and HpaI sites 
(McLeod, B. unpublished data). 
Chloramphenicol 
pBM20-L21A parGL21A allele cloned into pBM20 
vector by using BstXI and HpaI sites (this 
work). 
Chloramphenicol 
 
2.2 Recombinant DNA techniques 
2.2.1 Preparation of plasmid DNA 
Plasmid DNA miniprep was performed in order to isolate plasmid DNA on small-
scale from the bacteria. A bacterial colony was selected and inoculated aseptically in 
5 ml of sterile LB medium containing appropriate selective antibiotic for the 
plasmid. The culture was incubated overnight at 37
o
C. Following incubation, small 
scale plasmid DNA isolation was carried out using QIAGEN Miniprep or Machery-
Nagel kit according to the manufacturer’s instructions. The plasmid DNA was eluted 
in 100 µl of sterile Milli-Q water by centrifugation of the column for 1 minute at 
13000 rpm and stored at -20
o
C. 
  
2.2.2 Polymerase chain reaction (PCR) 
Amplification of genes for cloning was carried out by performing a polymerase 
chain reaction (PCR). The template DNA was isolated as described in 2.2.1. Primers 
were designed to anneal to the flanking DNA sequences of the gene of interest with a 
required alteration in the gene or the insertion of restriction sites. The list of primers 
obtained from Sigma Aldrich is given in Table 2.7. Milli-Q water was used to 
resuspend the primers at a concentration of 100 μM. 100 mM stock of each 
deoxynucleotide triphosphates (dNTPs) (Roche) was also prepared. The PCR 
reaction was set up as given in Table 2.8 on ice in a 0.2 ml PCR tube. The reaction 
mixture was quickly spun down in the tube after mixing and transferred to a 
thermocycler, which was programmed as given in Table 2.9. Instrument lid was 
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heated to 105
o
C. On completion, 5 μl aliquot of the PCR was checked on an agarose 
gel by electrophoresis. 
 
Table 2.7 List of the primers used in this study. 
Name Sequence 
ParG S2AForward 5’ GGA GTA GCC TGA ATG GCA CTT GAA AAA GCG 
3’ 
ParG S2AReverse 5’ CGCTTTTTCAAGTGCCATTCAGGCTACTCC 3' 
ParG L3A Forward 5’ GTAGCCTGAATGTCAGCTGAAAAAGCGCAT 3’  
ParG L3A Reverse 5’ ATGCGCTTTTTCAGCTGACATTCAGGCTAC 3’ 
ParG E4A Forward 5’ GCCTGAATGTCACTTGCAAAAGCGCATACG 3’ 
ParG E4A Reverse 5’ CGTATGCGCTTTTGCAAGTGACATTCAGGC 3’ 
ParG K5A Forward 5’ TGAATGTCACTTGAAGCAGCGCATACGTCA 3’ 
ParG K5A Reverse 5’ TGACGTATGCGCTGCTTCAAGTGACATTCA 3’ 
ParG H7A Forward 5’ TCACTTGAAAAAGCGGCTACGTCAGTAAAA-3’ 
ParG H7A Reverse 5’-TTTTACTGACGTAGCCGCTTTTTCAAGTGA-3’ 
ParG T8A Forward 5’-CTTGAAAAAGCGCATGCGTCAGTAAAAAAA-3’ 
ParG T8A Reverse 5’-TTTTTTTACTGACGCATGCGCTTTTTCAAG-3’ 
ParG S9A Froward 5’-GAAAAAGCGCATACGGCAGTAAAAAAAATG-3’ 
ParG S9A Reverse 5’-CATTTTTTTTACTGCCGTATGCGCTTTTTC-3’ 
ParG V10A Forward 5’CATACGTCAGCAAAAAAAATGACCTTTGGT3’ 
ParG V10A Reverse 5’ ACCAAAGGTCATTTTTTTTGCTGACGTATG 3’ 
ParG K11A Forward  5’ CATACGTCAGTAGCAAAAATGACCTTTGGT 3’ 
ParG K11A Reverse  5’ ACCAAAGGTCATTTTTGCTACTGACGTATG 3’ 
ParG K12A Forward  5’ CATACGTCAGTAAAAGCAATGACCTTTGGT 3’ 
ParG K12A Reverse  5’ ACCAAAGGTCATTGCTTTTACTGACGTATG 3’ 
ParG M13A 
Forward  
5’ TCAGTAAAAAAAGCGACCTTTGGTGAAAAC 3’ 
ParG M13A Reverse  5’ GTTTTCACCAAAGGTCGCTTTTTTTACTGA 3’ 
ParG T14A Forward  5’ TCAGTAAAAAAAATGGCCTTTGGTGAAAAC 3’ 
Table 2.7 contd. 
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ParG T14A Reverse  5’ GTTTTCACCAAAGGCCATTTTTTTTACTGA 3’ 
ParG E17A Forward  5’ AAAATGACCTTTGGTGCAAACAGAGATCTG 3’ 
ParG E17A Reverse  5’ CAGATCTCTGTTTGCACCAAAGGTCATTTT 3’ 
ParG G16A forward  5’GTAAAAAAAATGACCTTTGCTGAAAACAGAGATC
T 3’ 
ParG G16A Reverse  5’ AGATCTCTGTTTTCAGCAAAGGTCATTTTTTTAC 3’ 
ParG N18A Forward  5’ ATGACCTTTGGTGAAGGCAGAGATCTGGAA 3’ 
ParG N18A Reverse  5’ TTCCAGATCTCTGCCTTCACCAAAGGTCAT 3’ 
ParG D20A Forward  5’ GGTGAAAACAGAGCTCTGGAACGAGTAGTA 3’ 
ParG D20A Reverse  5’ TACTACTCGTTCCAGAGCTCTGTTTTCACC 3’ 
ParG L21A Forward  5’ GGTGAAAACAGAG ATGCGGAACG AGTAGTA 3’ 
ParG L21A Reverse  5’ TACTACTCGTTCCGCATCTCTGTTTTCACC 3’ 
ParGE22A Forward  5’ GAAAACAGAG ATCTGGCACG AGTAGTAACA 3’ 
ParG E22A Reverse  5’ TGTTACTACTCGTGCCAGATCTCTGTTTTC 3’ 
ParGV24A Forward  5’ AGAGATCTGGAACGAGCAGTAACAGCACCA3’ 
ParGV24A Reverse  5’ TGGTGCTGTTACTGCTCGTTCCAGATCTCT 3’ 
ParGV25A Forward  5’ GATCTGGAACGAGTAGCAACAGCACCAGTA3’ 
ParGV25A Reverse  5’ TACTGGTGCTGTTGCTACTCGTTCCAGATC 3’ 
ParGT26A Forward  5’ CTGGAACGAGTAGTAGCAGCACCAGTATCA3’ 
ParGT26A Reverse  5’ TGATACTGGTGCTGCTACTACTCGTTCCAG 3’ 
ParGP28A Forward  5’ CGAGTAGTAACAGCAGCAGTATCATCTGGA3’ 
ParGP28A Reverse  5’ TCCAGATGATACTGCTGCTGTTACTACTCG 3’ 
ParGV29A Forward  5’ GTAGTAACAGCACCAGCATCATCTGGAAAA3’ 
ParGV29A Reverse  5’ TTTTCCAGATGATGCTGGTGCTGTTACTAC 3’ 
ParGS30A Forward  5’ GTAACAGCACCAGTAGCATCTGGAAAAATC3’ 
ParGS30A Reverse  5’ GATTTTTCCAGATGCTACTGGTGCTGTTAC 3’ 
ParGS31A Forward  5’ ACAGCACCAGTATCAGCTGGAAAAATCAAA3’ 
ParGS31A Reverse  5’ TTTGATTTTTCCAGCTGATACTGGTGCTGT 3’ 
Table 2.7 contd. 
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ParGG32A Forward  5’ GCACCAGTATCATCTGCAAAAATCAAACGT3’ 
ParGG32A Reverse  5’ ACGTTTGATTTTTGCAGATGATACTGGTGC 3’ 
ParF-ClaIupstream-
F 
5’ ACCGGTGTTAAAGCATTTCGTACA 3’ 
pET-ParGL3A  5’ GAGGAAACCATATGTCAGCTGAAAAAGCG 3’ 
pET-ParGK5A  5’ GAGGAAACCATATGTCACTTGAAGCAGCG 3’ 
InvertRepPromoFor
BT 
5’ [Btn] AACCTTTACTCATACAAAGAGTATG 3’ 
InvertRepPromoRev 5’ ACCTGAACCCCCTTTCGGATTCAGA 3’ 
ParFG sequencing 
Primer 
5'GCTTTCTTATCACCCGTAAGATAGAAATGG 3' 
ParG2 5' TTCTTTCTCGAGTTCGTTCTCTTTGAG 3' 
ParF EGFP primer 5'CGCACTGCAGTAATAAGAAGGAGATATACATATG
AAAGTGATCTCAAAAG 3'  
pT18 ParG Forward 5' CTTCTTCTCGAGGATGTCACTTGAAAAAGCG 3'  
pT18 ParG Reverse 5' TCTCTCAAGCTTTCGTTCTCTTTGAG 3'  
pT18 for sequencing 5' ATGACCATGATTACGCCAAGC 3' 
 
Table 2.8 Reaction set up of PCR. 
Component Volume (μl) 
Template DNA (1:10) 1 μl 
Forward primer (5 pmol/ μl) 3 μl 
Reverse primer (5 pmol/ μl) 3 μl 
dNTPs (dATP, dCTP, dGTP, dTTP) (5 mM) 9.6 μl 
10x reaction buffer  6 μl 
dH2O To 60 μl 
Taq/phusion/Pfu polymerase 
1 
2 units 
1 When a Taq polymerase buffer was used, 3.6 μl of 5 mM MgCl2 was added to  
PCR reaction. 
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Table 2.9 Thermocycler programme for the PCR. 
Steps Temperature (
o
C) Time (minute) 
1. Initial denaturation 93 3 
2. Denaturation 92 1 
3. Annealing 50/42 1 
4. Extension 72 30 seconds 
5. Repeat steps 2-4 for 29 cycles 
6. Final extension 72 6 
7. Hold 10 ∞ 
 
2.2.3 Restriction enzyme digestion  
Restriction enzyme digestion was performed to analyse the positive clones and for 
the digestion of DNA fragments for different cloning experiments. Purified DNA 
was digested in a total volume of 10-40 μl, containing 1 unit of restriction enzyme/ 
μg of DNA, 1X restriction enzyme buffer, 1X BSA (bovine serum albumin) (if 
required) and sterile distilled water to make up the final volume of the reaction 
mixture. The total volume of the digestion reaction was dependent on the use of the 
digested DNA product. For restriction enzyme analysis of positive clones 10 μl of 
final volume was used and to produce digested DNA fragments for ligation reactions 
40 μl of final volume was used. Restriction digestion was carried out at 37oC for 2 h. 
 
2.2.4 Alkaline phosphatase treatment of DNA 
Plasmid DNA after digestion with restriction enzymes was subjected to alkaline 
phosphatase treatment. Digested DNA mixture was made up to 100 μl volume with 
10X phosphatase buffer (NEB), 2 μl (1 unit) of Alkaline Phophatase enzyme (NEB) 
and water. The mixture was incubated at 37
o
C for 30 minutes following which 
another 2 μl (1 unit) of Alkaline Phophatase enzyme was added with further 
incubation at 37
o
C for 30 minutes. After incubation 10 μl of 200 mM ethylene glycol 
tetraacetic acid (EGTA) were added and incubated at 75
o
C for 10 minutes. The 
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resulting reaction mixture was cleaned using a QIAGEN gel extraction kit as 
follows. To the above mixture, 300 μl of QG buffer were added and centrifuged for 1 
minute at 13000 rpm. The flow-through was discarded and the column was washed 
twice with 750 μl PE buffer with incubation at room temperature for 3 minutes 
before adding the PE buffer for the second time. The PE buffer was removed 
completely by centrifuging and the sample was eluted in 30 μl of EB buffer. 
 
2.2.5 Ethanol precipitation of plasmid DNA 
An ethanol/water mixture with a high concentration of inorganic salt is used to 
precipitate DNA generated either by PCR or restriction digestion to achieve a high level 
of purity. To X volume of DNA mixture, 0.1X of Sodium acetate (pH 5.3) and 2X 
volumes of cold ethanol (100%) was added. The mixture was mixed thoroughly by 
inverting the tube and incubated at -20
o
C for over 2 hours. After incubation, the 
mixture was centrifuged at 4
o
C for 30 minutes at 14000 rpm. The supernatant was 
carefully removed with a pipette and 500 μl of 70% ethanol were added. The mixture 
was again centrifuged at 4
o
C for 10 minutes. The supernatant was carefully removed 
with a pipette and any residual supernatant was removed by drying the tubes in a 
heating block. The precipitated DNA was resuspended in 20-30 μl of sterile Milli-Q 
water.  
 
2.2.6 Agarose gel electrophoresis 
All PCR products and DNA digestions were analysed using 1.2% w/v agarose gel 
electrophoresis. DNA fragments were visualised following intercalation with a 
fluorescent dye (SYBR Safe) and UV illumination. Gel was prepared by dissolving 
the required amount of agarose in 1X TAE buffer (40 mM Tris, 20 mM acetic acid, 
1 mM EDTA). Prior to gel electrophoresis, the DNA samples were mixed with a 6X 
loading dye (10 mM Tris.HCl, pH 7.6, 60% glycerol, 0.3% xylene cyanol, 0.3% 
bromophenol blue, 60 mM EDTA). To estimate the size of the fragments, a 1 kb 
DNA ladder, with defined sizes, was run in parallel. DNA samples (5-50 μl) were 
loaded into the wells of a gel and electrophoresed at 100 V until the DNA fragments 
separated. The DNA fragments were visualised to confirm the separation of expected 
DNA fragments using a UV trans-illuminator attached to a gel documentation 
system. 
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2.2.7 FlashGel DNA system 
Fast electrophoresis was carried out by using the FlashGel™ System (Lonza) which 
includes disposable precast agarose gel (1.2%) cassettes and a combination 
electrophoresis and trans-illuminator unit. This highly sensitive electrophoresis 
system separates DNA in 5-7 minutes. DNA samples were diluted with 1X 
FlashGel™ loading dye to make volume not less than 5 μl. Appropriate FlashGel™ 
DNA markers were used. White seals from cassettes were removed and wells were 
rinsed with distilled water. The cassette was inserted into the dock and samples were 
loaded. The gel was run at a high voltage power supply of 275 V until anticipated 
separation was reached. The gel image was captured by using the FlashGel™ 
Camera. 
 
2.2.8 Gel extraction  
DNA samples, either restriction digestion products or PCR products, were purified by 
electrophoresis on a 1.2% agarose gel and subsequent extraction from the gel using a 
QIAGEN kit following the manufacturer’s protocol. 
 
2.2.9 DNA ligation 
A DNA fragment (insert) and vector were digested with same enzymes. The digested 
insert was gel purified and the plasmid was dephosphorylated to avoid self-ligation. 
The insert and vector were always used in a 5:1 ratio in the ligation reaction. In a 30 
μl reaction volume, 3 μl 5X ligation buffer, 1 μl (2.5 units) T4 DNA ligase (Thermo 
Scientific) and sterile Milli-Q water (to make up the final volume) were added. The 
reaction was incubated at room temperature for 3 hours. The ligated DNA mixture 
was used directly to transform competent E. coli cells.  
 
2.2.10 Preparation of competent cells 
E. coli competent cells were prepared using rubidium chloride. The strain of E. coli 
was streaked aseptically onto a sterile LB agar plate and incubated overnight in a 
37ºC incubator. Following incubation, a single colony was picked from the plate and 
inoculated into 10 ml of sterile LB broth. The culture was incubated at 37ºC 
overnight on a shaker. 60 ml of sterile LB broth were inoculated with 0.3 ml of the 
overnight culture. The bacterial growth was assessed by measuring the absorbance at 
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600 nm (A600) at 1 h intervals using a spectrophotometer until the culture reached the 
optimal A600 of 0.4 - 0.6. The culture was incubated on ice for 10 minutes. The cells 
were harvested by centrifugation at 5000 rpm for 5 minutes at 4ºC. The medium was 
discarded and the cell pellet was resuspended in 20 ml of chilled RF1 buffer (15% 
glycerol, 100 mM RbCl, 50 mM MnCl2, 30 mM KCH3CO2, 10 mM CaCl2, pH 5.8, 
filter-sterilised and stored at 4ºC). The resuspended cells were incubated on ice for 1 
h, then harvested by centrifugation at 5000 rpm for 5 minutes at 4ºC. The medium 
was removed and the cell pellet resuspended in 4.8 ml of ice-cold RF2 buffer (15% 
glycerol, 10 mM MOPS, 10 mM RbCl and 75 mM CaCl2, pH 6.8, filter-sterilised 
and stored at 4ºC). The bacterial suspension was mixed gently followed by chilling 
on ice for 15 minutes. 400 μl aliquots were transferred into chilled, sterilised 
microcentrifuge tubes and immediately snap-frozen by immersing the tubes in liquid 
nitrogen. The tubes were stored at -80ºC until required. 
 
2.2.11 Transformation of competent cells 
The frozen competent cells were thawed on ice. For transformation, plasmid DNA 
(~10 ng) or the ligation mixture was mixed with 100 μl of competent cells in a 1.5 
ml micro centrifuge tube. The cells were incubated on ice for 30 minutes. The cells 
were heat-shocked at 42
o
C for 90 s. Following the heat shock, 400 μl of LB medium 
was added and the cells incubated on a shaker at 37
o
C for 1 h. Following incubation, 
100 μl of the transformed cell suspension was spread on LB agar plates containing 
suitable antibiotic. The plates were incubated at 37
o
C overnight (18-20 h).  
 
2.2.12 Screening of recombinant plasmids 
To check if the cloning of a mutant gene in a plasmid was successful, 10 
transformants were inoculated in sterile liquid LB medium with the required 
antibiotics and incubated at 37
o
C overnight with shaking. Plasmid DNA was isolated 
as per 2.2.1 and a restriction enzyme digestion screen was set up with appropriate 
enzymes (2.2.3). The digestion products were run on gel and plasmids containing the 
insert of the right size were sent for DNA sequencing. 
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2.2.13 DNA sequencing 
Plasmids harbouring the desired mutations were subjected to DNA sequencing. The 
primers used in the sequencing are given in the Table 2.7. All sequencing reactions were 
carried out by GATC Biotech Limited, Constance, Germany. The sequence data was 
analysed using Chromas software. 
 
2.3 Mutagenesis  
2.3.1 Site-directed mutagenesis by overlap extension PCR for parG 
mutagenesis 
The ParG N-terminal end comprises of 32 amino acids. To study each amino acid, 
alanine scanning mutagenesis was carried out changing individual amino acids to 
alanine. The method used to generate mutations was overlap extension mutagenesis 
which involves three PCR steps and 4 primers (Figure 2.1). The internal forward and 
reverse primers were designed to have the flanking parG gene sequence with 
mutation. The forward external primer was designed to have the parG upstream 
sequence and the reverse external primer contained the downstream sequence of the 
parG. Two PCR reactions were performed. In PCR 1, an external forward primer 
and an internal reverse primer were used. In PCR 2, an internal forward primer and 
an external reverse primer were used. PCR 1 and PCR 2 were performed according 
to 2.2.2. Pfu polymerase was the polymerase of choice and pFH547 was used as 
template DNA. The products from these reactions were purified on agarose gel using 
gel extraction (2.2.8) and further with ethanol precipitation (2.2.5). The products of 
PCR 1 and PCR 2 were then combined in a pre-cycle reaction. In a pre-cycle 
reaction, equal amounts of DNA from PCR 1 and 2 were added to make a total 
volume of 25 μl. Other components added in the pre-cycle reactions were dNTPs (5 
mM each dATP, dCTP, dGTP, dTTP), 10X Taq polymerase buffer, 5 mM MgCl2 to 
make a final reaction volume of 50 μl. This reaction was assembled in a 0.2 ml PCR 
tube and denatured at 93
o
C for 3 minutes in a thermocycler. The tube was removed 
and 0.5 μl (2.5 units) Taq polymerase (GoTaq Promega) was added. The tube was 
again returned to the thermocycler and 10 cycles of incubation at 94
o
C for 40 
seconds and at 72
o
C for 40 seconds were carried out. The pre-cycle step thus helped 
to promote annealing of the PCR1 and PCR2 fragments as shown in Figure 2.1. 
After the pre-cycle, extension products incorporating the desired mutations were 
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amplified in PCR3 using only the external primer pair. Forwards and reverse 
external primers (both at 25 pmol/ μl) were added to the tube and PCR 3 was carried 
out. The thermocycler was set up as per Table 2.8 (except the first denaturation step 
of 93
o
C for 3 minutes). The PCR product was run on 1.2 % agarose gel and purified 
by ethanol precipitation. The PCR fragment was digested with ClaI (Promega) and 
HpaI (Thermo Scientific) and cloned into the digested pFH547 vector. The mutation 
was confirmed by using GATC Biotech sequencing service.  
 
2.3.2 Cloning of the parG mutant gene in pET22b and pT18ParG 
To clone parG mutant allele in vector pET22b, forward primer was designed to have 
restriction site NdeI and the sequence flanking the parG gene. Reverse primer with 
restriction site XhoI was available in the lab stock as primer ParG2. For cloning parG-
L3A and parG-K5A, forward primers were designed to have the respective mutant 
sequences as well. As a template, partition vectors (i.e. pMB series) harbouring mutant 
parG allele were used. The PCR was set up as given in 2.2.2. Pfu DNA polymerase was 
used and the annealing temperature was set to 42
o
C. PCR products and pET22b vector 
were digested with NdeI (NEB) and XhoI (Fermentas) and further steps were 
followed similar to 2.3.1. To clone parG mutant allele in vector pT18ParG, partition 
vector harbouring parG mutations were isolated as per 2.2.1 and used as a template. 
The forward primer was designed to have a HindIII restriction site and ParG2 with 
XhoI restriction site was used as a reverse primer. PCR was carried out as per 2.2.2 
with Taq polymerase and an annealing temperature of 42
o
C. PCR products and 
pT18ParG vector were digested with HindIII (Thermo Scientific) and XhoI, further 
steps were followed similar to 2.3.1. 
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Figure 2.1. Schematic representation of overlap extension mutagenesis.  
Three PCR reactions are carried out to generate parG mutant allele. The primers used are a- 
ParF ClaI Forward primer (External primer), b- ParG Mutant Forward primer (internal 
primer), c- ParG Mutant Reverse primer (Internal primer), d- ParG2 Reverse primer 
(external primer). 
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2.3.3 Cloning of the parG mutant gene in vector pBM20 
Vector pBM20 contains the partition cassette parFGH and has the mCherry gene 
cloned in frame with parG in it. To clone a mutant parG allele into the pBM20 
restriction digestion was carried out. The partition vectors containing mutant parG 
alleles and the vector pBM20, were digested with BstXI (Promega) and HpaI. The 
mutant parG allele fragment was swapped into the digested vector pBM20 and 
transformed into DH5α cells. Transformants were screened using a restriction 
digestion screen and confirmed by DNA sequencing.  
 
2.4 Expression and purification of recombinant proteins 
2.4.1 Overproduction and purification of ParF  
The His-tagged ParF protein was overproduced in E. coli BL21(DE3). Around 8-10 
transformants were inoculated in ~8 ml of LB with ampicillin in a 125 ml conical 
flask. ParF was grown at 30ºC with shaking at 180 rpm, for two-three hours until the 
culture started to become turbid. This starter culture was then inoculated into 300 ml 
of pre-warmed LB with ampicillin and grown till it reached an OD600 = 0.8 – 0.9. 
The culture was induced with isopropyl-beta-D-thiogalactopyranoside (IPTG) 
(Melford) at a final concentration of 1 mM and incubated for a further 3 hours. Cells 
were then harvested at 15303 g for 5 minutes at 4ºC and pellets were stored at -80ºC. 
The protein was puriﬁed by Ni2+ afﬁnity chromatography as per the Novagen 
technical manual as follows. ParF containing cell pellets were re-suspended in 15 ml 
of 1X binding buffer (Table 2.10) and an EDTA free protease inhibitor tablet 
(Roche), 150 l of lysozyme (10 mg/ml) (Sigma) and 150 l of 
phenylmethylsulphonyl fluoride (PMSF; 100 mM in ethanol) were added. This 
mixture was incubated for 15 minutes at 30ºC, then an additional aliquot of 150 l of 
lysozyme solution was added followed by a further incubation for another 15 
minutes. The pellets were sonicated 12 times for 30 seconds each with 1 minute 
interval on ice. The sonicated mixture was centrifuged for 35-40 minutes at 11,000 
rpm at 4ºC and the supernatant was collected. A column was prepared with His-
binding resin (Novagen) with a 2.5 ml bed volume. The resin was charged with 1X 
50 mM NiSO4 and equilibrated with 1X binding buffer. The extract supernatant was 
loaded on this column in a close circuit for 1 h and 30 minutes at a peristaltic pump 
flow rate = 3.0. The column was washed first with 30 ml of 1X binding buffer and 
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then with 70 ml of 1X washing buffer (Table 2.10). Elution was carried out by using 
1X elution buffer (Table 2.10) and 12 fractions of 1 ml each were collected. DTT 
was added to 2 mM final concentration in each fraction. Protein fractions were 
quantified by Bradford assay using the Bio-Rad protein assay reagent (2.4.4) and 
highly concentrated fractions were buffer exchanged by using a 5 ml HiTrap 
desalting column (2.4.3) eluted and stored in the storage buffer (Table 2.10).  
 
Table 2.10 The composition of buffers used in ParF purification. 
1X ParF Binding Buffer 1X ParF Wash Buffer 1X ParF Elution Buffer 
50 mM Tris, pH 7.5-8.0 50 mM Tris, pH 8.0 50 mM Tris, pH 8.0 
500 mM NaCl 1 M NaCl 150 mM NaCl 
15 mM imidazole 85 mM imidazole 300 mM imidazole 
10% Glycerol 10% Glycerol 10% Glycerol 
Storage ParF Buffer All buffers were pH checked and filtered prior to use. 
30 mM Tris, pH 7.5-8.0 
100 mM KCl 
10% Glycerol 
2 mM DTT 
 
2.4.2 Overproduction and purification of ParG and mutant proteins 
The parG gene (wild type and mutant) was cloned into the expression vector pET-
22b. The His-tagged proteins were overproduced in E. coli BL21(DE3). Around 8-10 
transformants were inoculated in ~8 ml of LB with ampicillin and grown at 37ºC, 
shaking at 180 rpm for two-three hours until the culture started to become turbid. 
This starter culture was then inoculated into 300 ml of pre-warmed LB with 
ampicillin and grown at 37ºC on shaker at 180 rpm till it reached an OD600 = 0.8 – 
0.9. The culture was induced with IPTG at a final concentration of 1 mM and 
incubated at 37ºC on shaker at 180 rpm for a further 2 hours. Cells were then 
harvested at 15303 g for 5 minutes at 4
o
C. Pellets were stored at -80ºC. Proteins 
were puriﬁed by Ni2+ afﬁnity chromatography according to the Novagen technical 
manual as follows. ParG and ParG mutants containing cell pellets were resuspended 
into 10 ml of 1X binding buffer (Table 2.11) and 100 l of soybean trypsin inhibitor 
(1 mg/ml), 100 l of lysozyme (10 mg/ml) and 100 l of PMSF were added. This 
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mixture was incubated for 15 minutes at 30ºC, then additional 100 l of lysozyme 
solution were added, and further incubated for another 15 minutes. The pellets were 
sonicated 12 times for 30 seconds each with 1 minute interval on ice and then this 
mixture was centrifuged for 1 h at 16,000 rpm at 4ºC. The supernatant was collected. 
The column was prepared with 2.5 ml of His-binding resin. The resin was charged 
with 1X NiSO4 (50 mM) and equilibrated with 1X binding buffer. The cleared 
extract was loaded onto this column in a close circuit for 1 h and 15 minute at a 
peristaltic pump flow rate = 3.0. Then the column was washed, first with 30 ml of 
1X binding buffer and then with 70 ml of 1X washing buffer (Table 2.11). Elution 
was carried out by using 1X elution buffer (Table 2.11) and 12 fractions of 1 ml each 
were collected. Protein fractions were quantified by Bradford assay using the Bio-
Rad protein assay reagent (2.4.4) and highly concentrated fractions were buffer 
exchanged by using a 5 ml HiTrap desalting column (2.4.3), eluted and stored in the 
storage buffer (Table 2.11).  
 
Table 2.11 The composition of buffers used in ParG purification. 
1X Binding Buffer 1X Wash Buffer 1X Elution Buffer 
20 mM Tris, pH 7.5-8.0 20 mM Tris, pH 8.0 20 mM Tris, pH 8.0 
500 mM NaCl 1 M NaCl 500 mM NaCl 
15 mM imidazole 90 mM imidazole 400 mM imidazole 
Storage Buffer All buffers were pH checked and filtered prior to use. 
 50 mM Tris, pH 7.5-8.0 
50 mM KCl 
2mM DTT 
 
2.4.3 Buffer exchange using the HiTrap column 
A syringe was filled with ParF/ParG storage buffer. The stopper on the top of the 
HiTrap column (GE healthcare) was removed and connected to the syringe while the 
buffer was dripping. The column was equilibrated with 10 ml of storage buffer. 
Protein fractions with high concentrations were applied to the column in batches of 
1.5 ml. After loading each batch of 1.5 ml, protein was eluted in ParF/ParG storage 
buffer in two 1 ml fractions. Protein concentration was determined and fractions 
were analysed on SDS-PAGE. The fractions were aliquot into 100 µl volume and 
flash frozen in liquid nitrogen. 
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2.4.4 Protein concentration determination 
Protein concentrations were determined by using Bradford assay. Bovine serum 
albumin (BSA) was used as a protein standard in the concentration range of 0.4, 1, 2, 
4 and 6 µg/ml. Each one ml of reaction contained 1 part of Bradford reagent and 4 
parts of Milli-Q water. The reaction was incubated for 5 minutes. The absorbance 
was measured at 595 nm. A graph of protein concentration versus absorbance (A595) 
was plotted and a standard curve was obtained. The amount of 5 µl of the unknown 
protein was added to 795 µl of water and then 200 µl of Bradford reagent were 
added and the absorbance at 595 nm was recorded. Samples were tested in triplicate. 
 
2.5 Sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) 
2.5.1 Gels and buffers 
Gels were prepared by assembling the glass plate sandwich as per the manufacturer’s 
instructions. The resolving gel (15%) solution was prepared as described in Table 
2.12. The APS and TEMED solutions were added at the end and the solution was 
mixed gently to avoid formation of bubbles. The solution was poured between the 
glass plates to 3/4 of height leaving space for the stacking gel. The top of the 
resolving gel was covered with 70% isopropanol and the gel was allowed to solidify. 
The isopropanol was discarded and the gel was washed gently with water. The 
stacking gel solution was prepared as described in Table 2.13 and poured onto the 
resolving gel. 
 
Table 2.12 Composition of 15% resolving gel. 
Components Volume for 10 ml resolving gel 
solution for 15% gel 
Deionised water 3.4 ml 
30% Acrylamide mix 7.5 ml 
1.5 M Tris (pH 8.8) 3.8 ml 
10% SDS 0.15 ml 
10% Ammonium persulfate (APS) 0.15 ml 
TEMED 0.006 ml 
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Table 2.13 Composition of stacking gel. 
Components Volume for 5 ml stacking gel solution 
Deionised water 2.7 ml 
30% Acrylamide mix 0.67 ml 
1 M Tris (pH 6.8) 0.5 ml 
10% SDS 0.04 ml 
10% Ammonium persulfate (APS) 0.04 ml 
TEMED 0.004 ml 
 
2.5.2 Sample preparation 
Each protein sample of 10 µl was added to 10 µl of 2X SDS loading buffer (100 mM 
Tris (pH 6.8), 200 mM DTT, 4% SDS, 0.2% Bromophenol Blue and 20% Glycerol). 
The mixture was then heated to 95°C for 5 minutes and quickly spun down. A 
PageRuler Prestained Protein Ladder (Thermo Scientific) was used to allow the 
molecular weight of proteins to be estimated. 
 
2.5.3 Electrophoresis 
Gels were run using the Mini-PROTEAN (Bio-Rad) system and the apparatus was 
assembled according to the manufacturer’s instructions. Gels were put into the tank 
and then the tank was filled with 1X SDS running buffer (Table 2.14). Protein 
samples and a molecular weight marker were loaded and the gel was run for 
approximately 1 h (or till the blue dye front reached the bottom) at 25 mA. 
 
Table 2.14 Components of 5X SDS running buffer. 
Components Concentration 
Tris 125 mM 
Glycine 1.25 M 
SDS 0.5% 
 
2.5.4 Staining of SDS gels 
Staining of the SDS gels to detect proteins was carried out using Coomassie Brilliant 
Blue dye. The stain was prepared by adding 1.25 g dye into 250 ml methanol, 50 ml 
acetic acid and 250 ml sterile water. Gels were rinsed with water and then placed on 
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a rocker in the stain for 1 h. Gels were removed from the stain and placed into the 
destain solution overnight. The destain solution was prepared by adding 250 ml of 
methanol to 100 ml of water, followed by adding 50 ml of acetic acid and adjusting 
the final volume to 500 ml with water. 
 
2.6 Plasmid partition assay 
The efficiency of plasmid partition was tested by performing partition assays (Figure 
2.2). Plasmids harbouring no partition cassette (pFH450), wild type partition cassette 
(pFH547) and a mutant version of the partition cassette (pMB series having mutation 
in ParG N-terminal end) were transformed into the strain BR825 with selection for 
chloramphenicol resistance on LB medium. Ten transformants were selected and 
streaked on a sterile LB medium plates containing chloramphenicol and incubated at 
37°C overnight. One colony from each of these streaks was streaked on a sterile LB 
plates without antibiotics and incubated at 37°C overnight. Streaking on LB plates 
without antibiotics was repeated for one more day. This streaking on non-antibiotic 
media provides about 25 generation of non-selective growth. The following day, 
from each streak, 10 isolated colonies were stabbed onto LB plates with and without 
antibiotics which gives 100 colonies for each samples. The percentage of colonies 
which retain the plasmid was determined. Assays were performed at least in 
triplicate. 
 
2.7 Chemical cross-linking 
ParG mutant’s dimerization was studied by chemical cross-linking. The cross-linker 
used in this experiment is dimethyl pimelimidate (DMP) (Sigma) which is an amine-
reactive imidoester type of crosslinker. Imidoester crosslinkers react with primary 
amines to form amidine bonds. ParG and mutant proteins were used at a final 
concentration of 20 µM and DMP was added at increasing concentration of 0, 0.5, 1 
and 10 mM. A buffer (50 mM Hepes-KOH pH 8.5, 50 mM KCl, 5 mM MgCl2) was 
used. The ﬁnal reaction volume was 15 µl. The reactions were incubated for 1 h at 
37°C and then stopped by the addition of 1 µl of 0.5 M Tris-HCl pH 6.8. This was 
followed by addition of 1X SDS loading buffer. The samples were heated at 95°C 
for 5 minutes and analysed by SDS-PAGE.  
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Figure 2.2. Schematic representation of plasmid partition assay. 
On the first day BR825 cells were transformed with separate partition probe vectors which 
contain either no partition elements or wild type or mutant partition cassette. On day 2, 10 
colonies were streaked onto two LB with chloramphenicol containing plates. The streaking 
was carried out for the next two days on plates without antibiotics. On the 5
th
 day 100 
isolated colonies were stabbed onto LB plates with and without chloramphenicol. On day 6, 
colonies were counted which indicated the percentage of plasmid retention. 
 
2.8 Electrophoretic mobility shift assay (EMSA) 
2.8.1 Generating biotinylated DNA fragment 
EMSA was carried out to check the binding of ParG N-terminal mutant proteins to 
the parFG promoter sequence. The forward primer was designed to have a biotin 
label at the 5’ end and the sequence flanking the parFG promoter. The PCR was set 
up as per Table 2.7, pFH547 as DNA template, Phusion polymerase (NEB) and 5X 
high fidelity Phusion buffer were used. The thermocycler was programmed as per 
Table 2.15. The PCR product was analysed on agarose gel and purified by the gel 
extraction method. The DNA concentration was determined by using the Nanodrop.  
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Table 2.15 Thermocycler programme for PCR. 
Steps Temperature (
o
C) Time (seconds) 
1. Initial denaturation 98 30 
2. Denaturation 98 10 
3. Annealing 42 30 
4. Extension 72 15 
5. Repeat steps 2-4 for 29 cycles 
6. Final extension 72 6 minutes 
7. Hold 10 ∞ 
 
2.8.2 Preparation of samples and gel electrophoresis  
A reaction mixture of 20 µl was prepared in which 0.5 nM biotinylated DNA (parFG 
promoter sequence) and an increasing concentration (100 to 1000 nM) of ParG or 
ParG mutant proteins were added. The reaction mixture also contained poly(dI-dC) 
(1 µg/µl), 50% glycerol (1 µl), 100 mM MgCl2 (1 µl), 10X buffer (2 µl) and water to 
make it up to 20 µl volume. Reactions were incubated for 20 minutes at 25
o
C. A 6% 
native gel (Table 2.16) was used which was pre-run for 20 minutes at 100 V. All the 
samples were loaded onto the gel and run with 0.5X TBE buffer (Table 2.17) at 100 
V until the dye front reached 3/4
th
 of the gel. 
 
Table 2.16 Composition of 6% native gel. 
Components Volume 
5X TBE 1.2 ml 
30% Acrylamide 2.4 ml 
10% APS 70 µl 
TEMED 10 µl 
Distilled water  8.4 ml 
 
Table 2.17 Composition of 5X TBE buffer. 
Components Quantity 
Tris base 54 g 
Boric acid 27.5 g 
0.5 m EDTA, pH 8.0 20 ml 
Distilled water To make 1000 ml 
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2.8.3 DNA transfer onto a positively-charged nylon membrane 
DNA from the gel was transferred on to a positively charged membrane in an 
electrophoresis tank. A nylon membrane (Roche), 3 MM Whatman paper and 
sponges (Bio-Rad system) were cut to the size of the gel and soaked in 0.5X TBE 
buffer. In a transfer cassette (Bio-Rad system), one sponge and two pieces of 
Whatman 3MM paper were placed and then the gel was placed on Whatman paper. 
The nylon membrane was placed on top of gel avoiding air bubbles. Two pieces of 
Whatman 3MM paper and sponge were placed on the membrane. The sandwich was 
inserted in the cassette and placed in a tank to transfer the DNA to the positively-
charged membrane. The DNA transfer was carried out at 380 mA for 30 minutes in 
0.5X TBE buffer. The sandwich was then disassembled and the membrane was 
removed carefully and the position of the wells were marked. The membrane was 
dried on paper towel, wrapped in Saran wrap. The DNA was cross-linked to the 
membrane by placing DNA side down onto a UV transilluminator for 5 minutes. 
  
2.8.4 Detection of Biotinylated DNA using the LightShift
TM
 
Chemiluminescent EMSA kit (Pierce) 
The blocking buffer and the 4X wash buffer were warmed to 37-50
o
C in a water bath 
until all the particulate material was completely dissolved. The membrane was 
placed in a clean tray and 20 ml of blocking buffer were added and then it was 
incubated for 15 minutes on a shaker. The blocking buffer was discarded and the 
membrane was placed in a conjugate/blocking buffer solution in a tray for 15 
minutes on a shaker. The Conjugate/Blocking buffer solution was prepared by 
adding 1 µl streptavidin-horseradish peroxidase conjugate (Sigma-Aldrich) to 10 ml 
blocking buffer. 80 ml of 1X wash buffer were prepared by adding 40 ml of 4X wash 
buffer to 120 ml dH2O. The membrane was transferred to a new tray and washed 
with 20 ml of 1X wash buffer four times (5 minutes each). The membrane was then 
transferred to a new container containing 30 ml of equilibration buffer and incubated 
for 5 minutes on a shaker. The membrane was then removed and placed on paper 
towel to remove the excess buffer. The substrate solution was prepared by adding 1 
ml of luminol/enhancer solution to 1 ml stable peroxide solution and transferred to a 
small clean tray. The membrane was placed in the substrate solution with DNA side 
facing down and incubated for 5 minutes with gentle shaking. The membrane was 
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then removed and any excess of buffer was removed by tissue paper. The membrane 
was then placed in a film cassette and covered with an acetate sheet. After 10 
minutes, the membrane was exposed to a X-ray film first for 30 seconds, and then 
for longer or shorter time periods as appropriate. 
 
2.9 Catechol 2, 3-dioxygenase (CDO) reporter assay 
For the CDO reporter assay, two plasmids were used; the pDM3.0 plasmid in which 
the parFG promoter-operator region was cloned upstream of the xylE reporter gene 
and pET22b derivatives expressing the parG gene (wild type or mutant). E. coli 
BL21 (DE3) cells were co-transformed with pDM3.0 and pET22b derivatives and 
selected for kanamycin (pDM3.0) and ampicillin (pET22b) resistance. A single 
transformant colony was inoculated on 50 ml of LB broth containing ampicillin (100 
μg/ml) and kanamycin (50 μg/ml), and incubated at 37oC until the mid-logarithmic 
phase was reached (OD600 = 0.5). The cells were centrifuged and the pellets were 
resuspended in 10 ml of 100 mM potassium phosphate buffer, pH 7.4, with 10% 
acetone. Resuspended pellets were sonicated on ice with five 15 second bursts. The 
lysate was cleared by centrifugation. The protein concentration in the supernatant 
was determined using the Bradford Assay (2.4.4). Samples were diluted to a protein 
concentration of 0.05 mg/ml. A 1ml aliquot of protein sample was transferred in a 
cuvette and 20 μl catechol (10mM) (Sigma) were added. After 1 minute, absorbance 
at 375 nm was recorded (measurements performed at least in triplicate, each from an 
independent culture containing the plasmids). Cell extracts containing the xylE 
product become yellow within seconds in the presence of catechol. Catechol is a 
colourless substrate that is converted into a yellow coloured product, 2-
hydroxymuconic semialdehyde by catechol 2,3-dioxygenase. CDO units were 
determined by using the following equation: 
 
 
where A is absorbance, ε is the extinction coefficient. One CDO (μmol/ml) unit is 
the amount of enzyme that oxidizes 1 μmol of catechol per minute at 24ºC. 
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2.10 Dynamic light scattering (DLS) 
The Malvern Zetasizer Nano system was used to determine ParF polymerization by 
dynamic light scattering. Proteins to be analysed were centrifuged for 30 minutes at 
13,000 rpm in a refrigerated microcentrifuge. The supernatant was collected and 
quantified by Bradford assay (2.4.4). Proteins (ParF, ParG wild type and mutant) 
were diluted to 50 ng/l using the ParF/ParG storage buffer and kept on ice. In the 
DLS assay, 46.25 l of the ParF protein (final concentration 2.16 M) were added to 
a 50 l quartz cuvette and placed in a Zetasizer chamber at 30oC. Twenty readings 
were taken for the intensity of light scattering from which the hydrodynamic radius 
(Z-average) can be inferred. The cuvette was taken out of the chamber and MgCl2 
(final concentration 5 mM) and ATP (final concentration 500 M) was added to a 
final volume of 50 l. The cuvette was again placed into the chamber and further 
readings were taken for the intensity of light scattering. Approximately by 60
th
 
readings a plateau was reached. The cuvette was again taken out of the chamber and 
2.16 M ParG wild type or mutant protein was added. The solution was mixed by 
pipetting. The cuvette was returned to the chamber and further readings were taken 
till a plateau was reached. The intensity of scattered light is proportional to size and 
the concentration of the particles present in the solution.  
 
2.11 Sedimentation assay  
ParF polymerization stimulated by ParG was analysed by sedimentation assay in the 
absence and presence of nucleotides. ParF and ParG or mutant proteins (8 µM final 
concentration) were incubated at 30
o
C for 30 minutes in buffer F (Table 2.18) in 60 
µl reaction volume. ATP 2 mM and MgCl2 5 mM were added wherever indicated. 
After incubation, reactions were centrifuged at 14,000 rpm for 30 minutes at 4
o
C. 
The supernatant was collected, and to a 20 µl aliquot, 10 µl of 2X SDS loading 
buffer were added. The pellets fractions were dried by heating at 30
o
C for 5 minutes 
and resuspended in 15 µl of sterile water. To the resuspended pellets, 10 µl of 2X 
SDS loading buffer were added. Both the supernatant and the pellets were denatured 
at 95
o
C for 5 minutes and then analysed by SDS-PAGE and Commassie blue 
staining. On each gel, 100% of the pellet and 33% of the supernatant were loaded. 
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The bands were quantified with ImageJ (National Institutes of Health, Bethesda, 
MD). 
 
Table 2.18 Composition of Buffer F. 
Buffer F 
30 mM Tris, pH 8.0 
100 mM KCl 
2 mM DTT 
10% glycerol 
 
2.12 Bacterial two-hybrid assay 
E. coli SP850 cells were co-transformed with the two plasmids containing T18 and 
T25 fusions of interest (pT18 and pT25, pT18-zip and pT25-zip, pT18-ParG/mutants 
and pT25-ParF). Single colonies were inoculated into 5 ml of LB broth with 
appropriate antibiotics and 0.5 mM IPTG and the cultures grown at 30ºC overnight. 
Cultures were cooled down on ice for 20 minutes and diluted 1:5 with M63 medium 
(Table 2.19). A600 was recorded for all cultures. For each culture, three 1 ml aliquots 
were taken and centrifuged for 20 minutes at 13000 rpm. The supernatants were 
removed and the pellets were resuspended into 700 µl of buffer Z (Table 2.20). To 
this solution 20 µl of CHCl3 and 0.1% SDS were added and vortexed for 1 minute. 
These samples were incubated at 28ºC to equilibrate and then 200 µl of O-
Nitrophenyl-β-D-Galactopyranoside (ONPG) (4 mg/ml) (Sigma) were added. The 
time taken to develop yellow colour was noted and the reaction was stopped by 
adding 500 µl of 1M Na2CO3. Samples were spun for 1 minute to remove any debris 
and A420 and A550 were recorded for the supernatants. Miller units were calculated by 
using the following equation: 
 
 
where MU is Miller units, A is absorbance, t is time and V is volume. 
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Table 2.19 Composition of M63 medium. 
5X M63 medium
1
 
10 g (NH4)2SO4 
68 g KH2PO4 
2.5 mg FeSO4.7H2O 
Dissolved in 1 litre dH2O and adjust to pH 7 with KOH 
1 The above medium was sterilized by autoclaving and then 1 ml 1M 
MgSO4 and 10 ml 20% maltose (filter sterilized) were added. 
 
Table 2.20 Composition of Z buffer. 
Z buffer 
1
 
0.06 M Na2HPO4.7H2O 
0.04 M NaH2PO4.H2O 
0.01 M KCl 
0.001 M MgSO4 
Make to 1 litre with dH2O and adjust to pH 7 
1 To 20 ml of Z-buffer, 54 µl (0.05 M) β-mercaptoethanol (Sigma) were 
added just prior to use. 
 
2.13 ATPase assay  
ATPase assays were performed using thin layer chromatography (TLC). A 
polyethyleneimine (PEI)-cellulose plate (Macherey-Nagel) was pre-run in Milli-Q 
water in a TLC tank until the liquid reached the top of the plate. The plate was 
allowed to dry on the bench. The ParF ATPase activity was assessed in the presence 
of wild type and mutant ParG using [α35S] ATP (Perkin Elmer, UK). In a 16 µl 
reaction, 0.5 µM ParF was incubated separately with increasing concentrations (0.5, 
1, 2 and 5 µM) of wild type and mutant ParG protein fractions. [α- 35S] ATP was 
added at a final concentration of 50 nM together with 4 µl of 4X ATPase buffer 
(Table 2.21) and the volume was made up with dH2O. As a control all the ParG 
fractions were also run without ParF. The reactions were incubated for 1 h at 30ºC. 5 
µl aliquots of the reaction mixtures were loaded on the PEI plate ~1 cm apart from 
one another. The samples were applied ~2 cm from the bottom of the plate using 
standard filtered tips. The spots were allowed to dry in air. The plate was then run in 
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0.5 M KH2PO4, pH 3.5, in a TLC tank until the buffer reached the top of the plate. 
The plate was then dried in fumehood. The dried plate was placed in a cassette and 
exposed to a BIOMAX MR Kodak flim for a suitable time. The ADP and ATP spots 
were quantified by using the Bio-Rad Phosphomager. The stimulation of ParF 
ATPase activity in the presence of wild type ParG (5 µM) was considered as 100% 
and that promoted by the ParG mutant proteins was calculated as relative ATPase 
stimulation. 
 
Table 2.21 Composition of 4X ATPase assay buffer. 
4X ATPase Buffer Prepare 1ml aliquots and store at -20
o
C 
120 mM Tris, pH 7.5 
400mM KCl 
20 mM MgCl2 
8 mM DTT 
 
2.14 Microscopy 
2.14.1 Confocal microscopy 
BW25113 E. coli cells were co-transformed with pBAD-ParF and pBM20 
derivatives. The transformants were grown in 1 ml of M9 glucose medium with 
ampicillin (100 μg/ml) and chloramphenicol (30 μg/ml) for 1 hour at 37°C and then 
induced with 3 μl of 10% arabinose (final concentration 0.03%) for 3 hours at 30°C. 
The cells were harvested at 8000 rpm for 1 minute and the pellets were resuspended 
in 20 μl M9 medium without antibiotics. Agarose (1.2% in M9 medium with 
glucose) pads were prepared on a microscopy slide by using geneframes (ABgene). 
0.4 μl of the cell suspension was placed on the agarose pad and covered with a glass 
coverslip. 4',6-diamidino-2-phenylindole (DAPI) was used at 2 μg/ml concentration 
wherever indicated. Confocal microscopy was performed using a Zeiss LSM710 and 
488 nm and 561 nm lasers for eGFP and mCherry respectively. Images were 
analysed using the Volocity software (Perkin Elmer). 
 
2.14.2 3D-Structured Illumination Microscopy  
To study ParF localisation and its appearance in vivo on greater detail and at a higher 
level of resolution, super resolution 3 Dimensional-Structured Illumination 
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Microscopy (3D-SIM) was exploited The protocol applied was based on that 
described in (Schermelleh et al., 2008). The cells were grown and the microscopy 
slides were prepared by using the same protocol as in 2.14.1. Images were acquired 
at SULSA, University of Dundee, using a 100x 1.4NA, oil immersion objective lens 
(Olympus, Center Valley, PA) and an electron-multiplying charge - coupled device 
(EMCCD) cameras (Photometrics, Tucson, AZ) on the OMX version 3 system 
(Applied Precision) equipped with 405-, 488-, and 593-nm solid-state lasers. 
Samples were illuminated by a coherent scrambled laser light source that had passed 
through a diffraction grating to generate the structured illumination by interference 
of light orders in the image plane to create a 3D sinusoidal pattern, with lateral 
stripes approximately 0.2 µm apart. Raw images were processed and reconstructed to 
reveal structures with greater resolution implemented on SoftWorx, ver. 6.0 (Applied 
Precision, Inc.). The channels were then aligned in x, y and rotationally. The images 
were analysed by 3D opacity using the Volocity software (Perkin Elmer). 
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Chapter 3: Residues crucial for the partition of plasmid 
TP228 were identified in the N-terminal tail of ParG 
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3.1 Introduction 
The large, low copy number, multidrug resistant plasmid TP228 harbours the 
parFGH partition cassette, which consists of the two partition genes, parF and parG, 
and the cis-acting centromere sequence parH. ParF is a Walker-type ATPase, which 
forms polymers upon binding to ATP and acts as a motor to segregate plasmid DNA. 
ParG is a site-specific DNA-binding protein that associates to the centromere site 
parH, which is located upstream of the partition genes and recruits ParF to the 
segrosome to carry out plasmid segregation (Barillà et al., 2005). ParG also acts as a 
transcriptional repressor of the parFG genes. ParG is a dimer and each of its 
monomers consists of a folded C-terminal domain containing a ribbon-helix-helix 
(RHH) motif, whereas the first 32 amino acids of the N-terminus form a flexible tail 
(Figure 3.1) (Golovanov et al., 2003). 
 
Although the ParG N-terminal end is unstructured, it is involved in various functions 
implicated in the partition of plasmid TP228. They are as follows: 
 
1. the transcriptional repressor function of the ParG protein is modulated by its 
N-terminal end. Similarly, the binding affinity of ParG for the partition site is 
altered by the N-terminal end (Carmelo et al., 2005, Wu et al., 2011a).  
2. ParG enhances ParF polymerization possibly by bundling ParF filaments or 
stabilizing the proto-filaments and the N-terminal tail of ParG appears to be 
involved in this activity (Barillà et al., 2005).  
3. the ATP hydrolysis of ParF is augmented by ParG and this is attributed to the 
arginine finger motif present in the ParG N-terminal end (Barillà et al., 
2007). 
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Figure 3.1. Structure of the ParG dimer. 
The two β-sheets are arranged in an anti-parallel fashion into a β-ribbon (yellow) and four α-
helices are tightly packed together (red). N-terminal tails are shown in green. The structure 
was generated by using PyMol (DeLano, 2002). 
N- N- 
C- 
C- 
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Conventionally it is expected that the protein function is related to its tertiary 
structure and the unstructured region of protein is not functionally active (Dyson and 
Wright, 2005). However, it has been recently observed in various proteins that the 
unfolded regions are also involved in a variety of functions. It has been suggested 
that disordered domains present three advantages that appear to be universal for any 
protein with such regions (Dafforn and Smith, 2004). The first advantage is 
accessibility gained by protein using the flexible regions during binding the partner 
protein or cellular targets. While gaining lateral advantage it also gives spatial 
efficiency compared to the globular regions. The third advantage is cooperativity as 
protein might present more binding sites with the help of unstructured and flexible 
regions. If the interaction is weak due to the flexible region, this might ease assembly 
and disassembly, which is an added advantage for some proteins. The translocation 
domain of colicin E9, a bacterial toxin, is disordered and mobile (Collins et al., 
2002). The flexibility conferred by the unstructured region may assist the colicin to 
bind its partner proteins or outer membrane receptors during translocation, which 
eventually help to exert cytotoxic effect. Many proteins involved in regulation, 
recognition and cell signalling show presence of intrinsically disordered regions 
which might act as an identifying feature for such proteins (Uversky et al., 2005). 
Disordered regions are also reported to form a substantial part of the eukaryotic 
transcriptional factors (Miller, 2009). Even though the long stretches of flexible 
regions are not found in prokaryotic transcriptional factors like in their eukaryotic 
counterparts, transcriptional repressors like MetJ and Arc also exhibit short N-
terminal flexible regions, which make important DNA backbone contacts. In the 
argument for using flexible regions it has been suggested that the flexible regions of 
these proteins allow them to adapt to the conformational changes induced by for 
example bending of operator DNA (Raumann et al., 1994). The flexible region may 
also fold against the phosphate backbone of DNA which could reduce non-specific 
binding to retain a stable complex (Raumann et al., 1994). ParG is a member of the 
MetJ/Arc transcription repressor superfamily. The N-terminus of ParG might be 
involved in making DNA contacts as well as interactions with the partner protein 
ParF.  
 
The aim of this project was to study the ParG N-terminal region and establish the 
role played by individual amino acids of this flexible tail. This was achieved by 
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using alanine-scanning mutagenesis. Alanine is a widely utilised choice of 
substitution as it is non-bulky residue and conformational change in the protein due 
to alanine substitution is considerably less (Ziolkowska et al., 2006). The efficiency 
of an active partition system can be tested by employing a plasmid partition assay. In 
the absence of antibiotic selective pressure, low copy number plasmids are retained 
due to an active segregation process (Hayes, 2000). Partition assays were performed 
for all of the ParG N-terminal mutants to determine their partition efficiency. If 
plasmids carrying any of the mutant parG alleles show a retention rate lower than 
that of plasmids containing the wild type partition cassette this indicates that the 
residue change in the flexible tail of ParG plays a role in plasmid segregation.  
 
3.2 Results 
3.2.1 Construction of mutants in the N-terminal tail of ParG  
3.2.1.1 Experimental setup 
A stability probe vector, pALA136 was used in the past to identify the elements 
responsible for plasmid segregation (Macartney et al., 1997). Plasmid pALA136 is a 
pBR322 derivative having two origins of replication i.e. P1, for low copy number 
and ColE1, for medium copy number. Under conditions that support only low copy 
number replication, vector pALA136 is highly unstable. If partition genes are 
introduced into pALA136, its stability increases. In this project, two vectors were 
used viz. pFH450 (7510 bp) and pFH547 (8972 bp), which were derived from 
pALA136. Plasmid pFH450 was generated by introducing multiple cloning sites into 
pALA136 . While screening for the segregation stabilising region in plasmid TP228, 
a partition locus was identified and then cloned into pFH450 using the restriction 
sites SalI and EcoRI to generate pFH547 (Hayes, 2000). This locus was later 
characterised as the parFGH partition cassette of plasmid TP228. 
 
The pFH547 construct containing the wild type parFGH partition cassette was used 
as the template for mutagenesis in this project (Figure 3.2). Two restriction sites, 
ClaI in the parF gene and HpaI in the parG gene, were used to swap the wild type 
region with a fragment carrying a mutation in the 5’ end of parG. 
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Figure 3.2. Vector map of pFH547. 
Plasmid pFH547 harbouring the wild type parFGH partition cassette contains the 
chloramphenicol resistance gene and exhibits two origins of replication for low and medium 
plasmid copy number. The restriction sites used for generating mutations in the N-terminal 
end of ParG were ClaI and HpaI. 
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3.2.1.2 Amplification and cloning of mutant parG alleles 
Overlap extension PCR was carried out as outlined in the section 2.3.1, using two 
sets of external and internal primers to introduce mutations in the 5’ end of parG. 
The external forward primer contained a ClaI restriction site and the external reverse 
primer contained a HpaI restriction site. The internal forward and reverse primers 
were designed to contain the desired mutations. In PCR reaction 1, forward external 
primer and reverse internal primers were used to generate a 224 bp PCR fragment. In 
PCR reaction 2, the forward internal primer and reverse external primers were used 
to amplify a fragment around 254 bp in size. As an example, the PCR products 
leading to the construction of the mutant allele encoding ParG-M13A are shown in 
Figure 3.3. 
 
 The two fragments generated in separate PCR reactions display overhangs due to 
the overlapping sequence in the internal primers used in the amplification. These two 
PCR fragments were incubated together, allowed to anneal and the single strands 
extended in the absence of primers. Subsequently PCR 3 was carried out with the 
external forward and reverse primers to amplify the whole DNA fragment, which 
was approximately 434 bp. As an example, the product of PCR 3 leading to the 
construction of the mutant allele encoding ParG-N18A is shown in Figure 3.4A. 
 
The DNA product of PCR 3 was digested with ClaI and HpaI, which generated two 
fragments of 260 and 120 bp, of which the 260 bp one contained the parG mutation. 
This fragment was then cloned into pFH547 vector (Figure 3.4B). E. coli DH5α cells 
were transformed with the ligation mixture and a few colonies were picked to screen 
for positive clones by colony PCR (Figure 3.5). The same external primers used in 
PCR 3 were also used for colony PCR. Colonies containing potential positive clones 
were inoculated over-night in LB medium. Plasmid DNA extraction was carried out 
and the clones were screened by digesting the plasmid with ClaI and HpaI. 
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Figure 3.3. A representative agarose gel showing the products of PCR 1 and PCR 2 
used for parG mutagenesis. 
DNA fragments were subjected to electrophoresis on a 1.2 % agarose gel. Lanes: L, Gene 
ruler 10 kbp ladder; 1 and 2, products of PCR 1 (254 bp); 4 and 5, DNA products of PCR 2 
(224 bp).  
 
 
Figure 3.4. Representative agarose gels showing the product of PCR 3 and those of the 
restriction digest of PCR fragment and pFH547 vector used for parG mutagenesis.  
A. Previously generated DNA fragments from PCR 1 and 2 are incubated together and 
subsequently amplified to obtain the DNA fragment with the desired mutation. Lanes: L, 
Gene ruler 10 kbp ladder and 1, PCR 3 product (434 bp). B. Both PCR DNA fragment and 
vector were digested with ClaI and HpaI and run on a 1.2% agarose gel. Lanes: L, Gene 
ruler 10 kbp ladder; 1, digested products of PCR 3, generating two fragments of 260 and 120 
bp; 2, digested pFH547 vector (~8.5 kbp).  
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Potential positive clones were sent for sequence analysis to GATC Biotech. The 
resulting sequencing data was analysed to identify mutant alleles (Figure 3.6). The 
constructed plasmids containing the correct mutations were named as pMB along 
with the change of amino acid and its position e.g. pMBS2A.  
 
The ParG protein contains two alanines at positions 6 and 27. They were not 
changed. Several attempts were made to mutate the valine and aspartic acid residues 
at position 10 and 20
 
respectively, but they were unsuccessful. Other lab members 
had already constructed the F15A, R19A and R23A ParG mutants. An overview of 
the entire mutagenesis plan is given in Figure 3.7.  
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Figure 3.5. Representative agarose gels showing colony PCR products and restriction 
digestion screen of pFH547 plasmids potentially harbouring the desired mutation. 
Colony PCR was carried out on five samples. Lanes: L, Gene ruler 10 kbp ladder; 1 to 5, 
colony PCR product of five candidates.  
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Figure 3.6. Sequences traces of mutant parG alleles.  
ABI sequencing data of individual parG mutations obtained from GATC was analysed with 
Chromas software. Each mutated codon is highlighted with a red box.  
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Figure 3.7. The parG gene and aligned protein amino acid sequence.  
The parG wild type gene sequence is shown above. Nucleotides in green encode the N-terminal flexible region, whereas yellow and red nucleotides encode 
the folded C-terminal region. The secondary structure of the different regions of the ParG is drawn below the sequence. The unstructured N-terminal region is 
indicated by line. Amino acids in black were changed to alanine, those in cyan were not changed, those in orange had already been changed by other lab 
members and those in magenta proved refractory to convert to alanine. 
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3.2.2 Identification of amino acids crucial for plasmid segregation 
Once mutations were constructed, it was determined whether they had an in vivo 
phenotype, i.e. any impact on plasmid retention. This was achieved by performing a 
partition assay using E. coli BR825, which is a polA strain whose defective DNA 
polymerase I supports replication only from the P1 low copy number origin. The 
partition assay is based on the principle that if BR825 cells are transformed with low 
copy number plasmids and grown in the absence of antibiotics, plasmids are retained 
after multiple generations only if they contain an active partition cassette. The 
partition assay was performed for all the plasmids harbouring the parG mutants to 
determine their plasmid partition efficiency. Two controls used in this assay were 
plasmid pFH450, which harbours no plasmid partition genes, and plasmid pFH547, 
which contains the wild type parFGH partition cassette from plasmid TP228. 
Together with these controls, all the pMB plasmids encoding parG mutants, were 
tested at least in triplicate. Plasmid retention was assessed by replica plating on solid 
agar medium with and without antibiotics after a time interval corresponding to 
about twenty-five generations. As the plasmid stabilising sequence is absent in 
FH450, the plasmid became very unstable and on average showed plasmid retention 
of ~8%. Plasmid pFH547 showed a higher retention of 65%. This is due to the 
presence of the wild type parFGH partition cassette. If plasmid retention decreased 
to less than 40%, it was assumed that the mutation had affected the partition process. 
 
Mutations leading to amino acid changes in the 3
rd
, 5
th
, 11
th
, 12
th
, 13
th
, 18
th
 and 21
st
 
residues of ParG resulted in lower plasmid retention, indicating that changes in these 
positions affect the partition system (Figure 3.8). ParG-N18A was shown to be the 
least efficient in plasmid retention (0%), whereas lowered plasmid retention was 
observed for ParG-L3A (8%), ParG-K5A-(30%), ParG-K11A (41%), ParG-K12A 
(16%), ParG-M13A (12%) and ParG-L21A (32%). It had been previously 
established that changes in the 15
th
 residue (F15A) reduced partition efficiency 
considerably (13%, unpublished data), similarly a change in the 19
th
 residue (R19A) 
resulted in a 34.7% plasmid retention, indicating an important role for this residue in 
plasmid TP228 segregation (Barillà et al., 2007). The mutation leading to the change 
R23A had no effect on plasmid retention (Barillà et al., 2007). These partition 
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deficient mutants were selected for further analysis to elucidate the role of the N-
terminus in plasmid segregation.  
 
The role of these amino acids in various functions of ParG such as activation of ParF  
ATP hydrolysis, enhancement of ParF polymerization, centromere binding and 
transcriptional repression of the parFG genes will be examined in the following 
chapters. 
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Figure 3.8. Plasmid retention percentage of ParG N-terminal mutants.  
Plasmid pFH450 lacks a partition cassette and pFH547 harbours wild type partition cassette. 
Percentages of plasmid retention were determined after performing assay for empty plasmid, 
wild type cassette containing plasmid and each mutant encoding plasmid at least in 
triplicate. Error bars represent the standard error of mean.  
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3.3 Conclusions  
Each amino acid in the unstructured ParG N-terminal tail was converted to alanine to 
elucidate the role played in plasmid segregation. Plasmid pFH547, which contains 
the wild type partition cassette parFGH, was used as a parent vector for the 
mutagenesis. With the exception of two alanines at positions 6 and 27, valine at 10 
and aspartate at 20, all the
 
other amino acids were successfully converted to alanine. 
A plasmid partition assay was carried out to study the effect of changes in the ParG 
N-terminal end on the segregation process. In the assay, the E. coli BR825 strain that 
supports only low copy number replication was used, making it necessary for 
plasmids to have an active segregation process for their survival. Although the ParG 
N-terminal tail is flexible, even a single amino acid change in this region can alter 
the partition efficiency (Figure 3.9). Leucine at position 3 and 21 and lysine at 
position 5, 11 and 12 lowered plasmid stability, when changed to alanine. The 
positively charged lysines may be involved in DNA-binding and hence altering the 
partition function of ParG. ParG is a type I transcriptional repressor of RHH family 
where basic residues are present at the beginning of the β-strand (Golovanov et al., 
2003). The pair of basic residues KK in the flexible N-terminal region at position 11 
and 12 may help in additional DNA binding. Mutation of methionine at position 13 
also showed reduced plasmid retention. When asparagine at position 18 was mutated 
to alanine, plasmid partition was found to be reduced almost to zero. Asparagine 18 
is part of the arginine finger motif harboured in the flexible tail and thus its 
conversion to a different amino acid might affect the motif and alter ParG functions 
such as stimulation of ParF ATPase activity or enhancement of ParF polymerization. 
Here amino acids that are crucial for the partition of plasmid TP228 have been 
identified. However, the exact role played by these residues can only be determined 
by performing further biochemical assays.  
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Figure 3.9. Structure of ParG dimer showing the position of amino acids located in the N-terminal tail, which are crucial for plasmid partition. 
Residues in the N-terminal flexible tail of ParG, whose change cause plasmid segregation defects, are highlighted. The structure was generated with PyMol 
(DeLano, 2002). 
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Chapter 4: ParG N-terminal mutant proteins are dimers, 
bind to DNA and act efficiently as transcriptional 
repressors of the putative parFG operon 
Chapter 4 
 
111 
4.1 Introduction  
Mutations in the region of the parG gene encoding the N-terminal flexible region 
(L3A, K5A, K11A, K12A, M13A, F15A, N18A, R19A and L21A) affect the 
plasmid partition function of the ParG protein, as the stability of plasmids carrying 
these mutations is lower (Chapter 3). Here the mutant proteins were purified as 
recombinant polypeptides from E. coli using affinity chromatography. In this 
section, three questions will be addressed pertaining to ParG and its role in plasmid 
partitioning. The first is: do these mutations compromise the ability of ParG to 
dimerize? The second is: how do they affect the DNA binding function of ParG? 
And the third is: are these mutant proteins able to act as a transcriptional repressor of 
the putative parFG operon?  
 
The partition protein ParG exhibits a folded domain consisting of a RHH motif at the 
C-terminal end and a flexible tail at the N-terminal end. The folded domains of two 
ParG monomers interlace to form a dimer. Molecular hydrophobicity potential 
(MHP) contact plots revealed that the inter-monomeric hydrophobic contacts are 
stronger than the intra-monomeric hydrophobic contacts. Amino acid residues V37, 
V39, F41, K45, R48, F49, V64, L67, V68, W71 and L72 of the C-terminal domain 
are implicated in ParG dimerization (Golovanov et al., 2003). ParG is a member of 
the MetJ/Arc repressor family and a number of proteins from this family also show 
the conserved hydrophobic residues at similar positions. The ParG N-terminus 
(residues 1-32) is unstructured, but residues 17 - 23 form transient secondary 
structures (Golovanov et al., 2003). Even though the flexible region is not involved 
in dimerization, it was important to establish whether the mutant ParG proteins can 
still form dimers.  
 
ParG, a centromere binding protein (CBP), is functionally analogous to other ParB 
proteins like P1 ParB and RK2- KorB but it is structurally unrelated to them. Type Ia 
CBPs contain a N-terminal Helix-turn-helix (HTH) fold whereas type Ib, e.g. ParG, 
and type II, e.g. ParR, CBPs contain a RHH fold. Members of this functionally 
diverse superfamily regulate the transcription of genes that are involved in various 
cellular processes, including cell division and control of plasmid copy number. 
Structural analysis of MetJ and Arc proteins bound to their cognate DNA binding 
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site have shown that the antiparallel N-terminal β strands of the dimers are 
positioned in the DNA major groove (Somers and Phillips, 1992). Similarly, ParG 
makes contact with the DNA at the major groove through its antiparallel β-sheet. 
 
ParG binds DNA at the operator site of the parFG genes initially as a dimer of 
dimers and then as a pair of tetramers. Tetramer binding to DNA has been observed 
for other RHH transcriptional repressors in their protein crystal structures (Gomis-
Ruth et al., 1998, Raumann et al., 1994, Somers and Phillips, 1992). The flexible 
ParG N-terminal tail makes transient contact with DNA, facilitating the formation of 
a stable nucleoprotein complex. Deletion mutants in ParG N-terminus decreased the 
transcriptional repressor activity of ParG (Carmelo et al., 2005). The parFG operator 
site is “fine-tuned” for optimal ParG binding to attain parFG regulation. The flexible 
N-terminal tail modulates ParG interaction with the operator site (Zampini et al., 
2009). The DNA sequence upstream of the parFG genes comprises of 20 degenerate 
repeats with AT rich spacers. The first 12 repeats make the centromere site parH, 
whereas the later eight repeats form the operator site (OF) of the parFG genes. Both 
parH and OF have comparable centromere activity and ParG binds to them with 
similar affinity. A comprehensive analysis of the interaction of ParG with whole 
(full-length) and partial parH site was recently reported (Wu et al., 2011). ParG 
showed differential affinities to the sub-parts of the parH site. The N-terminal ParG 
deletion mutant Δ30, demonstrated strong binding to the whole parH sequence but 
showed less affinity to partial sequences (Wu et al., 2011a). ParG loses the 
specificity in the absence of the flexible tail, which testifies the multiple roles played 
by the ParG N-terminal end. 
 
In a variety of proteins, the unstructured domains perform prominent roles, which 
contradict the protein paradigm of “structure is equal to function”. Type I CBPs, 
ParB in plasmid P1and KorB in RK2 show disordered N-terminal regions along with 
HTH motif in the C-terminus (Rajasekar et al., 2010, Surtees and Funnell, 1999). 
Another type Ib CBP homologous to ParG, protein omega (ω) from plasmid 
pSM19035 shows an unstructured N-terminal region (Weihofen et al., 2006). Type 
II CBP, ParR from plasmid R1, contains a flexible tail in the C-terminus (Salje et al., 
2010). Transcriptional repressors like Arc, Mnt and MetJ also show small disordered 
region in the N-terminal end, which assist in establishing DNA contact and also 
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confer DNA binding specificity (Knight and Sauer, 1988, Knight and Sauer, 1989). 
The presence of disordered domains and the flexibility conferred by them, might 
give advantage to the CBPs and repressor proteins in carrying out functions like 
DNA binding, gene regulation and interacting with partner proteins (Rajasekar et al., 
2010). 
 
The flexible tail of ParG is implicated in DNA binding and determining specificity. 
In this chapter, the effects of the changes introduced in the N-terminal tail on ParG-
DNA interactions will be investigated. 
 
4.2 Results 
4.2.1 Cloning of mutant parG alleles into the expression vector 
pET22b  
ParG N-terminal mutant proteins were obtained using the pET expression system 
and tested in a number of biochemical assays. Each mutant parG gene was amplified 
by using a forward primer containing a NdeI restriction site and a reverse primer 
harbouring the XhoI site. The PCR product was a DNA fragment of around 250 bp. 
To amplify each mutant allele for cloning into the pET vector, the respective mutant 
partition plasmid (i.e. pMB plasmid series) was used as template DNA. The 
amplified DNA was then subjected to digestion with NdeI and XhoI, generating a 
250 bp fragment (Figure 4.1).  
 
These DNA fragments were then ligated into NdeI and XhoI digested pET22b vector 
and the recombinant plasmids selected on LB plates containing ampicillin. Plasmid 
DNA was isolated, screened by digestion with NdeI and XhoI to verify whether it 
contained the expected insert and potentially positive clones were sent for 
sequencing to GATC Biotech (Figure 4.2). On confirmation of the correct sequence 
these constructs were named as pET-MBL3A, pET-MBK5A, pET-MBK11A, pET-
MBK12A, pET-MBM13A, pET-MBN18A and pET-MBL21A. Plasmid pET-
ParGF15A had already been constructed and pET-ParF, pET-ParG and pET-
ParGR19A plasmids were part of the laboratory plasmid collection. 
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Figure 4.1. Representative agarose gel showing the restriction digestion of the PCR 
amplified parG mutant gene. 
The parG mutant gene fragment was obtained by PCR amplification and then digested with 
restriction enzymes NdeI and XhoI. The digested DNA material was run on 1.2% agarose 
gel. Lanes: L, Gene ruler 10 kbp and 1, a digested fragment of 250 bp, indicated by the 
arrow. 
 
 
Figure 4.2. A representative agarose gel showing products of the restriction digest 
screen of pET-parG plasmids harbouring mutations.  
Restriction analysis of plasmids was performed by digestion with restriction enzymes NdeI 
and XhoI. Lanes: L, Gene ruler 10 kbp and 1-6, digested DNA of clones isolated for 
screening.  
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4.2.2 Partition deficient mutant proteins were overproduced and 
purified  
Proteins were overproduced by using the pET expression system. His-tagged ParF, 
ParG and mutant ParG-L3A, ParG-K5A, ParG-K11A, ParG-K12A, ParG-M13A, 
ParG-F15A, ParG-N18A, ParG-R19A and ParG-L21A proteins were purified by 
Ni
2+
 affinity column. It has been previously reported that His-tagged partition 
proteins support plasmid partition in vivo as efficiently as native proteins (Barillà and 
Hayes, 2003). 
 
4.2.2.1 The ParF protein was purified by Ni
2+
 affinity chromatography 
The (His)6-tagged ParF protein is characterized by a molecular weight (MW) of 23 
kDa. The purification was carried out by using the protocol described in the section 
2.4.1 and the standard result is briefly outlined below. Pilot experiment estimated 3h 
as a suitable induction time for achieving a considerable level of parF gene 
overexpression. ParF was found to be soluble and bound to the Ni
2+
-charged resin. 
The eluted fractions were buffer-exchanged and quantified by Bradford assay, 
showing concentrations ranging between 0.3 mg/ml and 0.1 mg/ml. The purity of the 
fractions was analysed by SDS-PAGE (Figure 4.3).  
 
4.2.2.2 Purification of wild type ParG and the N-terminal mutant proteins by 
Ni
2+
 affinity chromatography 
The recombinant His-tagged ParG and the mutant proteins have a MW of 9.6 kDa. 
They were purified from the E. coli. by following the protocol described in the 
section 2.4.2. Two hours induction with IPTG was optimised to obtain a good yield 
of ParG protein. His-tagged ParG and mutant proteins bound to the Ni
2+
 column 
efficiently. The mutations did not affect solubility as all the mutant proteins were 
found to be stable in solution similar to wild type ParG. Typical concentration of 
ParG protein fractions ranged from 0.4 mg/ml to 0.9 mg/ml. All mutant proteins 
were separated without any major impurities. As representative examples, SDS gels 
for wild type ParG and ParG-L21A purification are shown in Figure 4.4 and 4.5, 
respectively. Transformation of BL21(DE3) with pET-parGF15A was not successful 
on several attempts hence ParG-F15A protein was not purified.  
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Figure 4.3. ParF protein was purified on Ni
2+
 affinity column. 
SDS-polyacrylamide gel showing various fractions collected during ParF protein 
purification process. Lanes: 1, un-induced cell culture sample before addition of IPTG; 2, 
pellets after centrifugation of sonicated induced culture; 3, the cell extract containing total 
soluble protein from the induced culture; 4, flow through; 5,6,8,9, buffer exchanged elution 
fractions of the ParF protein; 7, PageRuler Prestained Protein Ladder. His-tagged ParF is 
indicated by the arrow. 
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Figure 4.4. ParG was purified on Ni
2+ 
affinity column.  
SDS-polyacrylamide gel showing various fractions collected during ParG protein 
purification process. Lanes: 1, pellet fraction after centrifugation of sonicated culture; 2, cell 
extract containing total soluble protein; 3, flowthrough; 4, PageRuler Prestained Protein 
Ladder; 5-9, buffer exchanged elution fractions of the ParG protein. His-tagged ParG is 
indicated by the arrow. 
 
        
 
Figure 4.5. ParG-L21A purification.  
SDS-polyacrylamide gel showing various fractions collected during ParG-L21A protein 
purification process. Lanes: 1, PageRuler Prestained Protein Ladder; 2, uninduced cell 
culture sample saved before addition of IPTG; 3, pellet fraction after centrifugation of 
sonicated culture; 4, cell extract containing total soluble protein from the culture; 5, 
flowthrough; 6-10, buffer exchanged elution fractions of the ParG-L21A protein. His-tagged 
ParG-L21A is indicated by the arrow. 
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4.2.3 ParG N-terminal mutant proteins form dimers 
Dimerization of ParG mutants was studied by chemical cross-linking. Chemical 
cross-linking can detect both temporary and steady interactions, as covalent bonds 
are formed between two proteins. In this technique bi-functional reagents are used 
which contain reactive groups reacting with functional groups of proteins such as 
primary amines of amino acids. If two proteins are cross-linked, this indicates that 
they interact. The cross-linker used in this study was dimethyl pimelimidate (DMP) 
which is an amine-reactive imidoester-type cross-linker. Imidoester cross-linkers 
react with primary amines to form amidine bonds. 
 
ParG and mutant proteins were included in the cross-linking reactions at a final 
concentration of 20 µM and increasing concentrations of DMP were added ranging 
from 0 to 10 mM. Wild type ParG is a dimer (Golovanov et al., 2003). In the 
absence of DMP, ParG and all the mutant proteins ran as monomers in denaturing 
SDS-gels. When the proteins were incubated with DMP and then run on SDS-gels, 
all the proteins except ParG-K12A showed dimer formation and, at the highest DMP 
concentration, tetramers were visible (Figure 4.6). ParG-K12A failed to dimerize 
even at the highest concentration of DMP.  
 
When incubated with increasing concentrations of DMP, the dimerization pattern 
observed for ParG-R19A was not similar to that of other mutant proteins. At the 
highest concentration of DMP (10 mM), ParG-R19A showed a faint dimeric band 
(Figure 4.7A). With the exception of ParG-K12A, the remaining mutants displayed 
dimer formation in the presence of as little as 0.5 mM DMP. When ParG-R19A was 
incubated with DMP for a longer interval, it was possible to observe a band 
corresponding to dimeric proteins, but the extent of dimerization was not as strong as 
that seen for the other mutants (Figure 4.7B).  
 
The ParG-K12A residue change is in the flexible N-terminal end of ParG and is not 
expected to have any effect on ParG dimerization. To further investigate the apparent 
dimerization defect of ParG-K12A, a longer incubation with DMP was carried out. 
ParG-K12A at a concentration of 20 µM was used with 10 mM DMP, samples were 
incubated at 37°C for 1, 2 and 3 hours. ParG-K12A appeared unable to dimerize 
Chapter 4 
 
119 
even after extended incubation with DMP. After 3 hours no dimer formation was 
observed, whereas WT ParG dimers were visible after one hour (Figure 4.8A and 
4.8B). 
 
To further investigate whether ParG-K12A is impaired in dimerization, WT ParG 
and ParG-K12A mutant protein were analysed by Size Exclusion Chromatography 
associated with Multi Angle Laser Light Scattering (SEC-MALLS). The SEC-
MALLS data indicated that the elution profile of both WT and mutant protein was 
comparable. The molecular weight estimates were similar for WT and mutant 
protein. The determined mass was 20.4 kDa and it corresponded to the molecular 
weight of a dimer. No significant evidence of monomeric protein was found for 
either of the proteins (Figure 4.9). Thus, the SEC-MALLS analysis established that 
ParG-K12A is dimeric. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 120 
 
Figure 4.6. ParG mutant proteins are able to dimerize.  
SDS-polyacrylamide gels showing cross-linked products of WT and mutant ParG proteins following 1 h incubation at 37°C with and without increasing 
concentrations of DMP, i.e. 0.5, 1 and 10 mM. A. ParG and ParG-L3A B. ParG-K5A and ParG-K11A. C. ParG-K12A and ParG-M13A D. ParG-N18A and 
ParG-L21A. The protein concentration is 20 µM. L is PageRuler Prestained Protein Ladder in all gel images. 
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Figure 4.7. ParG-R19A forms dimers less efficiently.  
A. SDS-polyacrylamide gel showing the products of the incubation of ParG-R19A at 37°C for 1 h with and without increasing concentration of DMP i.e. 0, 
0.5, 1 and 10 mM. B. SDS-polyacrylamide gel showing the products of reactions in which DMP (10 mM) was added to 20 µM protein and incubated at 37°C 
for indicated time points. L is PageRuler Prestained Protein Ladder in all gel images. Monomer and dimer are indicated by the arrow on the right of each gel. 
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Figure 4.8. ParG-K12A does not show dimerization even after longer incubation with 
cross-linker.  
Reaction containing DMP (10 mM) and ParG-K12A (20 µM) were incubated at 37°C and 
run on SDS-polyacrylamide gels. A. ParG WT B. ParG-K12A. Lanes: L, PageRuler 
Prestained Protein Ladder in all gel images. Monomer and dimer are indicated by arrow on 
right of each gel. 
 
 
 
Figure 4.9. ParGK-12A is a dimer as established by SEC-MALLS.  
The protein samples with indicated concentrations were injected into a Superdex S75 
column. The Rayleigh ratio (light scattering signal, LS) is shown as a solid line and the MW 
traces are shown as a dashed line. The Astra software was used to estimate the MW from the 
RI (Refractive index) trace (proportional to concentration, not shown on the plot) and the LS 
signal by the standard Zimm fit. The experiment was performed and graph was prepared by 
Dr. Andrew Leech, Technology Facility, University of York 
. 
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4.2.4 Partition deficient N-terminal mutants bind to the putative 
parFG operator 
ParG is a centromere binding protein (CBP) that specifically recognizes the parH 
site. The centromere parH is made up of 12 degenerate repeats. Alongside parH, a 
parFG operator site is present upstream of the parF gene sequence. The operator site 
OF (Figure 4.11), consists of 8 degenerate repeats (3 direct and 5 inverted sequence) 
of 5’ ACTC- 3’. The tetramer motifs are separated by 4 bp, AT rich spacers 
(Zampini et al., 2009). ParG binds to the operator site and acts as a transcriptional 
repressor. The DNA binding ability of ParG mutant proteins was tested by 
electrophoretic mobility shift assays (EMSA) using a DNA fragment harbouring the 
operator site of the parFG genes. 
 
The 123 bp operator sequence upstream of parF was amplified by using a 
biotinylated forward primer (Figure 4.10). DNA binding can be studied by 
incubating different concentrations of protein with the same amount of DNA and 
running these complexes on native gel. Migration of these complexes depends on the 
size of the protein-nucleic acid complex.  
 
Figure 4.10. Agarose gel showing amplified parFG operator DNA sequence.  
The parFG operator sequence was amplified by PCR and run on 1.2% agarose gel. Lanes: L, 
PCR marker and 1, PCR product of operator sequence DNA, size 123 bp. 
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Figure 4.11. Operator of the parFG genes.  
The repeats present in the operator sequence are boxed and denoted by arrows. Start of parF gene is shaded in red. The green arrows indicate direct repeats 
whereas the blue arrows indicate inverted repeats.  
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EMSAs were performed using the biotinylated 123 bp DNA fragment (0.5 nM). 
ParG and mutant proteins at different concentrations ranging from 100 to 1000 nM 
were incubated with the DNA fragment and shift of the complexes was examined 
(Figure 4.12). ParG binds as a dimer of dimers on the two adjacent tetramer boxes in 
the operator site and produces a single nucleoprotein complex. As the concentration 
of the protein increases, ParG spreads over the entire operator site and assembles into 
a larger nucleoprotein complex. It has been observed previously that eight ParG 
dimers were required to cover the entire operator site (Zampini et al., 2009). DNA 
binding of ParG-L3A and ParG-K5A resembled the pattern observed for WT ParG 
with the exception of the reaction containing 100 nM protein which showed some 
unbound DNA. ParG-K11A did not shift all of the operator DNA until it reached a 
concentration of 400 nM, which may suggest a lower binding affinity. However, a 
further increase in protein concentration resulted in the formation of a nucleoprotein 
complex identical to that observed for WT ParG and other mutant proteins. ParG-
K12A, ParG-M13A, ParG-N18A and ParG-R19A also showed a complete shift of 
the DNA at the lowest concentration of 100 nM similarly to WT ParG. ParG-L21A 
exhibited a lower DNA binding affinity as some unbound DNA was still visible up 
to a protein concentration of 700 nM. At higher concentrations, ParG-L21A bound to 
all the DNA in the reaction and a complete shift was visible on the gel.  
 
Overall, these findings suggest that the N- terminal mutation do not adversly affect 
the DNA binding activity. However the behaviour of the mutant proteins at 
concentration below 100 nM was not tested for DNA binding and whether ParG 
mutants show altered binding still needs to be investigated. It has been reported that 
the deletion of the entire ParG N-terminal tail improves binding of ParG to the full 
length centromere as well as resulting in the loss of substrate specificity (Wu et al., 
2011a). It is possible that the ParG mutants described here may also be invoved in 
determing DNA binding specificity. 
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Figure 4.12. ParG mutant proteins retain the ability to bind DNA.  
Increasing concentrations of WT and mutant ParG proteins were incubated with the 123 bp 
DNA fragment (0.5 nM) harbouring the parFG operator and subjected to EMSA. Unbound 
DNA is indicated by a hollow arrow and the filled arrow indicates the shifted nucleoprotein 
complexes. 
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4.2.5 Partition deficient ParG N-terminal mutants are still proficient 
in transcriptional repression of the putative parFG operon 
To analyse the transcriptional repressor function of wild type and mutant ParG, a 
catechol 2-3 dioxygenase (CDO) reporter assay was carried out. This assay is based 
on the production of catechol 2, 3-dioxygenase encoded by the Pseudomonas putida 
TOL plasmid gene xylE. The pDM3.0 plasmid (Macartney et al., 1997) used in this 
assay contained xylE, cloned downstream of the parFG promoter region in order to 
have its expression modulated by ParG (Figure 4.13). This plasmid was transformed 
into E. coli cells together with parG expressing plasmids. Cell extracts containing 
the xylE product become yellow within seconds upon addition of catechol (Zampini 
et al., 2009). Catechol is a colourless substrate that is converted into a yellow 
coloured product, 2-hydroxymuconic semialdehyde by CDO. One CDO unit is the 
amount of enzyme that oxidizes 1 µmol of catechol per min at 24ºC. 
 
In this assay pET-MB ParG mutant constructs generated for protein production were 
used to express parG. BL21(DE3) cells were co-transformed with xylE containing 
pDM3.0 separately with pET22b, pET-ParG and pET-MB ParG mutant. Cells co-
transformed with pDM3.0 and pET22b vector showed 100% expression of the xylE 
gene, co-transformation of pDM3.0 and pET-ParG resulted in transcriptional 
repression of xylE, whereas co-transformation of pDM3.0 and pET-MB ParG 
mutants affected the expression of xylE depending on the consequence of the change 
of N-terminal end residues on ParG transcriptional repression activity. When 
pDM3.0 was co-transformed with pET22b, the expression of xylE resulted in 
approximately 1800 CDO units, but on co-transformation with WT pET-ParG, xylE 
expression was repressed and less than 100 CDO units were produced. It was 
observed that all the partition deficient ParG N-terminal mutants were not affected in 
their transcriptional repressor activity, as the CDO units generated did not vary much 
as compared to those obtained with WT ParG (Figure 4.14). The CDO units for 
ParG-L3A, ParG-K5A, ParG-K11A, ParG-R19A and ParG-L21A were similar to 
those observed for WT ParG. ParG-K12A, ParG-M13A and ParG-N18A showed a 
level of repression that was half of that displayed by WT ParG. However they were 
still proficient in xylE repression. This demonstrated that, even though all these 
mutants are deficient in plasmid segregation, they all are still able to repress 
Chapter 4 
 
128 
transcription. These results are in agreement with the finding that the partition 
deficient mutants are efficient to bind the parFG operator DNA and hence the 
transcriptional repression action is not altered.  
 
 
 
 
 
Figure 4.13. Vector map of pDM 3.0.  
Plasmid pDM 3.0 contains xylE reporter gene cloned downstream of the parFG promoter 
sequence.  
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Figure 4.14. The ParG N-terminal mutants retain their in vivo transcriptional 
repressor function.  
The repressor activity of WT ParG and mutant proteins was tested by CDO reporter assays. 
The results are averages of three experiments performed in triplicates and error bars 
represent the standard error of the mean, SEM.  
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4.3 Discussion and Conclusion 
ParG is a dimer and the antiparallel β-strands of this dimer make direct contacts with 
the major groove of DNA. As ParG dimer formation is necessary for DNA binding, 
the first step was to test the ability of the partition deficient proteins to form dimers. 
This was also necessary to rule out the possibility that, the observed plasmid 
partition defect was due to the impairment in dimerization of the mutant proteins. 
When tested by chemical cross-linking, except ParG-K12A and ParG-R19A, other    
mutant proteins appeared dimeric in nature, similar to WT ParG. Imidoester cross-
linkers react with primary amines to form amidine bonds. The DMP is not very 
stable and efficicent at higher pH and the amidine bond formed can be reversible. 
The cross-linker reacts with primary amine (-NH2) and in case of ParG-K12A, it 
appeared that DMP was not able to cross-link the protein in the absence of lysine and 
hence the reaction could not occur. However, with the SEC-MALLS experiment it 
was established that ParG-K12A was indeed a dimer. It is possible that the dimer 
formation in case of ParG-R19A was not very stable as weak bands were observed. 
The DNA binding and transcriptional repressor activities of ParG-R19A were not 
found altered. This may indicate that the eventhough cross-linking failed to 
demonstrate ParG-R19A dimerization; R19 has no prominent role in dimerization. 
The results obtained here support the previous finding that the ParG N-terminal 
domain has no detectable role in ParG dimerization. 
 
ParG binds as a dimer of dimers to the operator sites (Zampini et al., 2009) which 
results in the formation of a nucleoprotein complex in the EMSA experiments for 
ParG mutant proteins (Figure 4.12). When investigated for DNA binding function, 
overall the partition deficient ParG mutants showed no significant change in this 
activity at higher protein concentrations. However, the DNA binding was not tested 
below 100 nM protein concentration. ParG-K11A showed less affinity to the DNA at 
below 500 nM concentrations. Whereas ParG-L21A appeared the most affected 
mutant. L21 residue is in the region of a tail that may form transient secondary 
structure and involved in DNA binding. The change in L21 may lead to abolishing 
the DNA binding activity but it needs to be probed further. The dimerization and 
transcriptional repression activity of ParG-L21A was found to be similar to WT 
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ParG hence the aleteration in DNA binding and its implication on plasmid partition 
need to be examined in further details. 
 
When partition deficient ParG mutants were tested for the transcriptional repressor 
function, none of the mutants showed alleviation of the repression. It is speculated 
that the abundance of positively charged residues in the N-terminal end helps in 
binding to negatively charged DNA. As a result, a single amino acid change is 
unlikely to alter the DNA binding and repression function. Hence, the mutant 
proteins showed efficient DNA binding and retained the transcriptional repression 
function.  
 
The partition deficiency shown by ParG N-terminal mutants was not related to their 
DNA binding or transcriptional repressor function, hence their effect on activating 
ParF polymerisation and enhancing ParF ATPase activity were tested as the next 
step. 
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Chapter 5: ParG N-terminal tail is important for 
interaction with the partner protein ParF and stimulation 
its ATPase activity
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5.1 Introduction 
The focus of this project is on the unstructured and multifunctional N-terminal end 
of ParG. It has been reported in Chapter 3 that the mutations in the L3, K5, K11, 
K12, M13, N18, R19 and L21 of the ParG N-terminal end decreased the efficiency 
of plasmid partition. The partition deficient ParG mutant proteins were still able to 
form dimers, bind DNA efficiently and act as transcriptional repressors of the parFG 
operon (Chapter 4). The flexible N-terminal tail of ParG is involved in enhancement 
of ParF polymerization. In addition an arginine finger motif in the N-terminus has 
been shown to be responsible for the stimulation of ParF ATPase activity (Barillà et 
al., 2007). To further probe the consequences of these mutations on plasmid 
partition, the mutants were tested for their efficiency in stimulating ParF 
polymerization and ATPase activity and the results are reported in this chapter.  
 
Cellular organization in eukaryotes is attributed to cytoskeletal proteins like actin, 
tubulin and intermediate filaments. Recently, the prokaryotic homologues of these 
proteins were reported in various bacteria. The cell division protein FtsZ is a tubulin 
homologue whereas the shape determining protein MreB in rod-shaped bacteria is an 
actin homologue. In bacteria, there is another type of cytoskeletal proteins which 
have no eukaryotic counterparts and they are known as Walker A Cytoskeletal 
ATPases (WACAs) (Ingerson-Mahar and Gitai, 2012). Members of the WACA 
group fall under the superclass of P-loop NTPases. Nucleotide-dependent 
polymerization by NTPases plays an important role in fundamental processes like 
cell division, which are essential for the propagation of living species (Schumacher, 
2008). 
 
Previous investigations on ParF in the presence of ATP by negative-stain electron 
microscopy revealed that ParF forms a filamentous structure in vitro (Barillà et al., 
2005). Recently the crystal structure of ParF dimer was solved in the presence of 
non-hydrolysable ATP analogue, AMPPCP (Schumacher et al., 2012). ParF- 
AMPPCP crystal structure showed the striking feature of polymer formation. The 
building block of the linear ParF polymer was shown to be a dimer-of-dimer unit. 
The polymer formation appeared as a stacking of one dimer-of dimer unit over the 
second dimer-of dimer unit where tip of the one unit notches into the second unit 
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(Schumacher et al., 2012). ParG promotes ParF polymerization possibly through two 
mechanisms i.e. nucleation and bundling (Figure 5.1). When ParG binds to ParF in 
the absence of a nucleotide, it might bridge adjacent ParF monomers by employing 
the two N-terminal flexible tails present in the ParG dimer (Barillà et al., 2007). It is 
possible that the mobile extensions of ParG act as sticky tentacles binding to the 
ParF monomers in solution, assisting and stabilizing the formation of the nucleus 
critical for filament growth. This function can be designated as ‘nucleation’. ParF 
polymerizes upon binding ATP. When ParG is added to this ParF-ATP complex, 
multiple ParG dimers might associate with the ParF polymers along their length and 
might cross-link adjacent filaments. We refer to this ability of ParG as a ‘bundling’ 
function (Barillà et al., 2005). ParG mutants were tested for both nucleation and 
bundling activities to determine the exact role played by the ParG flexible tail in 
ParF polymerization.  
 
ParF polymerization is promoted by ATP and is inhibited by ADP. The nucleotide 
bound state may be a key factor in elucidating the underlying partition regulatory 
mechanism in vivo (Hayes and Barillà, 2006b). ParF is a weak ATPase and ParG 
stimulates this activity. The arginine finger motif in the ParG N-terminal tail is 
implicated in stimulating ParF ATPase activity (Barillà et al., 2007). The residues at 
position 3, 5, 11, 12 and 13 are not part of the arginine finger but still crucial for 
plasmid partition. These mutant proteins will be tested to investigate if they are still 
able to stimulate ParF ATPase activity. 
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Figure 5.1. Two potential mechanisms by which ParG might promote ParF 
polymerization i.e. nucleation and bundling. 
ParF monomers are shown as blue circles, ATP as orange triangle and ParG dimer with 
mobile tails as yellow ovals. A. Nucleation process: ParG dimers with their mobile N-
terminal tails bind ParF monomers and form a nucleus which serves as a starting point for 
polymerization. B. Bundling process. (i), Diagrammatic representation of ParF structure. 
ParF forms dimer on ATP binding and the dimers of ParF dimers get packed to generate 
polymers (Schumacher et al., 2012). (ii), ATP bound ParF proto-filaments are cross-linked 
by ParG and an extended mesh is formed.  
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5.2 Results 
5.2.1 Partition deficient ParG N-terminal mutants are able to 
stimulate ParF polymerization 
The effect of ParG on the polymerization of ParF was monitored in real time by 
Dynamic Light Scattering (DLS). DLS is different from static light scattering as it 
measures the hydrodynamic radius of the protein. Particles in solution follow 
Brownian motion and in DLS the measurement of this motion can be used to 
determine the size of the particles. The radius is denoted as hydrodynamic because 
DLS measures how a particle diffuses within the fluid. In DLS the intensity of the 
scattered light is also recorded. The changes in this intensity and particle size were 
analysed to study ParF polymerization. 
 
In a typical DLS experiment, ParF (2.16 µM) was monitored for a few minutes to 
obtain a baseline which also exhibits dispersed nature of ParF in the absence of 
nucleotide. On addition of ATP (500 µM), ParF started to polymerise extensively, 
which triggered an increase in the intensity of light scattering (6000 to 12000 kct/s) 
and a simultaneous increase in the size of the particles in solution. When a plateau 
was reached for ATP-induced polymerization, WT ParG (2.16 µM) was added. A 
steep increase in the intensity of light scattering was observed (~ 20000 kct/s), as 
polymerization was enhanced by ParG (Figure 5.2A). The instantaneous 
enhancement in ParF polymerization suggests that ParG might cross-link ParF proto-
filaments. In contrast, the particle size showed a steady increase rather than a swift 
change (Figure 5.2B). Particles of around 1000 nm were observed. ParF filament 
bundles observed by EM in the past showed a length of around 650 nm (Barillà et 
al., 2005). All the buffers, solutions of ATP, MgCl2 and fractions of WT and mutant 
ParG protein were tested separately in DLS experiment as a control to check if there 
was any residual or inherent polymerization associated with them. None of these 
components showed any increase in light scattering, which means that in the ParF 
polymerization reaction they do not contribute to the increased intensity of light 
scattering. 
 
The ability of ParG N-terminal mutant proteins to promote ParF polymerization was 
analysed. After defining the baseline for ParF and then recording ATP induced ParF 
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polymerization, ParG mutants (2.16 µM) were separately added to the reaction. All 
the mutants (ParG-L3A, ParG-K5A, ParG-K11A, ParG-K12A, ParG-M13A, ParG-
N18A and ParG-L21A) showed the same efficiency as WT ParG in enhancing ParF 
polymerization and showed the same pattern of sudden increase in intensity of light 
scattering (in the range of ~20000 to 30000 kct/s) and a steady increase in the 
particle size (Figure 5.2A and B). The increase in the intensity was speculated to be 
due to the bundling of adjacent ParF polymers by ParG, which may still not 
accelerate polymer growth per se. It has already been reported that the ParG-R19A 
induces a steep increase in ParF polymerization, as an increase of scattered light 
similar to that triggered by WT ParG was recorded hence the experiment was not 
repeated here (Barillà et al., 2007).  
 
It was previously shown that ∆9, ∆19 and ∆30 ParG N-terminal truncated proteins 
fail to stimulate ParF polymerization beyond the level induced by ATP. This may 
indicate that stimulation of ParF polymerization is not dependent on individual 
amino acids in the ParG tail, but it is a cumulative effect, exerted by the flexible tail 
possibly acting like ‘sticky tentacles’ as previously proposed (Barilla, et al. 2007). 
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Figure 5.2. Partition deficient ParG N-terminal mutant proteins are still proficient in 
enhancing ParF polymerization.  
A. DLS experiment in which the increase in the light scattering intensity (kct/s) was 
recorded for wild type ParG and all the mutants, whose profile is shown according to the 
colour code. For the first 3 minutes, the intensity of light scattered by ParF (2.16 μM) was 
recorded and a baseline obtained. Then ATP (500 μM) and MgCl2 (5 mM) were added and 
ParF polymerization was observed. Readings were taken for the next 9 minutes and then WT 
or mutant ParG proteins (2.16 μM ) were individually added in a 1:1 molar ratio and reaction 
was observed further for around 30 minutes. B. The size of the particles (nm) was recorded 
at the same time as the intensity of scattered light. The order of addition of ligands to the 
reaction is the same as in A. The data shown are representative examples of experiments 
performed in triplicate. 
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5.2.2 Partition deficient ParG-L3A and ParG-K12A mutant proteins 
failed to nucleate ParF polymerization 
As previously mentioned, ParG may promote ParF polymerization in the absence of 
ATP and this activity may be described as nucleation. To evaluate the ability of the 
ParG mutants to nucleate ParF polymers, a DLS experiment was designed and set up 
following a different protocol. To begin with, monomeric ParF (2.16 µM) was 
monitored to obtain a baseline and then WT ParG was added to the reaction at an 
equal concentration (2.16 µM) allowing ParF-ParG interaction in the absence of a 
nucleotides. An increase in the intensity of scattered light was immediately observed 
(500 to 3000 kct/s), although this was more modest, when compared to the 
polymerization occurring as a result of ParF-ATP interaction. To the ParF-ParG 
reaction mixture, MgCl2 (5 mM) and ATP (500 µM) were added and the reaction 
was monitored for 10 further minutes. The ParF-ParG nucleation core responded to 
the ATP and a second steep increase in the intensity of scattered light was observed 
(6000 to 9000 kct/s) (Figure 5.3). This confirmed the ability of ParG protein to 
nucleate ParF molecules in the absence of ATP. Although the overall intensity of 
scattered light recorded during the nucleation process was less pronounced, 
compared to that recorded during the bundling activity.  
 
All the mutant proteins were tested for the ability to nucleate ParF using the same 
protocol. ParG-N18A showed a nucleation pattern identical to that of WT ParG. It 
stimulated ParF polymerization, in the absence of ATP, to the same level of WT 
ParG and the core formed by ParF-ParGN18A, which responded to ATP, showed a 
similar increase in intensity of light scattering. ParG-K5A, ParG-K11A, ParG-
M13A, ParG-R19A and ParG-L21A showed comparable nucleation activity, as a 
similar increase in intensity was observed (500 to 3000 kct/s). However, when ATP 
was added, the increase in intensity of scattered light was less than that observed for 
the reaction containing WT ParG. This may indicate that the core formed by ParF-
ParG mutants was not able to respond to ATP in the same manner as that containing 
WT ParG. ParG-L3A and ParG-K12A showed a very small increase in intensity 
(~1000 kct/s), when added to ParF compared to other mutants and there was no 
increase in intensity at all on the addition of ATP (Figure 5.3).  
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The size of ParF polymers increased gradually in the presence of WT and mutant 
ParG proteins, however the maximum size was 400 nm compared to a particle size 
of 1000 nm seen during the ParF bundling by ParG and its mutants (Figure 5.4). The 
data for the particle size also appeared very noisy, indicating the formation of mixed 
populations of ParF oligomers of different sizes.  
 
Based on these results, the nucleation activity of ParG mutants can be divided into 
three categories: high, medium and low levels of nucleation. All the ParG N-terminal 
partition deficient mutant proteins are efficient in bundling ParF and stimulate 
polymerization, but they are dissimilar in nucleation. ParG-L3A and ParG-K12A are 
impaired in the nucleation of ParF thus giving a phenotype that can be summarized 
as bundling (+)/nucleation (-). ParG-K5A, ParG-K11A, ParG-M13A, ParG-R19A 
and ParG-L21A have not lost their nucleation activity completely, but they are not as 
efficient as WT ParG showing the phenotype bundling (+)/nucleation (+) whereas 
ParG-N18A showed the same high nucleation and bundling activity as that of WT 
ParG and exhibits a bundling (+)/nucleation (++) phenotype (Table 5.1). 
 
Table 5.1 ParG mutants are categorised depending upon their ability to carry out 
nucleation and bundling of ParF. 
Mutants Nucleation Bundling 
ParG WT ₊ ₊ + 
ParG-L3A - + 
ParG-K5A + + 
ParG-K11A + + 
ParG-K12A - + 
ParG-M13A + + 
ParG-N18A ₊ ₊ + 
ParG-R19A + + 
ParG-L21A + + 
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Figure 5.3. ParG mutant proteins show dissimilar performance in nucleation function.  
DLS experiment in which the increase in the light scattering intensity (kct/s) was recorded for wild type ParG and all the mutants, whose profile is shown 
according to the colour code. For the first 3 minutes, the intensity of light scattered by ParF (2.16 μM) was recorded and a baseline obtained. Then WT or 
mutant ParG proteins (2.16 μM ) were individually added in a 1:1 molar ratio and ParF polymerization by nucleation function was observed. Readings were 
taken for the next 9 minutes and then ATP (500 μM) and MgCl2 (5 mM) were added. Reaction was observed for further 12 minutes. Depending upon the 
intensity signal, mutants are categorised into high, medium and low nucleation, as shown on right hand side. Data shown is the average intensity calculated 
from six different experiments.  
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Figure 5.4. Change in particle size was observed during ParF polymerization caused by 
nucleation activity of ParG/mutant proteins.  
DLS experiment in which the increase in the average size (nm) was recorded for wild type 
ParG and all the mutants, whose profile is shown according to the colour code. The order of 
addition of ligands is indicated by arrow and is same as in Figure 5.3 Data shown is average 
size calculated from six different experiments.  
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5.2.3 Partition deficient ParG N-terminal mutant proteins behave 
differently in nucleating ParF proto-filaments  
Results obtained from DLS experiments show that the ParG N-terminal mutants 
might behave differently in nucleating ParF (nucleotide-independent ParF 
polymerization stimulated by ParG). Nucleation and bundling activity can be 
analysed together experimentally by performing a sedimentation assay. In this assay, 
ParF and ParG are incubated together before centrifuging and separating the pellet 
and supernatant. The polymerized protein sediment into a pellet. Polymerized and 
un-polymerized ParF fractions were resolved by loading 100% of the pellet and 33% 
of the supernatant, on a 15% SDS gel, which provides an insight into the process of 
ParF polymerization and the role of ParG.  
 
5.2.3.1 Experimental set up to study bundling and nucleation activities by 
sedimentation assay 
To evaluate the effect of WT ParG and mutants in ParF nucleation and bundling 
activities, three different types of reactions were set up (Figure 5.5). In reaction 
number 1, bundling activity was analysed. ATP (2 mM final) was added to ParF (8 
µM) and incubated for 30 minutes allowing ATP dependent ParF polymerization. To 
this mixture, ParG or the mutant proteins (8 µM, dimer) were added and incubated 
for further 30 minutes. Then the reaction mixture was centrifuged and the protein 
pellet and supernatant were separated and loaded onto a SDS gel. In the second and 
the third reactions, nucleation activity was studied systematically. In the second 
reaction, ParF and ParG/mutant proteins were incubated without ATP for 30 minutes 
and separated into pellet and supernatant and resolved on the gel. This determines 
how much ParF polymerization is promoted by ParG/mutant proteins in the absence 
of ATP. In the third type of reaction, samples were set up in the same way as for 
reaction 2, but after 30 minutes, ATP was added to the mixture and further 
incubation was carried out for 30 minutes. The fraction of pellet and supernatant 
were separated and analysed on gel. The response to ATP of the core formed by 
ParF-ParG/mutant proteins was investigated by this reaction.  
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Figure 5.5. Three different types of reactions were set up to analyse bundling and 
nucleation activity of ParG and mutants.  
Reaction number 1 tests the bundling activity as ParG is added to the ParF-ATP complex. 
Reaction 2 and 3 probes nucleation activity as formation of the ParF-ParG/mutant nucleus 
and its response to addition of ATP is analysed. 
 
5.2.3.2 Partition deficient ParG mutants efficiently bundle ParF polymers 
When ParF alone was analysed by the sedimentation assay in the absence of ATP 
around 30% of ParF was seen in the pellet, revealing the inherent self- association 
tendency of the protein. When ATP was added to ParF, almost 50% of ParF was 
seen in the pellet, as ATP binding initiates extensive ParF polymerization (Figure 
5.6A), although this value is more modest than that previously recorded (Barilla’ et 
al., 2005). In reaction set up one, when WT ParG was added to previously incubated 
ParF-ATP complex, ParF was recovered in the pellet and ParG co-sedimented with 
it, which reconfirmed that ParG was involved in ParF bundling. In this reaction, the 
amount of ParF in the pellet was more than 80% and that of the co-sedimented ParG 
was around 50% (lanes under bundling panel in Figure 5.6B). In the same type of 
reaction, in the presence of all the ParG mutant proteins ParF was similarly observed 
in the pellet (50-80%), which indicated that these mutants are efficient in ParF 
bundling activity, although the quantity of ParG mutants co-sedimented with ParF 
was not as much as WT ParG (lanes under bundling panels in Figure 5.6C - 5.6J). 
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Figure 5.6. ParG N-terminal mutant proteins show variations in nucleation and 
bundling functions.  
A. ParF (8 µM) incubated with and without nucleotide and separated on 15% SDS gel. B-J. 
ParG and N-terminal mutant proteins (8 µM) were incubated with ParF (8 µM) in the 
presence and absence of ATP (2 mM) in three different types of reaction setups as labelled 
at the top of the gels. 100% of pellet (p) fraction and 33% of supernatant (s) fractions were 
resolved on gels. The black and white arrowheads show ParF and ParG/mutant proteins 
respectively in all gels. Percentage of ParF and ParG/mutant protein in pellet fractions are 
given at the bottom of each gel. Gels and data shown are representative examples for WT 
and each mutant ParG protein from sedimentation assays performed in triplicate.  
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5.2.3.3 Partition deficient ParG mutants show variations in nucleating ParF 
polymers 
In the second type of reaction, when ParG interacted with ParF in the absence of 
ATP, ParG was still able to stimulate ParF polymerization, as shown by 63% of ParF 
found in the pellet. When ATP was added after the ParF-ParG incubation (reaction 
3), more than 80% of ParF was recovered in the pellet and ParG showed around 50% 
co-sedimentation. The pattern of ParF and ParG sedimentation in reaction 1 and 3 is 
very similar, suggesting that ParG equally promotes ParF bundling and nucleation. 
ParG-N18A performed in the same way as WT ParG in reactions 2 and 3 and the 
amount of ParF recovered in the pellet in the presence of ParG-N18A was very 
similar in the presence of that found with WT ParG (lanes under nucleation panel 
Figure 5.6B and 5.6H). This indicates that Asn18 does not appear to have specific 
role in the nucleation activity.  
 
When rest of the ParG mutants were analysed by the second type of reaction and 
added to ParF without nucleotide, ParF showed polymerization as around 50% of the 
ParF was found in the pellet. However, more than 80% of the ParG mutant proteins 
remained in the supernatant fractions. In the third type of reaction, the ParF-ParG 
mutant core responded to added ATP, which led to an escalation in ParF 
polymerization and pulled more than 80% of ParF in the pellet. But during this 
process also, more than 70% of ParG mutant proteins remained in the supernatant. 
The inability of ParG mutants to co-sediment with ParF might be related to the 
change in ParF-ParG interaction. The nucleus produced with this interaction 
although responded to the ATP and showed ParF polymerization, the nature of ParF 
polymers need to be examined in future. The presence of ATP was found to be 
helpful only to increase ParF polymerization and not to promote ParF-ParG 
interaction. The pattern observed during the sedimentation assay, reflects the 
findings from DLS, which indicated that, with the exception of ParG-N18A, the 
other mutant proteins are affected in nucleation function and display variable 
activity.  
 
In control sedimentation assays, ParG and the N-terminal mutant proteins (8 μM) 
were incubated on their own, with and without ATP. In both conditions, ParG and 
mutant proteins were found only in the supernatant, which indicated that ParG and 
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the mutant proteins do not self-associate in the presence or absence of ATP (data not 
shown). Thus, when ParG or the mutants are observed in the pellet in ParF-
containing reactions, it is because of the association with ParF. 
 
5.2.4 Partition deficient ParG N-terminal mutant proteins exhibit a 
weaker interaction with ParF 
DLS experiments and sedimentation assays showed that the ParG partition deficient 
mutants behave differently in stimulating ParF polymerization in the absence of 
ATP. This observation prompted an investigation of the interaction of the ParG 
mutants with ParF to elucidate the precise role of these amino acids in plasmid 
partition. It has been speculated that both the flexible N-terminal tails and RHH 
motif of the ParG dimer contribute to ParF interaction (Carmelo et al., 2005, 
Golovanov et al., 2003). ParF-ParG/mutants interaction was studied by using a 
bacterial two-hybrid system and quantified by performing β-galactosidase assays 
(Dobruk-Serkowska et al., 2012). The bacterial two-hybrid system allows a study of 
functional interactions between two proteins based on complementation of CyaA 
(adenylate cyclase) fragments. cyaA encodes the toxin adenylate cyclase produced 
by B. pertussis in a calmodulin-dependent manner. The catalytic domain of this 
protein, that consists of 400 amino acids, is proteolytically cleaved into two 
complementary fragments, T25 and T18. In the absence of calmodulin, T25 and T18 
cannot interact. E. coli lacks calmodulin, so when T18 and T25, fused with 
interacting proteins are expressed in a Cya-deficient E. coli strain, they re-associate 
resulting in cAMP synthesis. cAMP binds to the catabolite gene activator protein, 
CAP. The cAMP/CAP complex then can recognise the promoters of catabolic 
operons and switch on the transcription of the corresponding genes (Karimova et al., 
1998). 
 
Wild type parF and parG genes cloned into vectors pT25 and pT18 respectively. 
Constructs pT18ParG and pT25ParF were available in the laboratory plasmid 
collection. Mutant alleles parG-L3A and parG-K5A were cloned in pT18ParG by 
Benjamin Rodway and pT18ParG-K11A, pT18ParG-K12A, pT18ParG-M13A, 
pT18ParG-N18A, pT18ParG-R19A and pT18ParG-L21A were constructed as a part 
of this project. When the interacting proteins were not present and empty pT25 and 
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pT18 were co-transformed, the Miller units obtained in the assay were merely 70. 
Whereas WT ParG and ParF interaction generated more than 1200 Miller units. 
When ParF-ParG mutants interaction was tested, all partition deficient ParG N-
terminal mutant proteins showed reduced interaction with ParF as compared to WT 
ParG (Figure 5.7), as none of the interaction generated more than 800 Miller units. 
ParG-K11A and ParG-K12A exhibited the lowest interaction (less than 400 Miller 
units) amongst the mutants. This indicates that a change in these amino acids, in the 
flexible N-terminal end of ParG, affects the interaction with ParF more drastically. 
The weakened interaction of ParG mutant proteins with ParF may contribute to 
partition deficiency, either by affecting nucleation activity or by impairing 
stimulation of ParF ATPase activity or formation of the segrosome. 
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Figure 5.7. ParG N-terminal mutant proteins display a weaker interaction with ParF. 
ParF-ParG/mutant interaction was quantified using the β-galactosidase assays. Empty 
indicates the strain containing pT18 and pT25 vectors harbouring no genes, thus serving as 
the negative control. Plasmid pT25ParF was co-transform separately with plasmid 
pT18ParG/mut. The results are an average of three experiments carried out in triplicates and 
error bars represent the standard error of mean. 
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5.2.5 ParG N-terminal mutant proteins are impaired in triggering 
ParF ATPase activity 
ParF is an intrinsically weak ATPase and relies on its partner protein ParG for 
activating ATP hydrolysis. So far, evidence has been obtained indicating that the 
ParF-ParG interaction might be compromised when certain amino acids are changed 
in the ParG N-terminal tail. The change in these residues was detrimental to plasmid 
partition. It remains to be determined if these mutant ParG proteins are able to 
stimulate ParF ATPase activity. The effect of mutant ParG proteins on stimulating 
ParF ATPase activity was studied by employing thin layer chromatography (TLC) as 
explained in section 2.13. In this assay, when ParF is incubated with radioactive 
ATP, ATP and its hydrolysis product ADP are separated using TLC. The ATP and 
ADP spots can be visualised on autoradiography films and quantified using a 
phosphorimager. When ParG is added to this reaction, the increase in ATP 
hydrolysis results in generation of more ADP, which can also be seen and quantified. 
Similarly, N-terminal end mutant proteins can be added and the effect on ParF 
ATPase activity can be investigated.  
 
In the assay, ParF was incubated with [α35S] ATP, along with increasing 
concentrations of ParG at 30°C. Increasing amounts of ParG resulted in 
augmentation of ATP hydrolysis by ParF (Figure 5.8). All the ParG N-terminal 
mutant proteins tested in the assay were found to be impaired in stimulating ParF 
ATP hydrolysis. Even when the concentration was increased to 5 µM, the proteins 
were not able to enhance ParF ATPase activity beyond 30% of the stimulation 
produced by the WT ParG (Figure 5.9). ParG-L3A, ParG-K5A and ParG-K11A 
showed some intrinsic ATPase activity in the absence of ParF which is likely due to 
the presence of some contaminating ATPases in the purified protein preparations. 
This was normalised during quantitation of their relative ATPase activity. In the past 
ParG-R19A demonstrated the similar impairment and at a concentration of 5 µM less 
than 20% relative ATPase stimulation was reported (Barillà et al., 2007). 
 
ParG-N18A showed the lowest level of stimulation amongst all the mutants. This 
could be due to the fact that N18 is part of the arginine finger motif and a mutation at 
this position affects ParG function more than mutations more distant from the finger-
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motif. This result suggests that the defect in segregation shown by these mutants is 
related to a decrease in ParF ATPase stimulation. Interestingly, the ability of these 
mutants to repress transcription, to bind DNA and to enhance ATP dependant ParF 
polymerization was unaltered as suggested by results reported here and in previous 
chapters. This suggests that the N-terminal tail of ParG is involved in various 
functions.  
 
It was not possible to draw any conclusion for the ability of ParG-L21A to stimulate 
ParF ATPase activity. On all three occasions, WT ParG showed variation in 
stimulating ATP hydrolysis making it difficult to compare the stimulation caused by 
the mutant protein. ParG-L21A also showed variation and did not display any 
consistency (Figure 5.10). Although it sometimes appeared that the ATP hydrolysis 
was diminished in the presence of this mutant protein, the collective data analysis 
failed to suggest a definite effect. 
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Figure 5.8. The ParG mutants are impaired in stimulation of ParF ATP hydrolysis. 
Autoradiographic images showing the results of ATPase assays in which radioactive ATP 
([α35S] ATP) was incubated with ParF and ParG/mutant proteins. ATP and its hydrolysed 
product (ADP) were separated by TLC. ParG protein fractions were tested without ParF to 
check for the presence of potential contaminating ATPase. ATP and ADP are indicated by 
arrows in all the images. WT ParG was run every time along with the mutant proteins to 
calculate the relative stimulation. Representative images are shown for each mutant from 
experiments performed in triplicate. 
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Figure 5.9. ParG N-terminal mutant proteins are impaired in stimulating ParF ATPase 
activity.  
ATPase assays of ParF in the presence of ParG/mutant proteins harbouring the changes in 
L3A, K5A, K11A, K12A, M13A and N18A. Relative stimulation of ParF ATPase activity 
promoted by ParG/mutants plotted against protein concentration. The results are an average 
of three experiments. The error bars represent the standard error of mean. 
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Figure 5.10. ParG-L21A exhibits inconsistent stimulation of ParF ATPase activity. 
A. scan of the autoradiographic film showing the signal for ATP and its hydrolysis product 
ADP. B. The relative ATPase stimulation was plotted against the protein concentration. Both 
WT and mutant ParG showed variation in the ATPase stimulation. The results are an 
average of three experiments. The error bars represent the standard error of mean. 
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5.3 Conclusion 
ParG stimulates ParF polymerization in the absence and the presence of ATP. For 
the purpose of this study, these activities of ParG have been referred to as nucleation 
and bundling respectively. To investigate how ParG N-terminal mutant proteins 
affect these two functions of ParG, DLS and sedimentation assays were performed. 
In DLS experiments, ParG mutant proteins deficient in plasmid partitioning showed 
similar augmentation of ParF polymerization as that triggered by WT ParG in an 
ATP-dependent manner. Similarly, in the sedimentation assays, incubation of ParG 
mutant proteins with ParF and ATP resulted in ParF being pelleted, indicating these 
mutants are still proficient in somehow bundling ParF filaments. Interestingly, even 
though ParG mutants were able to bundle ParF polymers, they displayed differences. 
WT ParG and ParG-N18A co-precipitated with ParF, but other ParG mutant proteins 
failed to co-sediment with ParF.  
 
It was found that ParG could increase ParF polymerization by directly binding to 
monomeric ParF, even in the absence of nucleotides. ParG mutant proteins 
demonstrated variation in promoting ATP independent ParF polymerization. ParG-
N18A protein displayed very similar nucleation activity as that of WT ParG in DLS 
and sedimentation assays. In DLS experiments, among the other mutant proteins, 
ParG-L3A and ParG-K12A showed diminished nucleation activity as ParF 
polymerization was neither increased by ParF-ParG-L3A/K12A interaction nor on 
further addition of ATP. The rest of the mutant proteins caused an increase in ParF 
polymerization, but less substantial than that promoted by WT ParG. In the 
sedimentation assay, all these mutants brought ParF into the pellet by promoting 
ParF polymerization, but the percentage of ParF protein in the pellet was always less 
pronounced than that observed with WT ParG. In addition, the ParG mutant proteins 
(except ParG-N18A) did not co-sediment with ParF during nucleation type of 
reaction. 
 
As ParG mutant proteins showed a gradient in terms of nucleation activity, an 
investigation of the ParF-ParG interaction was conducted. The β-galactosidase assay 
used to analyse protein-protein interaction showed that all the ParG mutant proteins 
were compromised in the interaction with ParF. All the partition-deficient ParG N-
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terminal mutant proteins showed impairment in stimulating ParF ATPase activity. 
Along with altered ParF interaction, the diminished ParF ATPase activity could be 
the reason behind partition defects.  
 157 
Chapter 6: The ParG N-terminus is essential for in vivo 
ParF oscillation over the nucleoid  
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6.1 Introduction 
In order to establish the role of the flexible ParG N-terminal tail in plasmid partition, 
various mutations were constructed. Crucial residues in the ParG N-terminal end 
(L3, K5, K11, K12, M13, N18, R19 and L21) have been identified; amino acid 
substitutions in these positions result in a defect in plasmid partition (Chapter 3). The 
ParG N-terminal mutant proteins were able to dimerise, bind DNA efficiently and 
act as a transcriptional repressor of the parFGH genes (Chapter 4). It was also 
observed that all of these mutant proteins were able to bundle the ParF proto-
filaments and promote ParF polymerization. However, the ParF-ParG interaction 
appeared to be compromised due to a change in these residues. The major finding of 
this study so far has been the impairment in stimulation of ParF ATPase activity by 
the ParG mutant proteins (Chapter 5). This might explain the way these mutations 
confer the deficiency in plasmid partition, however to see a broader picture and to 
understand what happens in vivo, localisation of these proteins and analysis of 
plasmid positioning in vivo were investigated. 
 
There have been several efforts to determine the intracellular localization of ParA 
proteins. In numerous bacteria, ParA proteins and other Walker-type ATPases play 
an important role in the correct positioning and segregation of chromosomal and 
plasmid DNA within the cell (Lutkenhaus, 2012). The selection of the division site 
in E. coli is governed by the Min proteins. MinD, an ATPase, represents a dynamic 
cellular element and exhibits rapid pole to pole oscillation in the cell (Raskin and de 
Boer, 1999). MinD associates with the membrane at the pole and alternatively with 
its partner proteins MinC (an inhibitor of FtsZ polymerization) or MinE (a site 
specific suppressor of division inhibition). It has been shown previously that MinE 
stimulates MinD ATPase activity which results in the dissociation of MinD from the 
membrane (Hu et al., 2002). This dependence on the partner protein MinE is 
instrumental in MinD oscillation (Park et al., 2011). A chromosomal ParA protein 
Soj, from Bacillus subtilis on DNA binding forms nucleoprotein complexes that 
dynamically relocate in the cell (Marston and Errington, 1999). The relocation of Soj 
is attributed to ATP hydrolysis which is dependent on partner protein Spo0J 
(Leonard et al., 2005). ParA protein of plasmid pB171 forms cytoskeletal-like 
structures. In the presence of ParB and parC encoded by the par2 locus of plasmid 
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pB171, ParA was shown to dynamically relocate over the nucleoid. The N-terminal 
residue Arg-26 of ParB, is essential for the ParA dynamics and changes to this 
conserved residue abolish ParA dynamics (Ringgaard et al., 2009). Similarly, the 
partition protein SopA of F plasmid in E. coli is a member of the P-loop ATPases 
and in the presence of the partner protein SopB and partition site sopC, assembles 
into spindle like structures (Lim et al., 2005). SopA was shown to be dynamic in 
vivo owing to its polymerization and depolymerization cycle and thus playing an 
important role in plasmid positioning and segregation (Lim et al., 2005). However, 
in a cell-free system, the F plasmid partition was attributed to the concentration 
gradient of SopA protein and to a diffusion ratchet mechanism (Vecchiarelli et al., 
2013).  
 
It has been observed that ParF polymers are dynamic and when they bind to the 
ParG-DNA cargo, the dynamic relocation of ParF polymers facilitates the 
segregation of plasmids (McLeod, B. unpublished data). It has been observed that 
ParF oscillates over the nucleoid in the presence of the entire parFGH system (B. 
McLeod unpublished data). It becomes essential then to analyse the phenotype of the 
ParG N-terminal partition deficient mutants with respect to ParF oscillation. The 
effect of ParG N-terminal mutant proteins on ParF localisation and oscillation is 
reported in this chapter in order to propose a broader role for the unstructured ParG 
N-terminus in plasmid partitioning. 
 
Confocal microscopy was used as one of the methods for visualisation of ParF and 
ParG proteins in vivo. Light microscopy has always suffered from diffraction 
limitations since its conception, but recently new methods have been developed to 
overcome this constraint. These methods together are known as super resolution 
microscopy. To study ParF localisation and appearance in more detail in vivo, super 
resolution microscopy was conducted using an OMX microscope. The combined 
results from these two methods have been instrumental in understanding the 
segregation process of plasmid TP228 in vivo. 
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6.2 Results 
6.2.1 The partition gene parF and partition cassette parFGH were 
cloned into vectors suitable for in vivo imaging 
A fluorescent tagging system was used to study in vivo localisation of the partition 
proteins. The two plasmid vectors employed in the microscopy study were 
pBADparF and pBM20, which were provided by Brett McLeod (Daniela Barilla` 
group, University of York) (Figure 6.1). In the vector pBADparF, the fluorescent tag 
enhanced Green Fluorescent Protein (eGFP) encoded by the egfp gene was cloned in 
frame with parF, under the control of the arabinose-inducible promoter PBAD. The 
vector pBM20 is a derivative of the partition probe vector pFH547 containing the 
parFGH cassette. The mCherry gene, which encodes for the mCherry fluorophore 
was cloned in frame with parG in vector pBM20. Vector pBM20 has been shown to 
be stable in plasmid partition assays (B. McLeod, unpublished data). Both the 
partition proteins fused with the fluorescent tags were found to be functional (B. 
McLeod, unpublished data). In the localisation study, the pBADparF supplies ParF-
EGFP in trans and it was established that in the presence of this vector the stability 
of pBM20 was not altered. It was also established that the signal from ParG-
mCherry co-localises with the plasmid, as ParG binds to the centromere and operator 
sequences of the parFGH cassette (B. McLeod, unpublished data).  
 
The mutant parG alleles, responsible for plasmid partition defects, were cloned into 
the vector pBM20 by digesting the mutant partition vectors (i.e. pMBL3A and all the 
others) with restriction enzymes BstX1 and HpaI and ligating the resulting 456 bp 
fragment into the digested vector pBM20. Screening of the clones was carried out by 
restriction digestion of plasmid DNA with enzymes HpaI and BstX1. Clones were 
confirmed by sequencing and named according to the mutation encoded e.g. pBM20-
parGL3A. Digestion of the plasmid pMBL21A and cloning of parG-L21A fragment 
into pBM20 vector are shown in Figure 6.2 as an example, which led to the 
construction of the pBM20-L21A. 
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Figure 6.1. Plasmids used in the localisation of ParF and ParG proteins in vivo.  
A. Vector pBAD-parF contains fusion gene parF-eGFP under the control of the PBAD 
promoter. B. Vector pBM20 contains the wild type parFGH cassette and the mCherry 
encoding gene is cloned in frame with parG.  
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Figure 6.2. Representative agarose gels showing the digested mutant parG allele and 
the restriction digestion screen of pBM20 plasmids potentially harbouring the desired 
parG mutation.  
A. Mutant parG fragment of 456 bp size was cleaved and cloned into pBM20 vector. Lanes: 
L, Gene ruler 10 kbp ladder; 1 and 2, DNA fragment generated on digestion of pMB-L21A. 
B. Restriction digest of five pBM20 constructs potentially containing the mutant parG allele. 
Lanes: L, Gene ruler 10 kbp ladder and 1-5, digested plasmids from five candidates. 
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6.2.2 Localisation of ParF in the cell in the presence of the ParG 
WT/N-terminal mutant proteins  
In order to analyse how ParF drives plasmid segregation and how ParG supports this 
active partitioning, the dynamics of the intracellular localisation of these proteins 
were observed by confocal fluoroscence microscopy. E. coli cells (BW25113) were 
co-transformed with pBAD-parF and pBM20/pBM20-parG mutants and microscopy 
analysis was carried out. This strain supports the medium copy number plasmid 
replication. The cells were grown in the presence of antibiotic pressure to retain the 
plasmid. The analysis thus elucidate the localisation and dynamics of the partition 
elements rather than the actual partition process of low-copy number plasmids. It has 
been recently observed that ParF binds to the nucleoid in vivo (B. McLeod, 
unpublished data). To visualise the localisation of ParG, ParG mutants and ParF, 
with respect to the nucleoid, DAPI staining was used.  
 
When cells were co-transformed with pBAD-parF and pBM20, the distribution of 
ParF-eGFP appeared asymmetrical over the nucleoid, as the green signal was 
concentrated at either side of the nucleoid. The ParG-mCherry red signal was found 
to be rather diffuse and present throughout the cell (Figure 6.3A). Occasionally tight 
foci (1, 2 or 3) were observed at various positions such as the mid-cell, near the 
poles, 1/4 (one quarter) or 3/4 (three quarter) of the cell length. In the presence of 
ParG mutant proteins, a stark contrast was observed for the ParF-eGFP signal 
compared to results observed in the presence of WT ParG. ParF-eGFP was 
distributed evenly throughout the nucleoid rather than localised at one side. ParG 
mutant proteins were observed predominantly as tight red foci (Figure 6.3B-I). An 
interesting pattern was observed with ParG-N18A. In the presence of this mutant 
protein, ParF formed a compact green focus overlapping with the similarly compact 
red focus of ParG-N18A (Figure 6.3G).  
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Figure 6.3. Localisation of ParF in the presence of ParG WT/ N-terminal mutant 
proteins over the nucleoid visualised by confocal microscopy. 
Individual channels for DAPI (top-left), bright field (top-right), ParF-eGFP (middle-left), 
ParG-mCherry (middle-right), and merged (bottom-left) are shown. A. WT ParG, B. ParG-
L3A, C. ParG-K5A, D. ParG-K11A, E. ParG-K12A, F. ParG-M13A, G. ParG-N18A, H. 
ParG-R19A and I. ParG-L21A. Scale bar=0.5 µm in A, B, C, D, E, F, G and 1 µm in H and 
I. 
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The localisation of ParF was also studied in the absence of the partner protein. When 
E. coli cells were transformed only with the pBAD-parF vector (thus in the absence 
of the full partition system), the ParF-eGFP signal appeared diffuse throughout the 
nucleoid (Figure 6.4A). This indicated that a functional ParG protein along with the 
partition site parH is responsible for the asymmetric distribution of ParF in vivo. 
When WT ParG and ParG mutants were analysed in the absence of ParF-eGFP by 
transforming E. coli with vector pBM20/mutant only, wild type ParG formed 
multiple foci over the nucleoid (Figure 6.4B), whereas the mutant proteins appeared 
as single, compact red foci (Figure 6.4C). The appearance of tight foci for ParG 
mutants was observed both in the presence and absence of ParF-eFGP. The parFGH 
cassette in pBM20 expressed the wild type ParF under the native promoter, hence 
absence of pBAD-parF does not result in lack of ParF protein in the cell. 
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Figure 6.4. Individual localisation of ParF, ParG and ParG mutants observed by 
confocal microscopy. 
A. E. coli cells harbouring only pBAD-parF vector show ParF spread over the whole 
nucleoid. B. E. coli cells harbouring only pBM20 vector show diffuse ParG. C. E. coli cells 
harbouring pBM20-K12A show a tight red focus. In all the images the merge of green/red 
signal, DAPI staining and bright field is shown. The images are representative example from 
the set of at least 100 cells analysed for each sample. Scale bar = 0.5 µm. 
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6.2.3 ParG N-terminal mutations alter the positioning of plasmid in 
the cell  
Once the localisation of ParF and ParG proteins was determined in vivo, the 
positioning of the plasmid was scrutinised. Association of ParG with the plasmid 
partition site allowed tracking of the plasmid position by monitoring the ParG-
mCherry red signal. Plasmid segregation is a multi-step process during which the 
plasmid is first located at mid-cell during replication and subsequently segregated to 
1/4 or 3/4 positions of the cell, which will eventually serve as mid-cell position of 
the future daughter cells (Ebersbach and Gerdes, 2005). In the presence of ParF, 
ParG formed 1-4 foci per cell (Figure 6.5A). Although these foci looked distinct, 
they were diffuse. Most of the cells showed either 1 or 2 ParG foci. When there was 
only one focus, it appeared mostly at the mid-cell. In a cell population when two foci 
were observed, they were mainly located at the one quarter or three quarter location 
in the cell, probably taking up their position on the verge of segregation (Figure 
6.5A). 
 
The effect of partition deficient ParG N-terminal mutations on the positioning of the 
plasmid was also analysed (Figure 6.5Bi). Variable patterns were observed for the 
mutants. In the presence of ParG mutations L3A, K5A, K11A, M13A, R19A and 
L21A, cells with 1 to 4 red foci were observed in similar proportion. However, 
ParG-K12A containing cells showed mainly one or two foci in equal proportion, 
similarly to the pattern of wild type ParG. An unusual pattern was observed for 
ParG-N18A that showed over 60% of the cells harbouring a single focus, around 
30% of cells showed double foci and a negligible number of cells showed 3 or 4 foci. 
 
Whenever the cells containing plasmid with the mutations of ParG-L3A, M13A, 
R19A and L21A showed a single focus, it was observed that the plasmid was 
positioned along the entire cell length with less pronounced preference for mid-cell 
location as compared to cell harbouring wild type ParG. This suggested that the 
positioning of the plasmid was disturbed due to the effect of the mutations, when 
compared with wild type ParG. In the case of double foci, the plasmid localisation 
looked more disorganised for ParG-L3A, but ParG-R19A, ParG-M13 and ParG-
L21A showed a pattern similar to that of wild type ParG.  
Chapter 6 
 
168 
When plasmids encoding ParG-K5A, ParG-K11A and ParG-K12A mutations 
coalesced as a single focus, they were positioned in a fashion similar to wild type 
ParG encoding plasmids i.e. at the mid-cell. In the double foci scenario, K5A 
resembled the pattern of wild type ParG, with plasmids at the 1/4 and 3/4 positions. 
However, the localisation of double foci of ParG-K11A and ParG-K12A appeared 
more disorganised. Plasmids harbouring ParG-N18A mutation showed the highest 
number of cells with single focus at mid-cell similar to wild type ParG, however the 
double foci scenario was not very similar to that of wild type ParG (Figure 6.5Giii, 
iv). 
 
Plasmids harbouring ParG N-terminal mutations appear to be distributed more 
randomly along the cell length. It is possible that the movement from mid-cell to the 
quarter cell positions after replication and before segregation is affected. Majority of 
plasmids failed to reach their final destination. The randomness found in plasmid 
positioning suggested that plasmid transport was disrupted because of the mutation 
in the ParG N-terminal tail. 
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Figure 6.5. Effect of ParG N-terminal mutations on positioning of the plasmid 
containing the parFGH partition cassette. 
Confocal microscopy snapshots of cells containing the plasmid harbouring wild type parG 
or the mutant allele and quantitative analysis of the ParG-mCherry foci localisation. The 
cells were co-transformed with pBAD.parF and pBM20-parG/mutant as indicated on the 
panels. (i) Snapshot of the cells from a population used for quantitative analysis. Scale bar = 
1 µm in D and G, 2 µm in A, B, E, F and I, 4 µm in C and H. (ii) Number of ParG-mCherry 
foci per cell, counted for approximately 400 cells for each mutant. (iii) Position of single 
focus displayed on X-axis by taking the normalized distance from the pole in the population 
of cells shown in panel ii. (iv) Position of double foci displayed on X-axis by taking the 
normalised cell length in the population of cells shown in panel i. 
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6.2.4 ParF oscillation is abolished in the presence of ParG N-
terminal mutant proteins 
To examine the dynamics of the ParF-ParG localisation in vivo, time-lapse 
microscopy was employed. Cells were observed over 20 minutes and snapshots were 
taken at one minute intervals. Individual channels showing the ParF-eGFP and ParG-
mCherry signals were aligned and are presented here to show the dynamics of the 
system (Figure 6.6). Over time, ParF appeared to move from one side of the nucleoid 
to the opposite (Figure 6.6A and movie 6.1) and this oscillation pattern was observed 
in approximately 70% of the cells. At the beginning (first three frames i.e. for 3 
minutes) ParF-eGFP appeared to be localised at one side of the nucleoid. In the next 
two frames (4 and 5 minutes), the green signal gradually moved to the other side and 
eventually localised near the other nucleoid pole. ParF remained at this position for 
around 7 minutes and then began to migrate back to the opposite side of the cell. In 
the frames (14-19 minutes), the green signal slowly moved to the other side of the 
cell and before the end of 20 minutes, ParF had migrated back to the position 
observed at the start of the time-lapse series. Along with ParF-eGFP, the ParG-
mCherry signal also relocated. (Figure 6.6B). This signal always lagged behind the 
ParF-eGFP green signal, which may indicate that ParF pulls the ParG-plasmid cargo 
during partitioning (Movie S1). ParG also appeared to be co-localised with ParF-
eGFP at the start of the time sequence. After the 7
th
 minute, two ParG red foci were 
observed and the focus on the left side remained still till the end of the time-lapse 
experiment. This might suggest that ParF has placed this plasmid at its final position 
before cell division.  
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Figure 6.6. Localisation and dynamics of ParF and ParG during time-lapse 
microscopy.  
A. A representative 20 minutes time-lapse experiment, the first column shows the ParF-
eGFP signal and the second displays the ParG-mCherry signal. B. Snapshot of the cell 
during a time-lapse experiment with bright field (top-right), merged (bottom-right), mCherry 
(bottom- left) and eGFP (top-left) image. Scale bar = 0.5µm.  
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The effect of ParG N-terminal mutations on ParF oscillation was investigated by 
performing time-lapse experiments for each mutant. Approximately 100 cells were 
observed for each mutant and kymographs were generated for the ParF-eGFP signal 
to determine the presence of oscillation. All the movies from the 20 minute time-
lapse experiments, carried out for wild type and N-terminal ParG mutants are 
provided as supplementary files (Movies S1-S9). Due to photo-bleaching the green 
signal looked weaker at later time intervals; hence sometimes the signal has to be 
corrected for photo-bleaching. Bacterial cells displace from their original position on 
agarose pad over time of 20 minutes of time-lapse experiment hence while 
processing the data to create time-lapse movie the displacement of the cell needs to 
be corrected by using Volocity software.  
 
ParF oscillation was severely impaired in the presence of ParG mutant proteins and 
abolished in most of the cells containing the plasmid harbouring parG mutations. In 
comparison, 67% of the cells showed ParF oscillation in the presence of wild type 
ParG, whereas the percentage of cells showing ParF oscillation was much lower for 
the strains carrying the mutant N-terminal ParG proteins. The number of cells 
exhibiting ParF oscillation ranged from 1% in the presence of ParG-M13A to 15 % 
in the presence of ParG-K11A (Figure 6.7). ParF appears to be recruited into the 
defective segrosome and to remain locked in this complex displaying no movement.  
The movies, S2-S9, show that ParF-eGFP did not oscillate in the presence of mutant 
ParG proteins. The evenly spread localisation of the ParF-eGFP signal, which is 
presumably bound to the nucleoid as in the snap-shots in Figure 6.3, was observed 
throughout the 20 minute time span for all the mutants. Even though the overall 
pattern was lack of ParF-eGFP oscillation, the localisation pattern of mutant ParG 
proteins over time was different. In the presence of ParG-L3A, ParG-M13A, ParG-
R19A and ParG-L21A, ParF-eGFP was evenly distributed on both the sides over the 
nucleoid and made contact with mutant protein. Mutant ParG-plasmid complex was 
present at mid-cell without any movement towards the pole (movies S2, S6, S8 and 
S9). In case of ParG-K5A, ParG-K11A and ParG-K12A containing plasmids, ParF-
eGFP did not co-localise with these mutant ParG proteins although sometimes ParF 
polymers reorganised and relocated over the nucleoid as seen in the movies S3, S4 
and S5, but still ParF failed to transport the plasmid away from the mid-cell position. 
ParF-eGFP localisation was distinctive in the presence of ParG-N18A (movie S7). 
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Even though ParF-eGFP was distributed over the nucleoid, a substantial amount of 
ParF-eGFP co-localised with the ParG-N18A into a compact focus. This focus 
remained static over time and no movement was observed for plasmid and ParF. As 
a representative example, of the pattern displayed by the mutants, a snapshot and 
time-lapse of a cell harbouring the ParG-N18A mutant are shown in Figure 6.8.  
 
Movies legend 
Movies S1-S9. ParF-eGFP oscillation is disrupted in the presence of the ParG N-
terminal mutant proteins in vivo. E. coli cells harbouring plasmids pBAD-parF and 
pBM20-parG/mutant were imaged for 20 minutes in time-lapse experiment and displayed in 
movies with individual bright field, red and green channels. (S1) ParG WT, scale bar = 1 
µm. (S2) ParG-L3A, scale bar = 0.5 µm (S3) ParG-K5A, scale bar = 0.5 µm (S4) ParG-
K11A, scale bar = 0.9 µm (S5) ParG-K12A, scale bar = 1 µm (S6) ParG-M13A, scale bar = 
0.6 µm (S7) ParG-N18A, scale bar = 0.7 µm (S8) ParG-R19A, scale bar = 0.5 µm (S9) 
ParG-L21A, scale bar = 0.9 µm. 
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Figure 6.7. ParF does not dynamically relocate in the presence of the N-terminal ParG 
mutants. 
 Histogram showing the percentage of cells displaying ParF oscillations. The movement of 
the ParF signal was monitored by generating kymographs. Approximately 100 cells from at 
least three separate experiments were analysed for each mutant. 
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Figure 6.8. Localisation and dynamics of the ParF and ParG-N18A proteins.  
A. A 20 minute time-lapse experiment. The first column shows the ParF-eGFP signal and 
the second is ParG-N18A-mCherry. B. A Snapshot of the cell from the time-lapse 
experiment showing eGFP, bright field, mCherry and merge channels from left to right. 
Scale bar = 0.7µm. 
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A kymograph was obtained for the ParF-eGFP green signal during the 20 minute 
time interval, which helped to give a graphical representation of the spatial and 
temporal movement of ParF (Figure 6.9). In the presence of wild type ParG, ParF 
showed oscillation, which produced a wave-like appearance in the kymograph. On 
the contrary, in the presence of ParG N-terminal mutant proteins the ParF was static 
and failed to show any oscillation resulting in a stationary kymograph.  
 
 
Figure 6.9. Kymograph analysis of the ParF-eGFP signal in the presence of ParG N-
terminal mutant proteins during time-lapse experiment.  
The movement of the ParF-eGFP signal along the cell length over time in an E. coli cell 
containing pBAD-parF and pBM20-parG/mutant plasmids is displayed. The kymographs 
were constructed using the same time-lapse sequence which are displayed as movies S1-S9 
respectively. 
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6.2.5 Super resolution microscopy reveals that ParF forms a 
meshwork of polymers over the nucleoid 
Because of the limitation of resolution, confocal microscopy does not provide fine 
morphological details of the proteins hence three dimensional structured illumination 
microscopy (3D-SIM) was employed by using an OMX (Optical Microscopy 
eXperimental) microscope to investigate the features of the ParF structures in vivo. 
OMX set up includes isolated components for light source, imaging, microscope 
control and tracing the sample (Dobbie et al., 2011). In this microscopy, the lasers 
are beamed on the sample at multiple angles and in phases of the stripes to acquire 
and build up a compound image. The images have twice the resolution in the XY and 
Z planes after processing. Thus super resolution microscopy enhances resolution up 
to 100 nm in both axial and lateral directions. Approximately 50 cells were observed 
for each of wild type and mutant ParG containing plasmids. The images were 
analysed by 3D opacity using Volocity software (Perkin Elmer). As OMX 
microscope scans the sample for a longer interval, the photo-bleaching effect 
becomes a limiting factor.  
 
The pattern of the ParF-eGFP localisation observed by OMX was found to be similar 
to those observed in the confocal images. When wild type ParG was present, the 
ParF-eGFP was distributed asymmetrically over the nucleoid (Figure 6.10). Images 
obtained from 3D-SIM showed ParF as a meshwork with various ParF polymers 
forming cable-like inter-wined structures distributed over the nucleoid. Wild type 
ParG-mCherry bound plasmids were located along the ParF cables. The co-
localisation of multiple ParG-mCherry foci with ParF-eGFP appeared as beads on 
strings. A representative example of wild type ParG containing cells and the 
presence of ParF meshwork is given in Figure 6.10.  
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Figure 6.10. Structured illumination microscopy image of the ParF and ParG signal in 
E. coli cells.  
ParF-eGFP forms an asymmetric mesh of elongated structures over the nucleoid and ParG-
mCherry bound plasmids appear as compact foci along the ParF cables. The filled white 
arrowheads show ParF cables. Empty arrowheads show co-localisation of ParF and ParG. 
The channels shown are ParF-eGFP (top-left), ParG-mCherry (top-right), DAPI (bottom-
left) and merged (bottom-right). Scale bar, 1 unit = 0.415 µm. 
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The cable-like ParF structures were also observed in the presence of ParG mutant 
proteins. ParG mutant proteins appeared as tight foci mainly at mid-cell position. 
ParG N-terminal partition deficient mutants were not impaired in promotion of ParF 
polymerization, hence it was not surprising to see the cable-like structure of ParF in 
the presence of these mutants in OMX images. Images of E. coli cells containing 
plasmids with ParG mutations were analysed by 3D opacity using Volocity software 
and representative examples are shown in Figure 6.11 and 6.12. Sometimes 
asymmetrical distribution was observed as shown for ParG-K12A. The images 
obtained using 3D-SIM are also shown as movies (Supplementary files, movies S10-
S18). In the movies a rotation along the long axis suggests that the mesh forming 
cable-like ParF structures permeate the nucleoid.  
 
Mutant ParG-mCherry bound plasmids were found at a fixed position. ParF-eGFP 
was evenly distributed over the nucleoid. The meshwork of ParF was visible in the 
presence of all the ParG mutant proteins except ParG-M13A and ParG-N18A. The 
absence of ParF meshwork in case of ParG-M13A cannot be established 
quantitatively as the sample size was small. In case of ParG-N18A, the compact 
focus of ParF-eGFP and lack of meshwork feature was frequently observed. This 
mirrors the observation made during the confocal imaging where ParF and ParG-
N18A co-localised into a tight focus (Movie S7). In case of ParG-K11A sometimes 
two adjacent foci were observed at the mid-cell which might have arisen after 
replication. ParF-eGFP was spread around these ParG-K11A foci. In case of ParG-
K5A and ParG-K12A, although ParF meshwork was observed over the nucleoid, the 
area around the plasmid was devoid of ParF-eGFP signal. During time-lapse 
experiment in confocal imaging, less overlap was observed between ParF-ParG-K5A 
and ParF-ParG-K12A (Movies S3 and S5). This might indicate towards the altered 
interaction between ParF and these ParG mutants. In case of ParG-R19A and ParG-
L21A, co-localisation of ParF-ParG was observed. In the presence of ParG-R19A, 
long cables of ParF-eGFP were seen rather than a meshwork.  
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Movies legend 
Movies S10-S18. The ParF-eGFP meshwork over the nucleoid shows variation 
depending upon the ParG mutants. E. coli cells containing plasmids pBAD-parF and 
pBM20-parG/mutant were imaged on OMX microscope and displayed as a movie. (S10) 
ParG WT, Scale bar 1 unit = 0.316 µm; (S11) ParG-L3A, Scale bar 1 unit = 0.419 µm; (S12) 
ParG-K5A, Scale bar 1 unit = 0.581 µm; (S13) ParG-K11A, Scale bar 1 unit = 0.415 µm; 
(S14) ParGK12A, Scale bar 1 unit = 0.45 µm; (S15) ParGM13A, Scale bar 1 unit = 0.478 
µm; (S16) ParGN18A, Scale bar 1 unit = 0.577 µm; (S17) ParGR19A, Scale bar 1 unit = 
0.233 µm; (S18) ParGL21A Scale bar 1 unit = 0.517 µm.  
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Figure 6.11. Structured illumination microscopy images of the ParF distribution in the 
presence of ParG mutants inside E. coli cells.  
The channels shown are green, red, DAPI and merged in all the images. A. ParG-L3A, B. 
ParG-K5A, C. ParG-K11A, D. ParG-K12A. In each pannel, the channels shown are ParF-
eGFP (top-left), ParGmut-mCherry (top-right), DAPI (bottom-left) and merged (bottom-
right). Scale bar, 1 unit = 0.415 µm. 
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Figure 6.12. Structured illumination microscopy images of the ParF distribution in the 
presence of ParG mutants inside E. coli cells.  
The channels shown are green, red, DAPI and merged in all the images. A. ParG-M13A, B. 
ParG-N18A, C. ParG-R19A, D. ParG-L21A. In each pannel, the channels shown are ParF-
eGFP (top-left), ParGmut-mCherry (top-right), DAPI (bottom-left) and merged (bottom-
right). Scale bar, 1 unit = 0.415 µm. 
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6.3 Conclusion 
The orchestration of plasmid segregation was investigated by microscopy. ParF-
eGFP appeared asymmetrically distributed over the nucleoid and ParG-mCherry 
appeared distinct but diffuse and located either at the mid-cell (in case of a single 
focus) or at 1/3 or 3/4 position. ParF-eGFP was visualised as an oscillating entity 
over the nucleoid during time-lapse experiment. While performing its dynamic 
movement ParF also transported the ParG-plasmid cargo and placed it at a site ready 
for segregation which indicates that ParF oscillation drives plasmid segregation. In 
the presence of ParG N-terminal mutants, ParF localisation was altered and it was 
distributed evenly throughout the nucleoid. ParG mutant proteins appeared as tight 
red foci and disorganised in the positioning compared to wild type ParG. The 
partition defective ParG N-terminal mutations caused detrimental effects on ParF 
oscillation. In the presence of the ParG mutant proteins, ParF polymers were locked 
and the oscillation was stalled. The compact nature of mutant foci pointed towards 
the inertness of the plasmid, as a consequence of lack of ParF oscillation. When 
bound to ATP, ParF dimerises and ParG stimulates the assembly of ParF into higher 
order structures. Partition deficient ParG N-terminal mutant proteins are able to 
promote ParF polymerization, hence the ParF-eGFP signal and localisation was 
similar in all cases. Polymeric ParF assembles onto the nucleoid, however, in the 
absence of stimulation of its ATPase activity by the ParG mutants, no dynamic 
relocation is observed. The enhancement of ParF ATP hydrolysis is likely to be a 
prerequisite for polymer remodelling and disassembly. Thus when this stimulation is 
missing, no turnover of ParF polymers and no oscillation are detected. 
 
It was not possible to determine the effect of ParG-L21A on stimulation of ParF 
ATPase activity (Figure 5.10). However, as the ParF oscillation was abolished in the 
presence of ParG-L21A, it indicated that like other ParG mutants ParG-L21A might 
be impaired in stimulating ParF ATPase activity. 
 
3D-SIM was instrumental in exploring the structural features of the ParF protein and 
showed ParF polymers as a mesh of inter-wined cables going through the nucleoid. 
The super resolution images displayed ParG mutants as tight foci. 
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7.1 Discussion 
Genome replication and segregation with high precision is a prerequisite for all 
living cells. Large, low copy number plasmids ensure stable inheritance of the 
genetic material in the daughter cells via active partition system. The partition 
system of plasmid TP228 investigated in this work is evolutionarily different from 
the P1 and F plasmids. The segregation locus parFGH of plasmid TP228 encodes for 
partition proteins ParF and ParG and the centromere-like site parH. ParF is a 
Walker-type ATPase from a ParA superfamily and it is more closely related to cell 
division protein MinD than P1 ParA. The centromere binding protein ParG is also 
unrelated to other ParB-like proteins. ParG enhances ParF polymerization and 
stimulates ParF ATPase activity through its unstructured N-terminus (Barillà et al., 
2007). The present study dissected further the role of ParG N-terminal flexible tail in 
the partition of plasmid TP228 and interplay between ParF and ParG proteins.  
 
7.1.1 Single amino acid changes in the flexible ParG N-terminus 
affect plasmid partition  
It has been previously established that the N-terminal flexible tail is necessary for 
ParG functions, but the importance of several individual amino acids in the flexible 
region is a significant finding of this study. When plasmids carrying ParG N-
terminal mutations were tested for partition efficiency, residues L3, K5, K11, K12, 
M13, N18, R19 and L21 were found to be crucial for plasmid partition (Figure 3.8). 
Spectral density function calculations have shown that the first six to ten residues of 
the ParG N-terminus are part of the most flexible region (Golovanov et al., 2003). 
Leucine at position 3 and lysine at position 5 fall in this region. The pair of lysines at 
position 11 and 12 forms an important cluster of positively charged residues in the 
tail along with methionine at position 13. Secondary structure prediction 
programmes have suggested that the region of residues 17-23 might form an α-helix 
with limited movement (Golovanov et al., 2003). The crucial residues for plasmid 
partition N18, R19 and L21 are part of this less mobile region of the tail. The 
arginine finger formed by R19 is located in the same region and is implicated in 
partition (Barillà et al., 2007). Depending upon their location, these crucial residues 
can be grouped into three clusters (Figure 7.1) - 
1. Residues in the most flexible region- L3 and K5 
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2. Residues in the linker region- K11, K12 and M13 
3. Residues in the arginine finger motif region- N18, R19 and L21 
 
 
 
 
 
Figure 7.1. The flexible N-terminal end of ParG harbours crucial residues for plasmid 
partition.  
The residues that cause plasmid partition defect are shown as sticks in the ribbon diagram of 
ParG dimer. The residues in the flexible tail (green) region can be classified into three 
groups depending upon their location as displayed. The structure was generated by using 
PyMol (DeLano, 2002). 
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7.1.2 ParG does not rely upon single amino acids in the N-terminus 
for DNA-binding and transcriptional repression functions  
Across the different partition systems, the centromere binding ParB proteins and 
their functional homologues e.g. P1 ParB, SopB from plasmid F, omega from 
pSM19035, ParR from plasmid R1 and TubR from pBtoxis are present as a dimer 
(Moller-Jensen et al., 2007, Mori et al., 1989, Ni et al., 2010, Surtees and Funnell, 
1999, Weihofen et al., 2006). ParG, like other CBPs, forms a dimer and the 
dimerization which is carried out by C-terminal RHH domain is required for DNA 
binding. The ParG N-terminal mutant proteins were also found to be able to dimerize 
and all the purified mutant proteins were observed as dimers although with different 
abilities (Figure 4.6, 4.7 and 4.9). At higher protein concentration, the ParG N-
terminal mutants did not show any alteration to DNA binding (Figure 4.12). As the 
anti-parallel β-strands at ParG C-terminus are known to insert in the DNA major 
groove, the residues in the flexible region may not be required for DNA binding. 
ParG binding to the partition site parH was not tested, but as the centromere site 
contains repeats similar to those in the operator site, the centromere binding activity 
of ParG mutants is not expected to differ (Wu et al., 2011a). An auto-regulatory 
circuit maintains the partition proteins at optimal concentration and prevents plasmid 
loss that may result from an excess of partition proteins (Surtees and Funnell, 2003). 
The ParG N-terminal tail is reported to be involved in transcriptional repression as 
deletion mutations in the tail resulted in decreased repression of the parFG promoter 
(Carmelo et al., 2005). However, single amino acid changes in the tail did not alter 
the transcriptional repression activity of ParG as none of the N-terminal mutants was 
impaired as shown by gene reporter assays (Figure 4.14).  
 
ParG is a sequence-specific DNA binding protein and the N-terminus region is 
responsible for determining the sequence specificity (Carmelo et al., 2005). Unlike 
other DNA binding proteins in which the mobile tails become structured on DNA 
binding, the ParG N-terminal tail is reported to remain flexible and make transient 
DNA contact (Carmelo et al., 2005). The chemical shift mapping of ParG-DNA 
interaction did not report any change in non-specific DNA interaction but specific 
DNA interaction for K11, K12, M13, N18 and R19 showed an increased magnitude 
of change indicating their role in specific DNA sequence binding (Carmelo et al., 
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2005). In the ParB homologue, SopB from F plasmid, positively charged arginine 
(R219) is shown to be an essential centromere binding determinant apart from the 
DNA binding HTH domain. It has been proposed that the extra DNA binding 
domain in ParB proteins may confer high specificity (Sanchez et al., 2013). On the 
same line, it is possible that the residues implicated in partition defect even though 
displaying efficient DNA binding and transcriptional repressor activity may be 
involved in sequence specificity. It can be speculated that the advantage of the ParG 
flexible region depends on the entire domain and not on a single amino acid for 
DNA binding and transcriptional repression functions.  
 
7.1.3 Importance of ParG N-terminal flexible domain in 
enhancement of ParF polymerization and interaction with ParF 
Polymerising ParA proteins are mainly involved in genome segregation in bacteria 
(Schumacher, 2012). Various Walker-type ParA ATPases have shown a switch in 
the function depending upon their ADP/ATP bound state. ParA proteins dimerise on 
ATP binding whereas the ADP-bound form is monomeric. Some ParA proteins in 
complex with ATP undergo polymerization and display a nucleoid association. ATP 
hydrolysis may lead to depolymerization which facilitates the transport of DNA 
cargo by ParA polymers (Leonard et al., 2005, Lim et al., 2005, Ringgaard et al., 
2009). In case of ParF, ATP binding results in dimerization and polymerization 
which is further enhanced by ParG. Interestingly, the ParF mutants that are 
inefficient in polymerization are responsive to ParG (Barillà et al., 2005, Dobruk-
Serkowska et al., 2012). Thus ParF polymerization by ATP and ParG are 
independent of each other but are found to be additive (Dobruk-Serkowska et al., 
2012).  
 
ParG bundles polymers formed due to ParF-ATP complex and none of the partition 
deficient single amino acid ParG mutant proteins exhibited any adverse effect on 
ATP-dependent ParF polymerization i.e. bundling (Figure 5.2). If ATP is absent, 
ParG is still able to stimulate ParF self-assembly and we defined this activity of 
ParG as nucleation. In the absence of ATP, ParG mutants showed a different ParF 
polymerization pattern. ParG-L3A and ParG-K12A lost their ability to increase ParF 
polymerization in the absence of ATP (Figure 5.3 and 5.6 C and F). The exact 
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mechanism by which leu3 and lys12 facilitate ATP independent ParF polymerization 
is still elusive. Moreover, ParG-K12A also showed the weakest interaction with ParF 
among all the mutants tested (Figure 5.7). Due to the reduced ParF-ParG-K12A 
interaction, ParF may be unable to form a nucleus that responds to ATP in a suitable 
manner leading to polymerization. When in protein sedimentation assay, ParF and 
ParG mutants were incubated together, the amount of ParG mutants co-precipitated 
with ParF was found to be less (except ParG-N18A) than that of wild type ParG 
(Figure 5.6). This indicated that the residues implied in the partition defect might be 
involved in a ParF interaction. It was also observed that the presence of ATP 
enhanced ParF polymerization but did not assist in facilitating the ParF-ParG 
interaction. The level of ParF polymerization by nucleation activity was always 
found to be less compared to the bundling activity. The physiological relevance of 
the nucleation activity of ParG is not yet established. Nevertheless, this analysis 
helped us to explore the ParF-ParG interaction.  
 
In the presence of ATP, ParG enhances ParF polymerization and to do so ParG does 
not rely upon a single, specific residue of the N-terminal tail. ParG might use the 
flexible N-terminal as tentacles to bundle the ParF polymers formed by the ParF-
ATP complex (Barillà et al., 2007). Another RHH protein ParR from the R1 plasmid 
also shows a disordered tail at the C-terminus and plays an important role in 
stabilising ParM polymers. The flexible domain interacts with ParM and probably 
enforces conformational changes in the ParM polymers favourable for filament 
formation (Salje et al., 2010). It appears that the extensions in ParB proteins might 
perform a architectural role in facilitating and stabilising polymerization of the 
partner protein.  
 
In plasmid segregation, ParB proteins bound to the plasmid via the partition site 
interact with ParA proteins and form the segrosome (Hayes and Barillà, 2006b). 
Thus the ParA-ParB interaction is crucial step in plasmid segregation. The N-
terminus of a number of other ParB proteins is implicated in interaction with ParA 
proteins (Leonard et al., 2005, Ravin et al., 2003, Surtees and Funnell, 1999). The 
limited flexible region containing residues 17-23 in ParG is also speculated to be a 
determinant of ParF interaction (Golovanov et al., 2003). When ParG recruits ParF 
in the nucleoprotein complex to form the segrosome, it might use both C- and N-
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terminal domains for ParF interaction. Thus, it seems there are multiple ParF-ParG 
interfaces and interactions that are used during the plasmid segregation process. 
 
7.1.4 Stimulation of ParF ATPase activity is dependent on ParG N-
terminal domain 
Stimulation of nucleotide hydrolysis by the centromere binding partner is a unifying 
theme among ParA superfamily ATPases (Leonard et al., 2005). The ParG N-
terminal mutants showed impairment in stimulating ATP hydrolysis by ParF (Figure 
5.9). ParG is predicted to provide the basic residues that intercalate into the 
nucleotide-binding pocket of ParF, thereby promoting ATP hydrolysis (Barillà et al., 
2007). The crucial basic residues identified in the ParG N-terminus K5, K11, K12 
and R19 are located in the flexible tail, which may allow them to reach the ATP 
binding pocket of ParF during ATP hydrolysis. Arginine is also conserved in various 
other ATPase activators. In ParG, R19 acts as an arginine finger for stimulation of 
ParF ATPase activity (Barillà et al., 2007). Residues N18 and L21 are in the region 
of the arginine finger motif hence altering them might change the alignment of the 
arginine finger loop and cause impairment in stimulation of ParF ATP hydrolysis. In 
MinD proteins of various bacteria, asparagine (N45 in E. Coli MinD) is conserved 
and acts to stabilise the transition state of ATP hydrolysis (Park et al., 2012). It is 
tempting to suggest that the N18 in the ParG flexible region might be performing a 
similar role. How L3 and M13 are involved in stimulating ParF ATPase activity is 
not yet clear.  
 
Eukaryotic RasGAPs perform a similar function in enhancing Ras GTPase activity 
with an invariant arginine finger residue (Resat et al., 2001). Mutants of Ras are 
found in 25-30% of human tumours. Arg-789 of GAPs may play a dual role in 
generating the nucleophile as well as stabilizing the transition state for P-O bond 
cleavage (Resat et al., 2001). The N-terminal regions of MinE and Spo0J are 
indicated in stimulating ATPase activity of MinD and Soj respectively and 
interestingly these regions are also unstructured (Ghasriani et al., 2010, Leonard et 
al., 2005). In E. coli, MinE might provide the basic residues (R21 and K19) for 
stimulating MinD ATPase activity. The basic residue near the γ-phosphate oxygen 
may stabilise the negative charge in a transition state (Hayashi et al., 2001, Ma et al., 
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2004). A peptide containing lysine and arginine residues stimulates the ATPase 
activity of Soj (Leonard et al., 2005). In plasmid F, the ATPase activity of SopA was 
shown to be stimulated by the arginine finger R36 of partner protein SopB (Ah-Seng 
et al., 2009). The N-terminal domain of ParB protein from plasmid pB171 is also 
involved in stimulation of ParA ATPase activity (Ringgaard et al., 2009). The role of 
ParB proteins as an ATPase activator rather than a nucleotide exchanger is 
speculated to be favoured as it gives rise to monomeric ParA (Leonard et al., 2005). 
 
7.1.5 Role of the ParG N-terminus in ParF oscillation 
Analysis of ParF localisation in vivo, suggested that the ability of ParF to polymerise 
is not the only requirement for the parFGH system to function, but the ability to 
relocate dynamically in the cell is also crucial. ParF dimerizes when bound to ATP 
and ParG stimulates ParF polymerization. For ParF dynamics, the next required step 
is the dismantling of ParF polymers. ATP hydrolysis may lead to ParF 
depolymerization. ParF-eGFP was shown to oscillate over the nucleoid (Figure 6.6 
and movie S1). The cycle of assembly into polymers to carry plasmid and 
disassembly to release the cargo and relocate, is mediated by ParF oscillation. Due to 
the oscillation, ParF appeared asymmetrically distributed over the nucleoid in the 
presence of ParG bound plasmid. The plasmids were seen at 1/4 and 3/4 positions in 
case of wild type ParG, which indicates that the plasmids are placed at future mid-
cell position by ParF (Figure 6.5A). The ParG-mCherry signal in the case of all the 
N-terminal mutations appeared static in vivo showing that the ParG bound plasmid is 
not transported by ParF polymers for segregation. The ParF-eGFP was evenly 
distributed on the nucleoid in the presence of these mutants and the level of 
oscillation decreased considerably compared to wild type ParG. In the absence of 
ParF oscillation, plasmids harbouring ParG N-terminal mutations were found to be 
more randomly distributed along the cell length hence ParF oscillation appeared to 
facilitate positioning of the plasmids at the cell quarters (Figure 6.5). ParF polymers 
appeared to be cable-like structures forming a mesh in 3D-SI microscopy. The ParF-
eFGP mesh was spread evenly over the nucleoid around the plasmid foci in case of 
ParG mutants. The inert nature of plasmid when bound to mutant ParG (in the form 
of compact foci) was evident in both confocal and OMX microscopy experiments. 
Overall, similar to other ParA oscillating proteins, ParF exists in two forms, ADP-
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bound and ATP-bound states. ParF–ATP may form following the exchange of ADP 
for ATP and ParF–ADP is formed by the hydrolysis. Combining all the observations, 
it can be concluded that the impairment in stimulating ParF ATPase activity 
demonstrated by ParG N-terminal mutants may lead to a dearth in the ParF 
oscillation which causes the plasmid partition defect.  
 
Members of ParA/MinD type P loop ATPases form dimers on ATP binding which is 
required for anchoring them either to DNA or membrane (Hu et al., 2002, Hwang et 
al., 2013). In the case of MinD, the C-terminal amphipathic helix mediates 
membrane binding (Hu and Lutkenhaus, 2003), whereas the positively charged 
residues in the ParA proteins bind DNA non-specifically (Hester and Lutkenhaus, 
2007). In the ADP-bound form, ParA/MinD proteins are shown to be monomeric 
and randomly diffuse in the cell. The partner proteins ParB/MinE are activators of 
the ATPase activity of ParA/MinD proteins (Bouet and Funnell, 1999, Hu and 
Lutkenhaus, 2001). ParA ATPases polymerise due to ATP, DNA or ParB 
interactions and in vivo these proteins are found to be dynamic because of the 
polymerization and depolymerization (Leonard et al., 2005, Lim et al., 2005, 
Ringgaard et al., 2009). Chromosome segregation protein Soj in Bacillus subtilis is 
able to relocate on the nucleoid but in the absence of Spo0J, the movement ceases 
and Soj appears static on the nucleoid (Autret et al., 2001). In plasmid pSM19035, 
the N-terminal region of ω is required to stimulate redistribution of δ-GFP from the 
nucleoid to the cell poles (Pratto et al., 2008). The E. coli cell division regulator 
MinD exhibits similar oscillatory motion on a time scale of seconds due to 
membrane and MinE association (Raskin and de Boer, 1999). Thus, it can be 
supported that the movement of ParA proteins either by oscillation or by pattern 
formation is activated by ParB proteins.  
 
7.1.6 How ParG N-terminus performs multiple functions 
The data obtained for the residues crucial in plasmid partition reinforced that the 
ParG N-terminal tail is indeed multifunctional. The effect of point mutations in the 
ParG flexible tail on plasmid partition and on ParF related functions is presented in 
table 7.1.  
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The location of these residues within distinct clusters may indicate that ParG cleverly 
utilises its flexible tail to carry out multiple functions. ParG functions related to 
DNA-binding, transcriptional repression and enhancing ParF polymerization 
possibly require the entire N-terminus. The flexible domain may provide 
accessibility to the tail to reach its target of partition site, operator DNA sequence 
and the partner protein. The multifunctional nature of unstructured domain has also 
been reported in other ParB proteins e.g. P1 ParB and RK2 KorB (Rajasekar et al., 
2010, Schumacher and Funnell, 2005). 
  
On the other hand, the role of ParG N-terminus in ParF interaction, stimulation of 
ParF ATPase activity and ParF oscillation appeared to be divided among its different 
clusters. The stimulation of ParF ATPase activity by ParG maybe a result of two 
effects, which are interaction and activation. The most flexible region at the tip of the 
tail may give the tail access to reach the ATP binding pocket of ParF. The basic 
residue K5 in this region may activate ATP hydrolysis by ParF. The residue L3 may 
be involved in ParF interaction as ParG-L3A failed to form a ParF-ParG nucleus 
responsible for ParF polymerization (Figure 5.3 and 5.6). The region with residues 
K11, K12 and M13 is a linker between the most flexible and least flexible region so 
this region may serve as a hinge, which may help anchoring the arginine finger motif 
near the ATP binding pocket of ParF. ParG-K12A showed weakest interaction with 
ParF (Figure 5.3, 5.6 and 5.7). Nevertheless, being basic residues, the role of K11 
and K12 in activating ATP hydrolysis cannot be ruled out. Apart from stimulating 
ParF ATPase activity, the cluster of positively charged lysine (K11, K12) may 
perform additional roles. In E. coli MinE, the cluster of positively charged residues 
at positions 10-12 (RKK) is essential for membrane binding upon interaction with 
MinD (Hu et al., 2002). In case of the Min system, the membrane acts as a scaffold, 
similarly, in the case of the plasmid, the nucleoid acts as a scaffold. Thus, it might be 
that the lysine cluster in ParG provides additional contacts with the nucleoid upon 
interaction with ParF. Further investigation is required now for the lysine doublet. 
The residues N18, R19 and L21 in the arginine finger might be direct activators of 
ATP hydrolysis by ParF. It is also possible that the conformational changes required 
for ParF interaction are brought up by the limited flexibility and formation of 
transient secondary structure by this region. The change in asparagine at position 18 
showed the most detrimental effects on plasmid partition. The tight focus due to 
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ParF and ParG-N18A co-localisation in vivo might suggest the irreversible 
association between two proteins. It is possible that the residues in the ParG N-
terminus are strategically placed to carry out interaction and activation functions 
towards the common goal of coordinated interplay with ParF for efficient plasmid 
segregation. 
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Table 7.22 Summary of the effect
1
 caused by the ParG N-terminal mutants on various functions related to plasmid partition and ParF. 
 
Mutants Plasmid 
partition 
efficiency 
Dimerization DNA 
binding 
Transcriptional 
repression 
ParF 
bundling 
ParF 
nucleation 
ParF 
interaction 
ParF 
ATPase 
stimulation 
ParF 
oscillation 
ParG-L3A 
 
+++ + + + + +++ ++ +++ +++ 
ParG-K5A 
 
+++ + + + + ++ ++ +++ 
+++ 
ParG-K11A 
 
+++ + ++ + + ++ ++ +++ 
+++ 
ParG-K12A 
 
+++ ++ + + + +++ +++ +++ 
+++ 
ParG-M13A 
 
+++ + + + + ++ ++ +++ 
+++ 
ParG-N18A 
 
+++ + + + + + ++ +++ 
+++ 
ParG-R19A 
 
+++ ++ + + + ++ ++ +++ 
+++ 
ParG-L21A 
 
+++ + +++ + + ++ ++ +++ 
+++ 
1 The effect of ParG mutations on various functions are indicated by traffic light colour scheme, where red corresponds to severely affected 
(+++), orange to moderately affected (++) and green to not affected (+).  
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7.1.7 Plasmid partition model 
The presence of host factor in plasmid segregation has always been anticipated and 
now it has started emerging that the nucleoid could be that host factor which 
provides a scaffold for the orchestration of plasmid partition. Many ParAs bind 
nonspecific DNA in reversible fashion, which facilitates their movement on the 
nucleoid. The Par protein mediated plasmid segregation displays common features 
such as the use of a nucleoid as a scaffold, ADP or ATP bound form of ParA as a 
molecular function switch and use of disordered regions in the ParB proteins for 
stimulation of ParA ATPase activity. Discovery of the actin-type fold in type II ParA 
proteins (ParM) and tubulin-type fold in type III ParA proteins (TubZ) revealed the 
existence of bacterial cytoskeleton systems. These cytoskeletal-like proteins may 
provide the force required for plasmid segregation (Schumacher, 2012). The type I 
plasmid partition system is exemplified by ParA proteins which are Walker-type 
ATPases and proposed to be another class of cytoskeletal proteins, Walker A 
cytoskeletal ATPases (WACA) (Lowe and Amos, 2009). However, WACA proteins 
have no eukaryotic homologues. The segregation mechanism involved in the type I 
plasmid partition system mediated by ParA ATPases is still debated. As ParA is 
spread on the nucleoid, it pulls the plasmid in one direction but at the same time 
ParA depletion zone forms on the other side. Mathematical modelling has indicated 
that the continuous rounds of ParA assembly and disassembly are adequate for 
segregation of plasmids (Lutkenhaus, 2012). The assembly and disassembly has 
been demonstrated in vivo and in vitro but whether it is mediated by ParA 
polymerization or ParA gradient is still debated (Hwang et al., 2013; Ringgaard et 
al., 2009). The diffusion-ratchet mechanism is proposed for P1 plasmid partition 
whereas for the pB171 plasmid system a pulling model for segregation has been 
suggested. The presence of ParA polymers is also questioned in the P1 plasmid. In 
the present study, we reconfirmed the polymerization characteristic of ParF, but in 
contrast to the single filament reported for pB171 ParA protein, we found that ParF 
forms a web of cable-like polymers over the nucleoid. Based on the findings, a new 
model for plasmid partition is presented here (Figure 7.2).  
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Upon binding ATP, ParF dimerises and this may be the form favoured to bind the 
nucleoid. ParG binds to the partition site parH on the plasmid. When ParF in 
association with the nucleoid encounters the ParG-plasmid complex, ParF-ParG 
interaction results in segrosome formation. ParG may stimulate extensive ParF 
polymerization which might result into remodelling of ParF polymers in the form of 
a mesh. The ParG-plasmid cargo becomes embedded in the ParF mesh. ParG at low 
concentrations may enhances ParF polymerization but at high concentrations 
stimulates ParF ATPase activity (Barillà et al., 2005). ParF has weak intrinsic 
ATPase activity and it needs ParG N-terminus for ATPase stimulation. Our data 
suggest that the lack of ParF ATPase activity abolishes ParF oscillation. ParF 
depolymerization results in the disassembly of the mesh and then ParF re-assembles 
on the other side of the nucleoid (Figure 7.2). The ParG-plasmid cargo follows ParF 
over the nucleoid and the cycle restarts. Thus, ParF oscillates from pole to pole on 
the nucleoid and transports the plasmid for segregation. ParG bound to the plasmid 
via the centromere site is required for ParF oscillation and in turn, oscillation helps 
the plasmid to be placed in a position suitable for segregation. According to our 
model, the ParF assembly and disassembly is mediated by the ParG N-terminus. 
Alterations in the N-terminus residues bring out the adverse changes in ParF 
localisation and oscillation. ParF polymers may remain distributed evenly on the 
nucleoid or are locked with ParG mutant protein as a compact body. Depending upon 
our data, we proposed that the functional ParG N-terminal tail is a prerequisite for 
ParF oscillation and plasmid segregation. 
 
The importance of the unstructured domain in ParB proteins thus can be extended to 
the ParA oscillation or relocation in plasmid partition in various systems. The ParB 
proteins are structurally unrelated and their modes of action differ from each other 
for DNA binding and interaction with other partner factors. The presence of 
unstructured regions among ParB proteins emerges to be essential and common 
requirement for partitioning. The dynamics of plasmid segregation investigated in 
this study may also provide insights into chromosome segregation and may lead to 
the discovery of novel molecular targets to combat antibiotic resistance. 
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Figure 7.2. Plasmid partition model.  
A. ParF in complex with ATP forms a dimer and may become associated with the nucleoid. ParG bound to the plasmid interacts with ParF and may enhance 
ParF polymerization and remodel ParF polymers to form a mesh. ParG stimulates ParF ATPase activity through the N- terminus, which may lead to 
disassembly of the ParF polymers and release of ParF-ADP. ParF again forms a complex with ATP and binds nucleoid on the other side. The ParG-plasmid 
cargo is transported from one side to the other on the nucleoid by ParF oscillation. B. If the ParG N-terminal residues are altered (denoted by purple stars ) 
ParF polymers may distribute evenly on the nucleoid or maybe in some cases ParF is locked as an overlapping focus without any oscillatory movement hence 
lead to a stagnant plasmid. 
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7.2 Future work 
The ParG N-terminal tail is multifunctional and utilises multiple mechanisms for 
carrying out these functions. To move forward with this acquired knowledge about 
the parFGH partition system, different aspects need to be investigated further. 
 
DLS and sedimentation assays monitored ParF polymerization but the nature of the 
polymers formed was not detectable. High-magnification Electron Microscopy (EM) 
images showed that ParF fibres assembled in the presence of ParG were thicker and 
longer than those observed in its absence (Barillà et al., 2005). Even though ParG 
mutants showed efficiency in stimulating ParF polymerization the ParF polymers 
formed in the presence of ParG mutant proteins might not be as thick as those 
assembled in the presence of WT ParG. In the absence of ATP, ParG stimulated ParF 
polymerization and some of the mutants showed small increase in ParF 
polymerization but whether the polymers formed are of the same nature or not is yet 
to be tested.  
 
The ParF-ParG interaction is crucial step in plasmid segregation. The bacterial two-
hybrid assay was able to indicate a weak interaction between ParF and ParG mutants 
in a semi-quantitative manner but to dissect the exact role of individual amino acid in 
plasmid partition, more detailed interaction studies need to be carried out. Initial 
attempts were made to check the ParF-ParG interaction by Surface Plasmon 
Resonance (SPR), Isothermal Titration Calorimetry (ITC) and MicroScale 
Thermophoresis (MST). The self-association of ParF and oligomerization of ParG 
posed critical problems in performing the interaction studies. However, optimising 
experimental conditions will assist in gaining more knowledge about the interaction 
pattern of the ParG mutants. 
  
ParF has been shown to spread over the nucleoid, which indicates that ParF also 
binds DNA non-specifically. This additional factor in the ParF dynamics needs to be 
examined further by performing the ParF polymerization and ATPase activity studies 
in the presence of DNA. It will be interesting to find out the effect of DNA on the 
ParG mediated activation of ParF polymerization, ATPase activity and subsequently 
the influence on the functions of ParG N-terminus. This will help to gain more 
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insight into the mechanism of how the unstructured domain of ParG assists in 
plasmid partition.  
 
The localisation of ParF and ParG investigated by using fluorescent tagging system 
was instrumental in this study to build a plasmid partition model. However there are 
still some questions that remain unanswered. The time required for actual plasmid 
segregation and how it is coupled with bacterial cell division has not yet been 
established. The set up still needs to be optimised to mimic the actual physiological 
conditions of plasmid maintenance in the cell. OMX contributed to find out the exact 
nature of ParF protein over the nucleoid. Time-lapse experiments can also be 
performed in OMX which can help to check and analyse ParF mesh over the time. 
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Abbreviations 
 
E. coli - Escherichia coli 
kbp - kilobase pairs  
LZ - leucine zipper like 
HTH - helix-turn-helix motif 
θ - theta 
TA - toxin-antitoxin  
ATP - adenosine 5-triphosphate 
CBP - centromere binding protein 
RHH - ribbon-helix-helix 
IHF - integration host factor 
IR - inverted repeat 
OF - operator site 
AMPPCP - phosphomethylphosphonic acid adenylate ester 
EM - electron microscopy 
LB - luria-bertani  
dNTPs - deoxynucleotide triphosphates 
BSA – bovine serum albumin 
DLS - dynamic light scattering 
ONPG - O-nitrophenyl-β-d-galactopyranoside 
EMSA - electrophoretic mobility shift assay 
SDS-PAGE - sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
kDa – kilo dalton 
TLS - thin layer chromatography 
DAPI - 4', 6-diamidino-2-phenylindole 
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3D-SIM - 3 dimensional structured illumination microscopy 
MHP - molecular hydrophobicity potential 
MW - molecular weight 
SEC-MALLS - multi angle laser light scattering 
DMP - dimethyl pimelimidate 
CDO - catechol 2-3 dioxygenase 
WACAs - walker A cytoskeletal ATPases 
SPR - surface plasmon resonance 
ITC - isothermal titration calorimetry 
MST - microscale thermophoresis 
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